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1.1.Learning and memory  
Since ancient times, humans have tried to discover how memory works. Culture, complex 
societies or science exist thanks to human cognitive abilities. These achievements enable us to 
transmit information across generations and develop a cognitive complexity that is essential for 
survival and distinct than other organisms. Several theories and definitions of memory have 
been described, but the precise mechanism and universal definition remain to be elucidated 
(Spear & Riccio, 1994). Memory was considered to be a location where the information is stored 
(Stern, 1991). It was also defined as a process by which new experiences are encoded (learn) 
and stored so that the information can be retrieved (Lechner, Squire, & Byrne, 1999; Melton, 
1963; Sternberg & Sternberg, 2017; Tulving & Thomson, 1973). Memory was also defined as a 
group of activated cells during learning that persistently change their conditions to retain the 
information and can be reactivated it (memory engrams) (Semon, 1911).  
1.1.1.Classification of memory 
Memory can be classified following different criteria. The Atkinson-Shiffrin model postulates that 
the memory can be classified by time of retention as short-term and long-term memory (James, 
1950). Short-term memory (STM) retains the information for a short time, from seconds to 
minutes. The time is variable between subjects and studies (Cowan, 2008). It was suggested 
that STM could retain information of up to 7 items (G. A. Miller, 1956) and was considered to be 
part of working memory, but nowadays this is an independent type. Working memory 
participates in the manipulation of information for complex tasks (Baddeley, 2010; Chai, Abd 
Hamid, & Abdullah, 2018). During the consolidation phase, STM is converted to long-term 
memory (LTM) (Lechner et al., 1999). This phase consists of two principal mechanisms, synaptic 
and system consolidation (Dudai, 2004). Synaptic consolidation is a short process of 
stabilization (minutes to hours), whereas the system consolidation is a long process (weeks or 
more). During this last step, neurons in the cortical areas increase the number of signals and 
connections, till different neurons fire together (Dudai, 2004). It is possible with a process known 
as long-term potentiation (LTP). Long-term memory (LTM) can be stored for long periods of time 
inducing changes on synaptic connections (Atkinson, 1967; Brashers-Krug, Shadmehr, & Bizzi, 
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1996; Dudai, 2004; Jonides et al., 2008; McGaugh, 2000). Long-term memory can be 
distinguished as declarative  (similar as explicit) and non-declarative (similar as implicit) (Squire, 
1987; E. Tulving, 1985). Tulving introduced these new terms of declarative and non-declarative 
memories (E. Tulving, 1985; Tulving & Thomson, 1973). Graff and Schacter described for the 
first time implicit and explicit terms in 1985 (Graf & Schacter, 1985). Declarative or explicit 
memory is based on daily memories, which can be semantic memories, when are relate to facts, 
and episodic memories, when are related to an event on specific space and time (Endel Tulving, 
1985). One subtype of episodic memory is the autobiographical memory, and it refers to the 
retention of experiences of our own life (Conway & Pleydell-Pearce, 2000; Fivush, 2011). Non-
declarative or implicit memories generally are acquired without the intention to be learned by 
repetition and practice. These memories are unforgettable allowing humans to develop daily 
activities. There are different subtypes of non-declarative memories related to different 
conditions: priming, habits, skills, emotional response, skeletal musculature and habituation 
(Figure 1.1) (N. J. Cohen & Squire, 1980; Eichenbaum & Cohen, 2004; Gazzaniga, Ivry, & 
Mangun, 2002). 
Figure 1.1. Classification of memory.  
Classification of long-term memory and brain regions involved. Figure adapted from (Brem, Ran, & 
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1.1.2.Hippocampus in learning and memory 
Several clinical, brain imaging and brain region lesion studies indicate that many brain regions 
play a different role in distinct types of memory (Binder & Desai, 2011; N. J. Cohen, 
Eichenbaum, Deacedo, & Corkin, 1985; N. J. Cohen & Squire, 1980; Doyon et al., 2009; 
Eichenbaum, 2001; Eichenbaum & Cohen, 2004; Gazzaniga et al., 2002; Hikosaka, Nakamura, 
Sakai, & Nakahara, 2002; Wixted et al., 2018). Memories defined as non-declarative are more 
likely to be conducted for the cerebellum, basal ganglia, amygdala and motor cortex (N. J. 
Cohen & Squire, 1980; Doyon et al., 2009; Eichenbaum & Cohen, 2004; Gazzaniga et al., 2002; 
Hikosaka et al., 2002; LeDoux, 2003), whereas the medial temporal lobe (hippocampus) and the 
neocortex have been more associated with declarative memories (Binder & Desai, 2011; 
Eichenbaum, 2001; Wixted et al., 2018). Several studies in rodents showed the alteration of the 
amygdala in implicit fear memory (LeDoux, 2003; Rogan, Leon, Perez, & Kandel, 2005). One of 
the first studies that demonstrated the importance of temporal lobe (hippocampus) in declarative 
memory was the study of the patient Henry Molaison (H.M.) in 1957 (Scoville & Milner, 1957). To 
treat his epilepsy, the medial temporal lobe, the hippocampus and the amygdala were removed. 
After this surgery, his epilepsy was reduced, but he could not retain memories for long-term, only 
for short-term (Scoville & Milner, 1957). These findings suggest that temporal lobe 
(hippocampus) play an important role in the consolidation of declarative memories (Poldrack et 
al., 2001; Squire, 1986; Squire, Stark, & Clark, 2004). Hippocampus brain region is part of the 
medial temporal lobe in humans and is essential for acquisition and consolidation of memory 44. 
The specific hippocampal function in semantic (familiarity) or episodic (recollection) memory is 
still controversial (Jacoby & Dallas, 1981; O'Reilly & Norman, 2002), due to the complexity to 
identify specific neuron activation involved in new connections. Hippocampal neurons, known as 
place cells, are involved in spatial processing (Ekstrom et al., 2003; Moser, Kropff, & Moser, 
2008; O'Keefe, 1976). The activation of these cells provide information of the spatial position of 
the animal in the brain (O'Keefe & Dostrovsky, 1971; Saleem, Ayaz, Jeffery, Harris, & Carandini, 
2013), replay experiences of the past (A. K. Lee & Wilson, 2002; Skaggs & McNaughton, 1996) 
and build new trajectories (Gupta, van der Meer, Touretzky, & Redish, 2010). The stability of this 
spatial memory depends on the attention level (Frank, Brown, & Wilson, 2000; Kentros, 
Agnihotri, Streater, Hawkins, & Kandel, 2004; Muzzio, Kentros, & Kandel, 2009). Cell grids from 
entorhinal cortex also play an important role in spatial representation, providing information 
about the position, direction and distance (Fyhn, Molden, Witter, Moser, & Moser, 2004; Moser et 
al., 2008). The memory activity of entorhinal cortex (EC) has also been investigated in imaging 
studies (Suzuki, 2009). There are at least two pathways that connect the hippocampus with EC.  
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The hippocampus brain region from humans is divided into Cornu Ammonis (CA1, CA2 and 
CA3) and Dentate Gyrus (DG), which are interconnected. An indirect pathway, known as the 
perforant path, connect the EC (layer II) with the DG, then the DG is connected to the CA3 by 
mossy fibers and finally to CA1 by Schaffer collateral connections (Amaral & Witter, 1989). A 
direct pathway, known as temporoammonic pathway, connects EC (layer III) to CA1 (Witter, 
Groenewegen, Lopes da Silva, & Lohman, 1989) (Figure 1.1.). It seems that part of the 
hippocampal memory role is due to the adult neurogenesis in DG, but the precise mechanism 
remains to be elucidated (Dupret et al., 2007; Kropff, Yang, & Schinder, 2015; Lazarov & 
Hollands, 2016). Moreover, hippocampus region is also highly connected with other cortical and 
subcortical brain regions, such as basal ganglia (Atallah, Frank, & O'Reilly, 2004), cerebellum 
(Onuki, Van Someren, De Zeeuw, & Van der Werf, 2015), prefrontal cortex (J. Jin & Maren, 
2015), hypothalamus (Aggleton et al., 2010) and the amygdala (Hill, Sahay, & Hen, 2015; Sahay 
& Hen, 2007). Furthermore, hippocampus subregions also participate in spatial working memory 
(Olton, Walker, & Gage, 1978; Squire & Cave, 1991), navigation to a specific item (Broadbent, 
Squire, & Clark, 2006; R. Morris, 1984) and contextual fear memory (Anagnostaras, Maren, & 
Fanselow, 1999; S. H. Lee et al., 2012). Finally, the hippocampus and its connections are 
affected at early stages of Alzheimer’s disease and during the process of aging. Several studies 
found amyloid plaque deposition, neuronal loss and reduction of neuronal density in the 
hippocampus of human brain and mouse models of AD. The gradual loss of memory in AD 
cases was directly associated with alterations in the hippocampus (Arlt et al., 2013; Bonner-
Jackson, Mahmoud, Miller, & Banks, 2015; Padurariu, Ciobica, Mavroudis, Fotiou, & Baloyannis, 
2012). 
 
Figure 1.2. Hippocampus subregions and circuit connections.  
Hippocampus is formed by cornus ammonis (CA1, CA2 and CA3) and dentate gyrus (DG). The entorhinal 
cortex (EC) is connected to the CA1 via temporoammonic pathway and DG via the perforant pathway. 
Then, DG connects to CA through mossy fibers. Representation adapted from (E. R. Kandel, Dudai, & 





















1.1.3.Molecular mechanisms involved in learning and memory 
 Cellular and molecular mechanisms involved in memory and learning process have been 
actively investigated; however, the precise mechanisms remain to be elucidated. In 1949, Hebb 
theories established the bases of current theories of learning and memory. He considered that 
continuous presynaptic neuron stimulations excite the postsynaptic neuron inducing metabolic 
changes that increase the strength of the synapse during learning and memory (Hebb, 1949). 
From his postulations and based on an experimental approach in rabbit hippocampus, it was 
discovered that high-frequency synapse stimulations induce changes in the strength of these 
synapses that persist different days. This process was defined as long-term potentiation (LTP) 
(Bliss & Lomo, 1973; Lomo, 1966). LTP process is complemented with long-term depression 
(LTD) (Dudek & Bear, 1992). These processes of synaptic strength (synaptic plasticity) are the 
bases of memory engram formation. The induction of LTP varies in different brain regions and 
some subregions, such as CA1, which depends on N-methyl-D-aspartate receptors (NMDA). 
One of the first pharmacological investigations about spatial learning and LTP induction confirm 
that the inhibition of NMDA receptors block LTP induction and promote spatial cognitive 
impairments in Morris Water Maze task (Butcher, Davis, & Morris, 1990). The activation of 
NMDA receptors induces a postsynaptic Ca2+ influx necessary to produce LTP (E. R. Kandel, 
2001; Malenka & Bear, 2004). The proportion of Ca2+ transferred determines the strength of the 
synaptic connections (Madison, Malenka, & Nicoll, 1991; Malenka & Nicoll, 1999). These 
changes promote the activation of protein kinases, such as CaMKII, PKC, PKA, MAPK (Malenka 
& Bear, 2004), phosphatases (PP1 and Calcineurin) and the incorporation of AMPA receptors 
into the synapse membrane (Soderling & Derkach, 2000). The activation of AMPA receptor 
increases the amplitude of excitatory postsynaptic potentials (fEPSs). LTP is maintained for days 
and requires the synthesis of new proteins, induced by different protein kinases (PKA and 
MAPK) that stimulate different transcription factors (TFs), such as CREB-1 (Abel et al., 1997; 
Frey, Huang, & Kandel, 1993).  The activation of TFs promotes the activation of several RNA 
polymerases and therefore the synthesis of new proteins, which is a crucial step for the 
formation of new synaptic connections. Long-term memories require the synthesis of new 
proteins (H. P. Davis & Squire, 1984), whereas short memories require only posttranslational 
modifications (Routtenberg & Rekart, 2005). Moreover epigenetic factors regulate protein 
synthesis, such as histone modifications during the formation of long-term memory (Guan et al., 
2002). In summary, synaptic plasticity, gene expression and protein synthesis are essential 




Alzheimer’s disease (AD) is a neurodegenerative disorder that affects millions of people around 
the world. According to the World Alzheimer’s Report 2015, 47.47 millions of people worldwide 
showed symptoms of dementia in 2015, and it is expected to increase to 131.5 million of cases 
in the next 30 years (Figure 1.3A) (Prince et al., 2015). In the last decades, the expectancy of 
life and also the incidence of age-related diseases have raised. The main characteristic of age-
related diseases is that the number of cases rises exponentially along age. Alzheimer’s disease 
is part of this group of pathologies. According to the World Alzheimer’s Report 2015 (Prince et 
al., 2015), the number of cases in Europe in 2015 at the age of 65-74 was around 0.9%, from 75 
to 79 was 5.8% and more than 85 years old was 24.5% (Figure 1.3B). The prevalence of AD 
cases in women is higher than in men (Mielke, Vemuri, & Rocca, 2014; Vina & Lloret, 2010). 
Figure 1.3. Incidence and prevalence of dementia cases.   
(A) Number of dementia cases worldwide reported in 2015 and estimated in 2050. (B) Prevalence of 
cases of dementia in an age-specific range in Europe. Graphics were adapted from World Alzheimer’s 
Report 2015 (Prince et al., 2015).  
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1.2.2.Pathology of Alzheimer’s disease 
Alzheimer’s disease (AD) is the most common form of dementia. The most common alterations 
in AD are the loss of neurons and synaptic connections, neuroinflammation, reduction of the 
volume of the brain and oxidative stress (Bradshaw et al., 2013; Fox et al., 1996; Guerreiro et 
al., 2013; Hamos, DeGennaro, & Drachman, 1989; Jack et al., 2004; Katzman & Saitoh, 1991; 
C. Y. Lee & Landreth, 2010; Markesbery, 1997; Scheff, Price, Schmitt, & Mufson, 2006). The 
main visible signs are the loss of memory, difficulties in planning and solving problems, 
challenges to conclude daily activities, time and space confusion, difficulties with language, 
agitation and alterations of mood and personality (Reisberg, Ferris, de Leon, & Crook, 1988). 
The external symptoms advance dramatically from Mild Cognitive Impairment (MCI) to severe 
stages during the progression of the pathology and can be categorized into six Braak stages (I-
VI) depending on the deposition of tau protein in postmortem brain. At early AD stages, tau 
protein is detected in transentorhinal and entorhinal regions (I-II). Then, it is localized in limbic 
allocortex and neocortex at III-IV stages. Lastly, during V-VI stages, tau protein is spread 
throughout the neocortex (Braak, Alafuzoff, Arzberger, Kretzschmar, & Del Tredici, 2006; Braak 
& Braak, 1991). 
There are two forms of Alzheimer’s, the familiar or early-onset (eoAD) and the sporadic or late-
onset (loAD). The first form normally appears at early age, before 65 years, and accounts for 
small percentages of cases. The first form is linked to genetic mutations that affect gene for 
presenilin 1 or 2 (PS1 or 2) and amyloid precursor protein (APP) (Goate et al., 1991; Levy-Lahad 
et al., 1995; Rogaev et al., 1995; Sherrington et al., 1995). These genes show multiple mutations 
in different codons. For example, APP showed several mutations at codon 670/671, 692 or 717 
(Goate et al., 1991; L. Hendriks et al., 1992; Levy et al., 1990). Since these mutations have been 
directly connected to one form of Alzheimer’s disease, several groups have used these 
mutations to produce models of AD (Andorfer et al., 2003; Duff et al., 1996; Hsiao et al., 1996; 
Oakley et al., 2006; Pearson & Choi, 1993; Quon et al., 1991; Sandhu, Salim, & Zain, 1991). 
The second form of AD, sporadic form, is the most frequent and appears typically after 65 years 
old. Several factors cause the pathogenesis of LoAD, and it does not exist a direct connection 
with previously described genetic mutations, but it is strongly influenced by genetic components, 
such as ε4 allele from the apolipoprotein E gene (APOE- ε4) (Strittmatter et al., 1993).   
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1.2.3.Molecular mechanisms of Alzheimer’s disease 
Dr. Alois Alzheimer characterized “presenile dementia” for the first time in 1906. One of his 
patients was Auguste Deter, who suffered from memory loss, confusion and language difficulties. 
Once she died in 1906, he discovered that the autopsied brain contained dense formations 
outside the neurons and internal accumulations of filaments or tangles (Alzheimer, Stelzmann, 
Schnitzlein, & Murtagh, 1995; Hippius & Neundorfer, 2003). Afterward, these aggregations were 
considered to play an essential role in the pathology. The extracellular aggregation of protein 
beta-amyloid (Aβ) is currently known as Aβ plaques, and the intracellular aggregation of 
hyperphosphorylated protein tau is named as neurofibrillary tangles. In 1985 and 1987 amyloid 
precursor protein (APP) and microtubule-associated protein tau (MAPT, coding for tau protein) 
genes and proteins were identified (Goldgaber, Lerman, McBride, Saffiotti, & Gajdusek, 1987; 
Kang et al., 1987; Masters et al., 1985; Tanzi et al., 1987; Weingarten, Lockwood, Hwo, & 
Kirschner, 1975). Since 1987 several studies have been investigated the physiological functions 
of APP, an integral type I transmembrane protein; however, the main function remains unclear. 
APP coding protein has been linked to cell and synaptic adhesion (Beher, Hesse, Masters, & 
Multhaup, 1996; Soba et al., 2005), trophic and synaptic activity (Bell, Zheng, Fahrenholz, & 
Cuello, 2008), neurogenesis (Rohe et al., 2008) and iron export (Duce et al., 2010). 
The APP is cleaved by several secretases in different positions (α-, β- and γ-secretase) to obtain 
different amyloid peptides. Specifically, Aβ peptide is formed by cleavage of β-secretase 
(BACE-1) and then γ-secretase (Haass, Hung, Schlossmacher, Teplow, & Selkoe, 1993). Υ-
secretase cleaves at different levels of the C-terminal, producing different isoforms with distinct 
lengths (Figure 1.4). Around 34 to 50 forms of APP have been identified (Kummer & Heneka, 
2014; Takami et al., 2009). To note, these distinct forms show different levels of 
amyloidogenesis. The specific role of these peptides or aggregation forms at physiological or 
pathological state remains to be elucidated. There is new evidence confirming the role of these 
amyloid forms in AD pathology (Selkoe & Hardy, 2016), and therefore amyloid forms are still 
therapeutic targets (Hardy & Selkoe, 2002). The most common isoforms are Aβ40 and Aβ42. At 
physiological state, Aβ40 isoform is higher expressed than Aβ42. In contrast, Aβ42 isoform is 
linked to the pathological state, probably because this last isoform is more hydrophobic and is 
more prone to aggregate than Aβ40 (Haass & Selkoe, 2007; Jarrett, Berger, & Lansbury, 1993). 
Mutations in PS1 or APP genes increase the proportion of Aβ42 peptide (Scheuner et al., 1996; 
Y. I. Yin et al., 2007). Following cleavage steps, all isoforms of the APP are released to the 
extracellular environment. Mature peptides can accumulate inside the neurons forming from 
soluble oligomers till fibrils that aggregate in insoluble plaques (Serpell, 2000). This plaque 
formation is correlated with a decrease of intraneuronal Aβ levels (Mori et al., 2002; Oddo, 
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Caccamo, Smith, Green, & LaFerla, 2006). Although there is an apparent increased of beta-
amyloid plaques in AD patients, it is still not clear the impact of oligomers and plaques on the 
progression of the disease (Hardy & Selkoe, 2002; Puzzo & Arancio, 2013). Some studies 
revealed that Aβ oligomers promote LTP deficits in the hippocampus (Gong et al., 2006) and 
cognitive decline (Cleary et al., 2005).  
Figure 1.4. Schematic representation of APP processing and Aβ aggregation.  
The APP is cleaved by α-, β- and γ-secretases in different steps synthesizing different amyloid peptides 
that can form oligomers and plaques. Figure was adapted from (Eric R. Kandel, 2013). 
Alois Alzheimer also identified an intracellular structure known as neurofibrillary tangles (NFT). In 
1980, it was described that NFT were composed of aggregates of tau proteins that were 
hyperphosphorylated (Goedert, Wischik, Crowther, Walker, & Klug, 1988; Grundke-Iqbal et al., 
1986; Ihara, Nukina, Miura, & Ogawara, 1986; Kosik, Joachim, & Selkoe, 1986).  Tau protein 
belongs to the family of microtubule-associated protein (MAP), and it is abundant in the central 
nervous system, where it participates in the assembly of tubulin into microtubules and 
stabilization of their structure (Grundke-Iqbal et al., 1986; Mietelska-Porowska, Wasik, Goras, 
Filipek, & Niewiadomska, 2014; Weingarten et al., 1975). There are different isoform variants of 
tau that come from the same gene, but different alternative splicing forms (Niblock & Gallo, 
2012). These isoforms showed different tubulin-binding repeats (Goode, Chau, Denis, & 
Feinstein, 2000; M. Lu & Kosik, 2001). Under a pathological state, there is an unbalance of 
dephosphorylated and phosphorylated levels of tau, increasing the number of 





























Mandelkow, 2012). These alterations increase the number of single tau fractions and posterior 
lead to fibrillation and aggregation of tau (Figure 1.5) (Kuret et al., 2005). From Alois Alzheimer, 
the relation between tau-pathology and Alzheimer’s disease has repeatedly been investigated 
(Blurton-Jones & Laferla, 2006; Oddo, Caccamo, Tran, et al., 2006). However, the mechanism 
involved remains to be fully characterized. An alteration of the physiological status of tau protein 
promotes changes in axonal transport leading to a synaptic dysfunction and neurodegeneration 
(Roy, Zhang, Lee, & Trojanowski, 2005; Trojanowski, Smith, Huryn, & Lee, 2005). A previous 
study has shown that a reduction of physiological tau protein improves Aβ-induced deficits in a 
mouse model of AD (Rapoport, Dawson, Binder, Vitek, & Ferreira, 2002). 
Figure 1.5. Schematic representation of the stabilization of microtubules by tau protein.  
Hyperphosphorylation of tau induces aggregation and formation of neurofibrillary tangles.  Figure adapted 
from (Brunden, Trojanowski, & Lee, 2009). 
1.2.4.Mouse models of Alzheimer’s disease 
The selection of which animal model will be used depend on several factors. Among these 
factors are taxonomy shared with humans, life expectancy, genome, level of manipulation, size 
and economic costs. In the last decades, the number of animal models increased exponentially. 
One of the most commonly used animals is mouse species, more precisely Mus musculus. 
Animal models are necessary to investigate the pathology and molecular mechanisms of several 
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human diseases. Specifically, these models are essential for studying human regions that are 
inaccessible, such as brain region, which can be only investigated in human postmortem tissues. 
For the last decades, different types of AD models have been generated to mimic certain 
pathological symptoms and to further elucidate the biological basis of AD and the potential 
targets for treatments (Allen et al., 2002; Oakley et al., 2006; Radde et al., 2006).  
First transgenic mice were based on the early-onset AD, overexpressing one or multiple 
mutations of human genes involved in the familial AD, such as amyloid precursor protein (APP) 
and presenilin 1 (PS1). In 1991, first models expressed high levels of Aβ, overexpressing the 
isoform β-APP751, C-100 fragment of the human APP or the entire human APP (Pearson & 
Choi, 1993; Quon et al., 1991; Sandhu et al., 1991). These models showed high levels of Aβ, but 
they did not show other characteristics from AD brains.  After these first models, new models 
were designed for expressing human mutated genes associated with specific promoters. 
Mutations such as London (V717I) (Goate et al., 1991; "Molecular classification of Alzheimer's 
disease," 1991), Swedish (K670N and M671L) (Mullan et al., 1992) or Arctic (E693G) (Kamino et 
al., 1992) have been used to produce several models of AD. Mutations of PS1 were also used to 
design models of AD, such as L286V (Sherrington et al., 1995) or M146L (Duff et al., 1996). 
Models of AD with single (APP, PS1 or TAU) (Andorfer et al., 2003; Duff et al., 1996; Hsiao et al., 
1996), double (APP and PS1) (Holcomb et al., 1998; Jensen, Mottin, Cracchiolo, Leighty, & 
Arendash, 2005; Radde et al., 2006), triple mutated-genes (APP, PS1 and TAU) (Oddo et al., 
2003) or even more mutations were generated (Oakley et al., 2006). For example, one model 
currently used is 5XFAD that carries 5 FAD mutations in the APP (K670N/M671L/I716V/V717I) 
and PS1 (M146L/L286V) regulated by Thy1 promoter (Oakley et al., 2006). The 5XFAD model 
shows an increase of intraneuronal Aβ content and extracellular plaque deposition, neuronal 
loss in cortical layer 5 (not in the hippocampus), age-dependent motor impairments and working 
memory decline (Oakley et al., 2006). Another well-established mouse model of AD is 
APPPS1-21, which contains a double Swedish mutation in APP and L166P mutation in PS1 and 
is regulated by Thy1 promoter (Radde et al., 2006). This model exhibits human APP protein, 
neuronal loss, alterations in LTP and amyloid plaque deposition (Gengler, Hamilton, & Holscher, 
2010; Radde et al., 2006). Formation of plaques was firstly observed in neocortex after 2 
months, DG at 3 months and CA1 at 5-6 months. Different studies tested this model in different 
tasks and they observed cognitive deficits at different ages and behavior tasks (Govindarajan, 
Agis-Balboa, Walter, Sananbenesi, & Fischer, 2011; Radde et al., 2006; Serneels et al., 2009). It 
was reported that these mice show impairments in reversal learning of a food-rewarded four-arm 
spatial maze at 8-months of age (Radde et al., 2006). Besides, APPPS1-21 mice showed spatial 
learning and memory deficits in Morris water maze at 7-8 months and alterations of associative 
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memory in fear conditioning paradigm at 12-months of age (Govindarajan et al., 2011; Serneels 
et al., 2009; Zovoilis et al., 2011). 
1.2.5.Diagnosis and treatment of Alzheimer’s disease 
One of the main difficulties to treat or diagnose Alzheimer’s disease (AD) is that is more likely a 
multifactorial process, which starts years before the external symptoms are detectable (Bateman 
et al., 2012). From 1984, Alzheimer’s disease cases have been diagnosed based on clinical 
observations, conduct test of memory, patient record and information from family members (G. 
McKhann et al., 1984). Nowadays, the criteria established in 1984 have been redefined, and 
new tools are used to detect the pathology, performing medical tests (blood and urine tests) or 
using brain scans such as magnetic resonance imaging, computed tomography or positron 
emission tomography (Frisoni, Fox, Jack, Scheltens, & Thompson, 2010; Hort et al., 2010; G. M. 
McKhann et al., 2011; Sen, Majumder, Arora, Yadu, & Chakrabarti, 2017; X. Y. Zhang, Yang, Lu, 
Yang, & Zhang, 2017). However, it does not exist a fix protocol for AD diagnosis, since the 
results using different techniques show controversial values. More studies are necessary to 
obtain a precise diagnostic (Dolci et al., 2017; Sperling & Johnson, 2013). Besides, it does not 
exist an effective treatment to prevent or cure AD. Currently, the only pharmacological 
treatments that exist try to reverse symptoms associated with the pathology of AD, but not to 
reduce or stop the neuronal loss responsible for the progression of Alzheimer’s symptoms 
(Lane, Hardy, & Schott, 2017).  Thus, it is important to investigate further the molecular 
mechanisms involved in the pathology and redefine the treatment approach based on the fact 
that AD is a multifactorial disease (Hampel et al., 2018; Weinstein, 2018). Another system to 
prevent the pathology is reducing daily habits that promote specific modifiable risk factors 
associated with Alzheimer’s disease (D. E. Barnes & Yaffe, 2011).   
1.2.6.Risk factors for Alzheimer’s disease 
Several risk factors were linked to Alzheimer’s disease including, aging, genetic factors, heart 
diseases, diabetes, stroke, hypertension, high cholesterol, smoking, diet, exercise or level of 
education (Appleton, Scutt, Sprigg, & Bath, 2017; Moonga et al., 2017; Profenno, Porsteinsson, 
& Faraone, 2010; Sah, Lee, Jang, & Park, 2017; Saito, Diaz, Chung, & McMurtray, 2017; Sharp 
& Gatz, 2011). There are intrinsic risk factors that cannot be modified, such as aging, familial 
predisposition or genetic factors. One of the most relevant factors is aging. The probability to 
develop Alzheimer’s disease increases dramatically with age (Prince et al., 2015). Regarding 
genetic factors, one example is APOE-ε4 protein, which is part of a cholesterol transporter 
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family. There are three variants of APOE protein; the most frequent is APOE-ε3, but individuals 
that carry APOE-ε4 showed major risk to develop AD and number of plaque deposition than 
APOE-ε3 (Bales et al., 1997; Corder et al., 1993; Strittmatter et al., 1993). The modifiable risk 
factors are related to cardiovascular diseases (hypertension, high cholesterol, diabetes, obesity) 
(Appleton et al., 2017; Moonga et al., 2017; Profenno et al., 2010) and quotidian habits 
(smoking, diet, exercise and education) (Sah et al., 2017; Saito et al., 2017; Sharp & Gatz, 
2011). For example, an increase of insulin levels has been linked to increased levels of APP 
(Farris et al., 2003). Moreover, epidemiological studies showed that exercise reduces the risk of 
AD by half (Rolland, Abellan van Kan, & Vellas, 2008). 
1.2.7.Gene expression and exon usage associated with AD  
The expression of specific genes at specific time establishes the full functions of a cell by 
encoding proteins. Thus, mRNA molecules reflect the cellular state at a specific time.  The 
process of gene expression is extremely regulated and this regulation determines the production 
of a certain amount of specific proteins (Neaves, 2002). François Jacob and Jacques Monod 
were the firsts to show a model for regulation of protein synthesis in 1961. They investigated 
how a bacteria regulate the synthesis of an enzyme called beta-galactosidase (Jacob & Monod, 
1961). The process of gene expression comprises two main parts: transcription and translation 
(Djebali et al., 2012; Hahn, 2004; Hampsey, 1998; T. I. Lee & Young, 2000; Neaves, 2002). In 
the last decades, specific gene mutations and alterations of gene expression have been related 
to Alzheimer’s disease (AD). Mutations in Amyloid Precursor Protein (APP), Presenilin 1 and 2 
(PS1 and PS2) are the cause of AD familiar form (Goate et al., 1991; Levy-Lahad et al., 1995; 
Rogaev et al., 1995; Sherrington et al., 1995). Increase levels of certain variants of genes 
promote a higher susceptibility to develop AD, such as APOE-ε4 gene (Strittmatter et al., 1993), 
TOMM40 (translocase of outer mitochondrial membrane 40 homolog) (Roses et al., 2010), CR1 
(complement C3b/C4b receptor 1) (Lambert et al., 2009), CLU (Clusterin protein), ABCA7 (ATP 
binding cassette subfamily A member 7) (Hollingworth et al., 2011), BIN1 (bridging integrator 1) 
(Seshadri et al., 2010)  or PICALM (phosphatidylinositol binding clathrin assembly protein) 
(Harold et al., 2009). Moreover, gene expression studies performed in cell lines, mouse model 
brains and human postmortem brain regions found different transcriptional profiles during AD 
progression (Bossers et al., 2010; Matigian et al., 2010; Pasinetti, 2001). Some of these studies 
investigated a specific period of the pathology, early or late AD stages (Gatta, D'Aurora, 
Granzotto, Stuppia, & Sensi, 2014; Pasinetti, 2001; Twine, Janitz, Wilkins, & Janitz, 2011). A 
recent study in human postmortem brain regions identified gene expression and splicing 
changes in the temporal and frontal lobes. In the frontal lobe of AD, there was an increase of 
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expression of genes involved in synaptic transmission and regulation, neurotransmitter transport 
and negative regulation of neuronal apoptosis. Contrarily, the expression of genes associated 
with axon transport and neurotransmission was increased in the temporal lobe of AD brain 
(Twine et al., 2011). Another study investigated in which level genes linked to immune or 
inflammatory pathways are expressed in different areas of the human brain such as entorhinal 
cortex, superior frontal gyrus and hippocampus during aging and AD (Cribbs et al., 2012). They 
found that genes related to immune and inflammatory pathways showed more alterations during 
aging than AD progression. Furthermore, other studies have screened the expression at different 
stages of AD (Blalock et al., 2004; Bossers et al., 2010; Katsel, Li, & Haroutunian, 2007). Gene 
expression analysis in the human medial frontal brain region from different Braak stages showed 
that 922 genes have a direct correlation with Braak stages (Bossers et al., 2010). Gene-
expression patterns from early stages were distinct than from late stages, suggesting a direct 
connection between the transcriptional alterations and the neurofibrillary tangle changes. Genes 
that increased during the progression of AD were linked to differentiation and proliferation, metal 
ion binding and inflammation. Genes that decreased during the progression of the pathology 
were associated with synaptic activity and cell adhesion, such as genes linked to exocytosis of 
neurotransmitters  (VAMP7, SYT4, SNAP25) and potassium voltage-gated channels (KCNS3, 
KCNB1) (Bossers et al., 2010). In addition to human studies, the transcriptional profile of AD 
mouse models has also been investigated (Blalock et al., 2004; Gatta et al., 2014; J. A. Miller, 
Oldham, & Geschwind, 2008; Parra-Damas et al., 2014; Seshadri et al., 2010; Twine et al., 
2011). Gene expression in the hippocampal brain subregion of 3xTg-AD mouse model showed 
multiple changes at 3 and 12 months of age. During early stages of AD genes related to 
mitochondrial activity, regulation of Ca2+, inflammatory response and synaptic activity were 
altered. In contrast, at late stages, AD hippocampus showed expression changes in genes 
related to synaptic activity, differentiation, cell division, neuronal proliferation and cognitive 
decline (Gatta et al., 2014). Although the transcriptional profile of brain regions of AD humans 
and mouse models has been intensively researched, the precise role of transcriptional changes 
remain poorly understood and some results are still controversial.  
In addition to transcriptional changes, recent studies indicate that alterations in mRNA 
processing contribute to AD (M. K. Lai, Esiri, & Tan, 2014; Mills et al., 2013; Stilling et al., 2014; 
Tollervey et al., 2011; Twine et al., 2011). The last step of transcription is RNA processing, in 
which introns are removed from the RNA structure, and exons are spliced together. Multiple 
small nuclear ribonucleoproteins rich with Us (snRNPs: U1, U2, U4, U5 and U6) drive the mRNA 
processing step (Busch, Reddy, Rothblum, & Choi, 1982; Weinberg & Penman, 1968). The 
combination of these 5 snRNPs and specific proteins forms the spliceosome. In conjunction with 
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the rest of transcription steps, it is highly regulated by exonic splicing enhancers and silencers, 
intronic splicing silencers and heterogeneous nuclear ribonucleoproteins (hnRNPs) (Neaves, 
2002; Qian & Liu, 2014). Alternative splicing is an essential process for complex organisms 
providing a high level of proteomic complexity since this promotes an exponential increase of 
mRNA variants from a single gene (Neaves, 2002; C. W. Smith & Valcarcel, 2000). A previous 
study indicated that 92 to 94% of the human genes showed alternative splicing forms (E. T. 
Wang et al., 2008). Deregulation of alternative splicing can play an important role in the 
progression of a disease (Buratti, Brindisi, Pagani, & Baralle, 2004; Disset et al., 2006; 
Sebestyen, Zawisza, & Eyras, 2015). Genes that participate in the progression of AD pathology 
have alternative splicing forms, such as APP, PS1, PS2, TAU and APOE genes. For example, 
APP has an alternative exclusion in exon 8 (Penna et al., 2013), PS1 gene in exon 4 (De Jonghe 
et al., 1999), APOE gene in exon 5 (Mills et al., 2013) or TAU present an exon 10 inclusion 
(Andreadis, Brown, & Kosik, 1992). These alternative variants might play an important role in 
AD. For example, APP variant with exon 7 has higher levels in the AD than the control group and 
is associated with beta-amyloid production (Alam, Suzuki, & Tsukahara, 2014). Moreover, global 
changes in splicing events have been investigated for the AD pathology. In some cases, these 
changes correlate to gene expression, in others not (Stilling et al., 2014; Tollervey et al., 2011; 
Twine et al., 2011). For example, a recent study identified alterations of distinct pathways 
associated with gene expression and splicing changes in an AD mouse model. Gene expression 
changes affected pathways related to inflammation, whereas genes with different splicing forms 
were linked to neuronal plasticity. Similar to the transcriptomic data, further investigations are 
required to fully understand the role of alternative splicing during the progression of AD. 
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1.3.Aging 
The major risk factor for developing Alzheimer’s disease is aging. Aging is a complex process 
based on the progressive dysfunction of almost every tissue and cells from the most living 
organism at different times. Furthermore, there is high variability between old individuals; some 
individuals exhibit normal cognition, whereas others show memory loss or physical problems 
(Koivisto et al., 1995; Montesanto, Dato, Bellizzi, Rose, & Passarino, 2012). Thus, aging is a 
complex process to study. Multiple theories postulated different causes of aging, such as the 
formation of mitochondrial free radicals (Harman, 2003), inflammatory response (Chung, Kim, 
Kim, & Yu, 2001), activation of immune system (Franceschi, 1989), mitochondrial dysfunction 
(Cadenas & Davies, 2000) or telomere shortening (Martin-Ruiz et al., 2006). There is a global 
agreement that aging is caused by a progressive accumulation of molecular damage that at a 
certain time cannot be repaired or removed it (Harman, 2003; Kirkwood et al., 2003; Vijg & 
Campisi, 2008). Several external factors can contribute to this damage, such as stress, 
irradiation, UV light, toxins, genetics, epigenetics or exercise (Jansen-Durr & Osiewacz, 2002). 
However, the precise causes and mechanisms involved remain unclear. Nowadays, there is a 
global consensus that multiple molecular mechanisms cause aging (Kirkwood, 2005; Kowald & 
Kirkwood, 1996; Weinert & Timiras, 2003). Aging process affects almost every tissue, including 
the brain. The process of aging in mammalian brains affects the structure and activity of 
neurons, promoting alterations in dendritic patterns (Burke & Barnes, 2006), reduction of white 
matter density (Bartzokis et al., 2003; Hedden & Gabrieli, 2004), alteration of frontal cortex 
connections with the hippocampus (Hedden & Gabrieli, 2004) and reduction synapse number (X. 
Liu, Erikson, & Brun, 1996). These changes in brain structure induce cognitive deficits and motor 
impairments 252,253. Specifically in human brains, aging promotes a delay of verbal information 
recalling, deficits in working and spatial memory, reductions of the processed speed (Albert, 
Duffy, & Naeser, 1987; Craik, Moscovitch, & McDowd, 1994; Petersen, Smith, Kokmen, Ivnik, & 
Tangalos, 1992; Zelinski & Burnight, 1997). Imaging studies of human brains found a reduction 
of brain region connections, reduce activations and poorly organized activations in regions 
involved in cognition (Andrews-Hanna et al., 2007; Logan, Sanders, Snyder, Morris, & Buckner, 
2002; Persson et al., 2004). One of the most conserved aged features between mammalian 
species is spatial cognitive impairment (Govindarajan et al., 2013; Head et al., 1995; Z. C. Lai, 
Moss, Killiany, Rosene, & Herndon, 1995). It is difficult to separate cognitive decline and 
functional changes originated from neurodegenerative diseases and aging. Previous studies 
using functional magnetic resonance imaging correlated a reduction of metabolic activities in the 
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subiculum and dentate gyrus with normal aging, whereas a reduction of activity in the entorhinal 
cortex was correlated with Alzheimer’s disease (Small, Tsai, DeLaPaz, Mayeux, & Stern, 2002).  
1.3.1.Molecular, gene expression and mRNA processing changes 
along aging 
Aging promotes deregulation of the expression of specific genes, affecting pathways that are 
well conserved between species. For example, changes in genes related to stress response or 
mitochondrial functions during aging were observed in Caenorhabditis elegans (McCarroll et al., 
2004), Drosophila (McCarroll et al., 2004; Pletcher et al., 2002; Zou, Meadows, Sharp, Jan, & 
Jan, 2000), rats (Blalock et al., 2003), mice (Jiang, Tsien, Schultz, & Hu, 2001; C. K. Lee, 
Weindruch, & Prolla, 2000) and humans (T. Lu et al., 2004). Aged-animals show alterations to 
genes related to similar pathways, which were defined as the gene hallmarks of aging. The 
majority of genes altered in aging are involved in stress response and DNA damage, immune 
system, protein synthesis, mitochondrial function, gene expression, mRNA processing and 
growth factor signaling. The deregulation of these genes is in agreement with previous aging 
theories that described alteration of certain of these pathways. There is a close relation between 
transcriptional changes and functional alterations. 
Genes related to oxidative stress are strongly up-regulated in aged mice, including genes 
involved in DNA damage, cellular defense and immune system (Fraser, Khaitovich, Plotkin, 
Paabo, & Eisen, 2005; C. K. Lee et al., 2000). Caloric restriction in aged-mice reverses certain 
age-associated changes in gene expression and delays oxidative stress (Hyun, Emerson, Jo, 
Mattson, & de Cabo, 2006; C. K. Lee et al., 2000). DNA damage has been extensively 
associated with aging. Internal and external factors, such as reactive oxygen species (ROS), 
chemicals or spontaneous mutations, can alter the integrity of DNA promoting telomere 
shortening, translocations and gene mutations (Faggioli, Wang, Vijg, & Montagna, 2012; 
Hoeijmakers, 2009). In case of Werner syndrome, mutations in DNA helicases induced 
accelerated-aged pathology (Burtner & Kennedy, 2010).  
Furthermore, aged-brain shows changes in immune and inflammatory systems (Salminen, 
Kaarniranta, & Kauppinen, 2012; Weiskopf, Weinberger, & Grubeck-Loebenstein, 2009). There 
is a reduced reaction against pathogens and alter over-activity in physiological stages 
(Franceschi & Campisi, 2014; Salminen et al., 2012). This over-activity of inflammation, known 
as “inflammaging”, can be induced by tissue damage, increased of senescent cells or 
enhancement of NF-kB transcription factor (Salminen et al., 2012). Inhibition of NF-kB 
transcription factor activity in models of accelerated aging delays aged-associated 
characteristics (Osorio et al., 2012). Genes related to inflammatory responses and immune 
 29
systems were up-regulated in aged human blood and brain (Berchtold et al., 2008; de 
Magalhaes, Curado, & Church, 2009; Mirza, Pollock, Hoelzinger, Dominguez, & Lustgarten, 
2011; Peters et al., 2015).  
There is a significant reduction of synaptic connections and genes linked to synaptic activities, 
such as genes related to glutamate receptors, calcium signaling pathway, synaptic vesicles and 
signal transduction in the human frontal cortex during aging (T. Lu et al., 2004). Reduction of 
genes related to synaptic activities was also observed in other brain regions of aged-organisms 
(Blalock et al., 2003; Fraser et al., 2005; Loerch et al., 2008). 
There is evidence confirming that mitochondrial dysfunction contributes to aging (Cadenas & 
Davies, 2000; Green, Galluzzi, & Kroemer, 2011; Harman, 2003). These alterations affect mainly 
mitochondrial DNA (mtDNA) and respiratory chain. The mitochondrial respiratory chain provides 
the energy (ATP) to rest of tissues, including the brain. Alteration in this process can stimulate 
the formation of reactive oxygen species (ROS). Several mechanisms protect the mitochondria 
against ROS. However, these defenses are reduced during aging process. In the past, the 
mitochondrial free radical theory postulated that an increase of ROS induces macromolecular 
damage, causing the process of aging (Harman, 1965). In contrast, recent studies suggested 
that an increase of ROS might extend the lifespan of yeast and Caenorhabditis elegans (Doonan 
et al., 2008; Mesquita et al., 2010) and do not accelerate aging (Van Remmen et al., 2003; Y. 
Zhang et al., 2009). Nowadays, the connection between aging and ROS involve stress response 
(Hekimi, Lapointe, & Wen, 2011). Other alterations in mitochondrial functions have been 
associated with aging. Mitochondrial DNA (mtDNA) is more vulnerable to suffer mutations, due 
to the oxidative condition and reduced efficiency of mtDNA reparation (Linnane, Marzuki, 
Ozawa, & Tanaka, 1989). Mutations in mtDNA and increase of oxidative DNA damage have 
been identified in aging and Alzheimer’s disease brains (Honda et al., 2005; T. Lu et al., 2004; 
Mecocci et al., 1993). These mutations in mtDNA decrease the activity of respiratory chain 
enzymes (Lin, Simon, Ahn, Kim, & Beal, 2002). Removing mitochondrial DNA polymerase 
promote a decrease in lifespan, accelerated aging and mitochondrial dysfunction (Trifunovic et 
al., 2004; Vermulst et al., 2008). Moreover, genes related to mitochondria were down-regulated 
in different animals with aging (Blalock et al., 2003; T. Lu et al., 2004).  
Moreover, genes related to protein synthesis are also altered in different species during aging, 
such as genes related to ribosome biogenesis and translation. Both functions play an important 
role in mechanistic target of rapamycin pathway (mTOR), which has a crucial effect in 
stimulation of translation, inhibition of autophagy and longevity (Iadevaia, Liu, & Proud, 2014; S. 
C. Johnson, Rabinovitch, & Kaeberlein, 2013; Lamming, 2016). This down-regulation of 
ribosome-associated genes have been observed in yeasts (Janssens et al., 2015; Kamei, 
Tamada, Nakayama, Fukusaki, & Mukai, 2014), Caenorhabditis elegans (Ma et al., 2016), mice 
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(W. Zhang et al., 2015) and humans (Berchtold et al., 2008; Kumar et al., 2013). Furthermore, 
genes related to the process of gene transcription were altered during aging. Alterations in 
transcription during aging enhance mRNA heterogeneity (Martinez-Jimenez et al., 2017; Wiley et 
al., 2017).  
There is an alteration post-transcriptional processing during aging. Moreover, genes related to 
splicing and polyadenylation were deregulated in human aging (Harries et al., 2011; Meshorer & 
Soreq, 2002) and mice (S. A. Rodriguez et al., 2016). Over-expression of splicing factor 1 
(SFA-1) increases lifespan in Caenorhabditis elegans (Heintz et al., 2017). Several genes show 
a differential exon usage in the skin, muscle, bone, white adipose, thymus and hippocampus 
brain region of aging mice (S. A. Rodriguez et al., 2016; Stilling et al., 2014). In summary, aging 
is a complex process that is affected at different levels for multiple dysfunctions in the organism.   
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1.4.Epigenetic factors 
Conrad Waddington firstly defined the epigenetic concept in 1939. He defined it as “the causal 
interactions between genes and their products, which bring the phenotype into 
being” (Waddington, 1939; C. H. Waddington, 1957; Waddington, 1959, 2012). In 1957, he 
published the book “The strategy of genes” where he defined how cells with an exact genetic 
background could differentiate to a distinct tissue (Figure 1.6) (C.H. Waddington, 1957). The 
epigenetic process is a mechanism that promotes reversible changes in gene expression without 
altering the sequence of DNA itself (epigenetic, above genes) (Holliday, 1987; V. E. A. Russo, 
Robert A. Martienssen, & Arthur D. Riggs, 1996). It is considered to be the bridge between the 
external environment and internal integration of this information, playing an essential role in the 
adaptation to different external or internal conditions (Van Speybroeck, 2002). Epigenetic factors 
are related to several physiological functions and also linked to several disease pathologies 
(Cao & Sudhof, 2001; Crosio, Heitz, Allis, Borrelli, & Sassone-Corsi, 2003; Dompierre et al., 
2007; Fischer, Sananbenesi, Wang, Dobbin, & Tsai, 2007; Guan et al., 2002; Neumann et al., 
2006; Tsankova, Kumar, & Nestler, 2004). These epigenetic changes can be reversed or persist 
during the whole life and even be transmitted to the next generations. Recent studies found that 
different types of epigenetic factors can be transmitted to the offspring promoting changes of 
physiological conditions (Anway, Cupp, Uzumcu, & Skinner, 2005; Byrnes, 2005; Carone et al., 
2010; Chamorro-Garcia et al., 2013; de Castro Barbosa et al., 2016b; Dias & Ressler, 2014b; 
Dunn & Bale, 2009; Gapp et al., 2014; Ng et al., 2010; Ost et al., 2014; Ribeiro et al., 2017; 
Schmauss, Lee-McDermott, & Medina, 2014; Vassoler, White, Schmidt, Sadri-Vakili, & Pierce, 
2013; Wei et al., 2014; S. Zhang et al., 2017). This inherited transmission can occur for one 
generation (intergenerational) or more (transgenerational). 
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Figure 1.6. Waddington epigenetic landscape.  
Model of Waddington to describe the cellular decisions during development. The cell with unique genetic 
information is represented by a ball that rolls down to different cell fates (colors) controlled by epigenetic 
factors till reaches one of the valleys (maturation form). Representation was adapted from Waddington, 
1957 (C.H. Waddington, 1957). 
Epigenetic changes involve different factors, including post-translational histone modifications, 
DNA methylation and non-coding RNAs. Histone modifications bind to the tail domain of 
histones. Histone proteins constitute the structure where the DNA is wrapped around forming the 
nucleosomes. This structure (histone octamer) is formed for two of each histone: H2A, H2B, H3 
and H4 and the histone linker H1 (Luger, Mader, Richmond, Sargent, & Richmond, 1997). 
Transcription depends on the level of DNA condensation. Multiple histone tail modifications, 
such as the addition or removal of acetyl, methyl, phosphoryl and ubiquitin groups regulate the 
level of DNA compaction. These incorporations promote different levels of compaction and 
therefore distinct stimulation of transcription process (Bradbury, Inglis, Matthews, & Sarner, 
1973; Goldknopf et al., 1975; Murray, 1964; Tanner et al., 1999; Verdin & Ott, 2015). Several 
genes participate in those processes of adding or removing groups from the tails, such as 
acetyltransferases (HATs), deacetylases (HDAC), methyltransferases (HMT) or demethylases 
(Allfrey, Faulkner, & Mirsky, 1964). These histone tail modifications alter distinct process 
associated with aging and Alzheimer’s disease (AD). For example, H4K12 acetylation and 
H4K16 acetylation proportion increases with aging, whereas as H3K9 methylation proportion 
decreases with aging (Benito et al., 2015; Fraga & Esteller, 2007; Han & Brunet, 2012). Inhibition 





Moreover, changes in DNA methylation or hydroxymethylation also regulate the gene expression 
process. DNA methyltransferases (DNMTs) transfer a methyl group specifically to cytosine 
residues in regions enriched with cytosine and guanine nucleotides, called CpG islands, 
silencing gene transcription (B. Jin, Li, & Robertson, 2011; Okano, Xie, & Li, 1998). There is a 
reduction of levels of methylation and hydroxymethylation in samples of AD patients or AD 
mouse models (Mastroeni et al., 2010; Shu et al., 2016). In 2010, there was a study that 
described a reduction of 5-methylcytosine in neurons of postmortem cortical tissue of AD 
patients (Mastroeni et al., 2010).  
Lastly, non-coding RNAs (ncRNAs) regulate gene expression at different levels, transcriptional 
and post-transcriptional levels. The first described RNAs that play a role in transcription and 
translation were the ribosomal RNA (rRNA) and transfer RNA (tRNA), which were discovered in 
the 1950s (Roberts, 1958). Thirty years later, the first non-coding RNA structures were described 
in Caenorhabditis elegans (R. C. Lee, Feinbaum, & Ambros, 1993). NcRNAs are transcribed 
RNAs from non-coding regions of the genome, which do not translate into proteins. These non-
coding regions represent more than 90% of the genome (Carninci et al., 2005; Mehler & Mattick, 
2006). NcRNAs regulate several physiological functions of the organism, such as development, 
metabolism, memory formation, synaptic plasticity, homeostasis and cell death (Bernard et al., 
2010; Mehler & Mattick, 2006; Rani et al., 2016). In contrast, ncRNAs also participated in the 
pathology of several diseases, including neurodegenerative diseases (Esteller, 2011; Gangwar, 
Rajagopalan, Natarajan, & Deiuliis, 2018; Hebert et al., 2010; Qureshi & Mehler, 2013; Salta & 
De Strooper, 2017; Tan et al., 2014). Furthermore, several studies indicate that ncRNAs are 
tissue-specific over a specific time (Belgard et al., 2011; Credendino et al., 2017; Krichevsky, 
Sonntag, Isacson, & Kosik, 2006; Ludwig et al., 2016; Mercer, Dinger, Sunkin, Mehler, & Mattick, 
2008). Depending on the length, ncRNAs are classified in small non-coding RNAs (sncRNAs) 
with less of 200 base pairs or long non-coding RNAs (lncRNAs) with more than 200bp.  
The most studied sncRNAs are the microRNAs (miRNAs), which are small RNA structures 
formed by 19-25 nucleotides. These structures are synthesized from a primary form of miRNA 
(pri-miRNA) that is first cleaved by DROSHA ribonuclease in the nucleus and then by DICER1 
ribonuclease in the cytoplasm (Lagos-Quintana, Rauhut, Lendeckel, & Tuschl, 2001; Mattick & 
Makunin, 2005; Qureshi & Mehler, 2012). The mature miRNA is combined with Ago proteins 
forming the RNA-induced silencing complex (RISC) (Qureshi & Mehler, 2012). The miRNAs bind 
to the complementary mRNA repressing or deleting the expression (Mattick & Makunin, 2005). 
Interestingly, one miRNA can bind to multiple mRNA targets, and multiple miRNAs can bind to 
the same mRNA. Thus, one or few miRNAs can regulate complex networks (Qureshi & Mehler, 
2012). A wide variety of miRNAs are expressed in mouse (Bak et al., 2008; He et al., 2012) and 
human brains (Ludwig et al., 2016; Lukiw, 2012). MiRNAs participate in nervous system 
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physiological functions, such as synaptic plasticity and neurogenesis (Kawasaki & Taira, 2003; 
Shibata, Nakao, Kiyonari, Abe, & Aizawa, 2011; Smirnova et al., 2005; Tognini, Putignano, 
Coatti, & Pizzorusso, 2011). Moreover, miRNAs are involved in memory and learning process 
(Konopka et al., 2010; W. Wang, Kwon, & Tsai, 2012). In contrast, miRNAs also participate in 
neurological pathologies, such as Alzheimer’s or Parkinson diseases (W. Wang et al., 2012).  
Changes in miRNAs expression have also been detected during the process of aging 
(reference). Since miRNA expressions have an impact in several pathological processes and are 
stable in organism fluids, these non-coding structures have been proposed and used as disease 
biomarkers. Moreover, extracellular miRNAs can reflect changes from other internal tissues, 
facilitating the diagnosis of pathologies associated to tissues of difficult access, such as the brain 
(Rao, Benito, & Fischer, 2013). MicroRNAs from the brain are secreted to the extracellular 
spaces inside exosomes (Valadi et al., 2007), bind to high-density lipoproteins (Vickers, 
Palmisano, Shoucri, Shamburek, & Remaley, 2011) and forming a complex with Ago proteins 
(Arroyo et al., 2011; Turchinovich, Weiz, Langheinz, & Burwinkel, 2011). Detection of circulating 
miRNAs in the blood could provide information for the diagnosis of pathology (X. Chen et al., 
2008; S. J. Cohen et al., 2008; Y. K. Kim, 2015; Rao et al., 2013).  
Furthermore, there are other forms of small RNAs, which are less known, the small nucleolar 
RNAs (snoRNAs) and Piwi-interacting RNAs (piRNAs). Small nucleolar RNAs (snoRNAs) are 
small structures of 60-170 nucleotides expressed in the nucleolus. There are two classes of 
snoRNAs, the box C/D snoRNAs and box H/ACA snoRNAs. The most known function of 
snoRNAs is the posttranscriptional maturation of ribosomal RNAs (rRNAs) (Cavaille, Nicoloso, & 
Bachellerie, 1996; Ganot, Bortolin, & Kiss, 1997). These structures also participate in the 
guidance of RNA modifications, regulation of splicing (Kishore et al., 2010; Scott et al., 2012; Q. 
F. Yin et al., 2012), regulation of chromatin structure (Schubert et al., 2012) and mediation of 
oxidative stress (Michel et al., 2011; Scott et al., 2012). Some of the snoRNAs are exclusively 
identified in the brain (Cavaille et al., 2000; Huttenhofer et al., 2001; Rogelj, Hartmann, Yeo, 
Hunt, & Giese, 2003), and others were identified in other tissues (Jorjani et al., 2016). SnoRNAs 
have also been related to neurological pathologies and process of aging (Sridhar, Gan, & 
Schlick, 2008; Steinbusch et al., 2017). Specific snoRNAs also play a role in associative memory 
(Rogelj et al., 2003). Furthermore, snoRNAs can be cleaved into small fragments (20-24 
nucleotides), known as snoRNA-derived RNA (sdRNAs) (Scott, Avolio, Ono, Lamond, & Barton, 
2009; Taft et al., 2009). Multiple studies showed that these fragments are precursors of miRNAs 
or have similar roles than miRNAs (Brameier, Herwig, Reinhardt, Walter, & Gruber, 2011; Ender 
et al., 2008; Falaleeva & Stamm, 2013; Garcia-Lopez et al., 2015; Ono et al., 2011; Scott et al., 
2009). However, the precise mechanism of synthesis and functional activity remains to be 
elucidated. Piwi-interacting RNAs (piRNAS) are small structures of 20-35 nucleotides that are 
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detected in large proportion in germline cells of different species, such as Drosophila, 
Caenorhabditis elegans, Xenopus tropicalis, mice and rats (A. A. Aravin et al., 2003; A. A. Aravin 
et al., 2001; A. A. Aravin et al., 2008; A. Aravin et al., 2006; Armisen, Gilchrist, Wilczynska, 
Standart, & Miska, 2009; Batista et al., 2008; Lau et al., 2006). PiRNAs play an essential role in 
the development of germ-line cells, silencing the transposable elements (TE). For that, piRNAs 
bind to PIWI proteins (A. A. Aravin, Sachidanandam, Girard, Fejes-Toth, & Hannon, 2007; Zheng 
& Wang, 2012). PiRNAs have also been identified in somatic cells of the nervous system, liver, 
kidney, spleen and lung (E. J. Lee et al., 2011; Yan et al., 2011). However, the piRNA function in 
somatic cells remains unknown. Recent studies suggest that piRNAs could be involved in spine 
formation (E. J. Lee et al., 2011) and could participate in Alzheimer’s disease (Qiu et al., 2017).  
 36
1.5.Intergenerational inheritance 
1.5.1.History of evolution: Lamarck  
For almost two centuries the theory of evolution from Lamarck was forgotten. However, in the 
last decades, it gained importance again. Jean-Baptiste Pierre Antoine de Monet, Chevalier de 
Lamarck published the “Philosophie zoologique ou exposition des considerations relatives à 
l'histoire naturelle des animaux“ in 1908. In this publication, he mainly formulated two concepts. 
First, he postulated that organisms change their characteristics according to external conditions 
and repetitive use of specific parts of the body. Secondly, these changes can be transmitted to 
the next generations (Lamarck, 1809). Moreover, Conrad Waddington described for the first time 
the concept of epigenetics in 1939 (Waddington, 1939). Nowadays, the definition of epigenetic 
factors is the combination of heritable factors that promote changes in gene activity without 
altering the DNA sequence (Bird, 2007). There is emerging evidence that phenotypic changes 
induced by paternal exposition to specific external conditions can alter the phenotype of the 
offspring through the transmission of certain epigenetic factors 219,(Danchin et al., 2011). This 
new concept of epigenetic transmission is closely related to Lamarck postulations and do not 
contradict Darwin theory of evolution. For the last decades, there is an exponential increase of 
studies of epigenetic inheritance. Despite this increase of research, it does not exist an official 
and universal definition of this kind of transmission (Bird, 2007; Griesemer, 2002; Jablonka & 
Raz, 2009; Ptashne, 2007; Vincenzo E. A. Russo, Robert A. Martienssen, & Arthur D. Riggs, 
1996). In general, epigenetic transmission or epigenetic inheritance refers to the transmission of 
specific phenotype to the next generation potentially through epigenetic factors. The existence of 
epigenetic marks in germ-line cells suggests that these factors might participate in the 
transmission of certain information to the next generations 98-112. The exact mechanism is 
poorly understood. This process of transmission can pass to one generation or several, 
according to that it will be an intergenerational or transgenerational inheritance (Figure 1.7A-B). 
The intergenerational inheritance consists in the transmission of changes only to the first 
generation (F1), which is also indirectly in contact with the external condition (F1 germ cells) 
(Dias & Ressler, 2014a; Franklin et al., 2010; Rodgers, Morgan, Bronson, Revello, & Bale, 2013; 
Roth, Lubin, Funk, & Sweatt, 2009). Moreover, it is also the transmission of changes between 
F1, who is exposed to a condition in the uterus or after birth, and their offspring (F2). On the 
other hand, the process of transgenerational inheritance consists in the transmission of non-
genetic information for at least three generations. The third generation is the first one that is not 
exposed to the external condition (Anway et al., 2005; Newbold, Padilla-Banks, & Jefferson, 
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2006; Skinner, 2008). This transmission is probably due to a stable modification of the 
epigenome profile in germ cells (Anway et al., 2005; Skinner, Anway, Savenkova, Gore, & 
Crews, 2008). F3 generation from F0 exposed to vinclozolin exhibited changes in anxiety 
behaviors and gene expression in the hippocampus and amygdala (Skinner et al., 2008).  
1.5.2.Mechanisms of transmission 
The epigenetic phenotypic changes can mainly be transmitted independently or through the 
germ-line (Youngson & Whitelaw, 2008). The early development and adult behavior depend on 
the maternal and paternal care (Figure 1.7C) (I. C. Weaver, 2007). Licking, grooming and 
nursing behaviors can have a substantial impact in the offspring, promoting changes that can 
remain till adulthood. Multiple animal species showed altered behavior phenotypes due to 
different maternal or paternal cares (Gerra et al., 2007; Kikusui, Isaka, & Mori, 2005; Lovic, 
Gonzalez, & Fleming, 2001; Maestripieri, 2005). For example, female rat offspring who was 
subjected to maternal care deprivation showed deficits in maternal care in adulthood (Gonzalez, 
Lovic, Ward, Wainwright, & Fleming, 2001). These phenotype alterations commonly do not pass 
to the second or third generations, since the transmission depends on maternal and paternal 
care in each generation. In some cases, this maternal or paternal care promotes changes in 
gene expression and epigenetic factors that might induce alterations in the adult pattern and be 
transmitted to the next generations (Champagne, 2008; Champagne et al., 2006; Franklin et al., 
2010; Gapp et al., 2014; Meaney, 2001; I. C. Weaver et al., 2004; I. C. Weaver et al., 2005). 
Offspring from males that suffer maternal deprivation showed behavioral changes and alteration 
of DNA methylation profile in the brain (Franklin et al., 2010). Moreover, the interaction of 
pregnant female with specific external conditions could alter the embryonic epigenetic profile, 
inducing phenotypic changes during development that can persist till adult stages. This type of 
exposition can even modify the molecular profile of F1 germ-line. Stress, drug administration or 
changes in the diet during pregnancy can alter several factors of the embryo, promoting changes 
in the adult phenotype (Anway et al., 2005; M. Chen & Zhang, 2011; Noorlander, Visser, 
Ramakers, Nikkels, & de Graan, 2008; Plagemann, 2005). For example, exposure of pregnant 
females to an estrogenic or antiandrogenic compound promotes a reduction of spermatogenesis 
and fertility in the next generation (Anway et al., 2005). Cocaine intake during pregnancy 
stimulates dopaminergic system and stress reactivity in the offspring (Malanga, Pejchal, & 
Kosofsky, 2007; W. Wang et al., 2013). Furthermore, exposure to distinct environmental factors 
might alter the phenotype and the epigenetic profile of F0 and corresponding germ-line (F1), 
transferring changes to the next generations (Anway et al., 2005; Byrnes, 2005; Carone et al., 
2010; Chamorro-Garcia et al., 2013; de Castro Barbosa et al., 2016b; Dias & Ressler, 2014b; 
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Dietz et al., 2011; Dunn & Bale, 2009; Gapp et al., 2014; Ng et al., 2010; Ost et al., 2014; Ribeiro 
et al., 2017; Schmauss et al., 2014; Vassoler et al., 2013; Wei et al., 2014; S. Zhang et al., 
2017). In some cases, it represents a protective change for the offspring (Ribeiro et al., 2017; 
Vassoler et al., 2013; S. Zhang et al., 2017). For example, offspring born to fathers that train in 
spatial tasks show an increase in cognitive performance and synaptic plasticity 98. In contrast, 
these changes can have a negative repercussion to the offspring, promoting stress, reduction of 
fertility or increasing the range of obesity (Anway et al., 2005; Byrnes, 2005; Chamorro-Garcia et 
al., 2013; de Castro Barbosa et al., 2016b; Dunn & Bale, 2009; Gapp et al., 2014; Ng et al., 
2010; Ost et al., 2014; Schmauss et al., 2014; Wei et al., 2014). Some of these positive or 
negative phenotypic changes are gender-specific or at least they have been investigated 
exclusively in one gender (Byrnes, 2005; Carone et al., 2010; Dunn & Bale, 2009; Ng et al., 
2010). Few studies have examined the phenotypic alterations in the offspring born to a father or 
a mother exposed to the same condition (Madathil et al., 2015; Qvarnstrom & Price, 2001; 
Whitaker, Jarvis, Beeken, Boniface, & Wardle, 2010). A recent study showed that maternal 
weight has a major impact on the children obesity than paternal weight (Whitaker et al., 2010).  
Moreover, this intergenerational inheritance can alter the phenotype of both gender offspring (de 
Castro Barbosa et al., 2016b; Dietz et al., 2011) or exclusively affect one sex (Alter et al., 2009; 
de Castro Barbosa et al., 2016b; Vassoler et al., 2013). For example, adult females and not 
males from fathers fed with high-fat diet (HFD) suffer glucose intolerance and resistance to gain 
weight when they are fed with HFD (de Castro Barbosa et al., 2016b).  
1.5.3.Candidates of germ-line transmission 
Multiple epigenetic factors have been found in germ-line, specifically in sperm, suggesting that 
they might play a crucial role in the transmission of specific non-genetic phenotypes to the 
offspring (Kobayashi et al., 2012; Rodgers, Morgan, Leu, & Bale, 2015; Vassoler et al., 2013). At 
the same time, there is emerging evidence that an epigenetic resetting process occurs during 
gametogenesis, to ensure a totipotent zygote (Hajkova, 2011; J. R. Weaver, Susiarjo, & 
Bartolomei, 2009). For example, during spermatogenesis histone modifications are removed, 
and histones are replaced to protamines (Fischer, Sananbenesi, Mungenast, & Tsai, 2010). 
However, it seems that the reprogramming does not erase all the epigenetic factors allowing the 
transmission of specific information through epigenetic factors (G. D. Johnson et al., 2011; 
Kobayashi et al., 2012; Krawetz, 2005; Rodgers et al., 2015; Vassoler et al., 2013). Furthermore, 
specific non-coding RNAs are expressed in germ-line and might participate in this epigenetic 
transmission (G. D. Johnson et al., 2011; Krawetz, 2005; Rodgers et al., 2015).  
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One of the candidates for transmission is DNA methylation. In certain conditions, DNA 
methylation can escape reprogramming and transmit information to the next generations 
(Denham, O'Brien, Harvey, & Charchar, 2015; Kobayashi et al., 2012; Radford et al., 2014) 
(Jenkins et al., 2017). For example, humans that train for 3 months have different levels of DNA-
methylation in the sperm, and this might alter the features of the next generation (Denham et al., 
2015). Moreover, DNA methylation participates in genomic imprinting, a process by which one of 
the parental alleles of a specific gene is selected by silencing the other with DNA methylation 
(Bartolomei & Ferguson-Smith, 2011; S. Feng, Jacobsen, & Reik, 2010; Paoloni-Giacobino & 
Chaillet, 2006; Reik & Walter, 2001; Sha, 2008; J. R. Weaver et al., 2009).  
Secondly, some histone modifications can also transmit certain changes by the germ-line. The 
probability is lower since 98% of histones in mice and 85% in humans are replaced by 
protamines in sperm cells (Balhorn, Brewer, & Corzett, 2000; Hammoud et al., 2009; G. D. 
Johnson et al., 2011; Ward & Coffey, 1991). The remainder of histones in the sperm might 
transmit some information (Ben Maamar, Sadler-Riggleman, Beck, & Skinner, 2018; 
Brykczynska et al., 2010; Hammoud et al., 2009; Terashima et al., 2015). A recent study found 
different H3-occupancy at genes associated with the process of embryogenesis and higher 
levels of H3K4me1 at transcription factor genes in the sperm of fathers fed with high-fat diet 
(Terashima et al., 2015).  
Finally, different forms of non-coding RNAs have been found in the mature sperm or oocytes 
cells. Different studies indicate that these structures can play an important role in the 
transmission of information from parents to the offspring by affecting the transcriptional and 
translational process, and consequently changing the phenotype of the next generation (Gapp et 
al., 2014; Hamatani, 2012; Krawetz et al., 2011; K. V. Morris, Chan, Jacobsen, & Looney, 2004; 
Rodgers et al., 2013; Suh & Blelloch, 2011; Younger & Corey, 2011). The injection of sperm RNA 
(combination of miRNAs and piRNAs) from males with induced trauma into a naïve-fertilized 
oocyte alters the behavioral phenotype and metabolism of the offspring. This behavioral 
phenotype is similar to the offspring from maternal separation combined with unpredictable 
maternal stress parents (MSUS) (Gapp et al., 2014). Interestingly, some studies suggest that 
alter patterns of non-coding RNAs originated in different parts of the organism can be 
transported inside exosomes to the sperm and then transmitted to the next generations (Blake & 
Watson, 2016; Cossetti et al., 2014; Vojtech et al., 2014). However, the precise mechanism is 
poorly understood, and further investigations are required.  
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Figure 1.7. Process of inheritance.  
(A) Paternal transmission (B) Maternal transmission (C) Maternal or paternal care transmission. F0 = 


























Alzheimer’s disease (AD) is the most common form of dementia. According to the World 
Alzheimer Report from 2015, around 50 million people suffered from AD (Prince et al., 2015). 
Despite the large number of cases, no cure exists to date and the diagnosis of the pathology is 
too late. This difficulty to identify an effective drug is probably due to the complexity of the 
pathology, which is caused by several factors, such as genetic and environmental factors. Such 
genome-environment interactions are mediated by epigenetic processes that control gene 
expression at the systems level. There is accumulating evidence that such changes in gene 
expression are key processes underlying the etiology of AD and age-associated dementia 
(Annese et al., 2018; Blalock et al., 2004; Bossers et al., 2010). Thus, it is crucial to evaluate 
gene expression changes at different stages of AD pathology and in aged individuals. The 
overall aim of my PhD work was to better understand these gene expression changes in the 
context of memory decline. I used three complementary approaches and tested: 
1. if gene expression changes at early AD stages affected the pathology and cognitive 
deficits. 
2. if intergenerational effects have an impact on AD-related memory decline and the 
interpretation of results obtained from commonly used mouse models for amyloid deposition, a 
key hallmark of AD. 
3. if gene expression changes might play a role in inter-individual differences during cognitive 
aging. 
1. Regarding the first aim, I performed a thorough analysis of memory function in the 
APPPS1-21 mouse model for amyloid deposition at early stages. I also tested hippocampal 
gene-expression in these mice in order to identify candidate genes and pathways for further 
investigations of early treatments and diagnosis. 
2. To assay transgenerational effects I decided to specifically analyze at the behavior and 
molecular levels the wild-type offspring originating from either a transgenic APPPS1-21 father or 
mother. I reasoned that the corresponding data would allow me to test if the breeding scheme 
could explain a well-known phenomenon, namely that phenotypes of mutant mice can change 
over time (Casellas, 2011; Wahlsten, Bachmanov, Finn, & Crabbe, 2006) and if genetic factors 
present in parents may also impact on the offspring cognitive health via epigenetic inheritance. 
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3. In the third objective, I decided to study another well-known observation, namely that some 
individuals develop age-associated cognitive decline, while others remain cognitively intact even 
at an advanced age. Thus, I used a mouse model for age-associated memory decline to define 
such groups of individuals and subsequently analyze their gene expression profile. Finally, I tried 
to detect biomarkers that would allow for the assessment of cognitive levels in a non-invasive 
manner. These would provide a marker to identify first changes of memory and target-





3. MATERIALS AND METHODS  
3.1.Animals 
3.1.1.Housing conditions  
All mice were housed in IVC ventilated cages (365x207x140mm) with free access to food and 
water under standard light/dark cycle (12/12h), fix room temperature (RT) at 22°C and air 
humidity of 58%. Food and water were provided ad libitum. Housing, breeding and experimental 
procedures were conducted in accordance of the German Federal Act on the Protection of 
Animals. APPPS1-21 mice were housed in groups of maximum 5 mice per cage and were single 
caged in the holding room one week before starting with the behavioral battery.  
In case of the C57BL/6J wild-type mice used for the aging project, the first batch of mice was 
ordered at 16 months of age, singled cage and after 1 month used for the behavioral 
experiments. The second batch of wild-type mice was ordered at 13 months of age, kept in 
groups of maximum 5 mice and singled cage one month before the behavioral experiments.  
3.1.2.APPPS1-21 transgenic mice and C57BL/6J wild-type mice 
All transgenic and wild-type mice used for the early AD genetic and intergenerational inheritance 
projects were obtained from APPPS1-21 mouse line B6-Tg (Thy1-APPswe; Thy1-PS1 L166P) 
that comes from C57BL/6J strain background (Radde et al., 2006). This mouse line was first 
established by Mathias Jucker (German Center for Neurodegenerative Diseases; Tübingen, 
Germany) (Radde et al., 2006). Transgenic animals are heterozygous for both human amyloid 
precursor protein (APP) gene and human presenilin 1 (PS1) gene. APP gene contained a 
Swedish mutation (K670N (lysine to asparagine) and M671L (methionine to leucine) and PS1 
contain a L166P mutation (leucine to proline). Thy1 promoter regulates the transgene. All 
APPPS1-21 experimental and control groups were obtained from a colony maintained in-house 
by crossing male and female described in the figure below (Figure 3.1). APPPS1-21 male and 
female transgenic and wild-type mice at 3 and 9 months of age were used for the behavioral 
experiments.  




Figure 3.1. Experimental groups.  
(A) 3-month old wild-type or transgenic APPPS1-21 animals born to transgenic father (wttgwt and tgtgwt) or 
mother (wtwttg and tgwttg) vs. control wild-type animals born to wild-type parents (wtwtwt). (B) 9-month old 
APPPS1-21 wild-type or transgenic animals born to transgenic father (wttgwt and tgtgwt) or mother (wtwttg 
and tgwttg) vs. control wild-type animals born to wild-type parents (wtwtwt).   
3.1.3.Genotyping 
To identify the animals genotypes, mouse tail biopsies were lysed in 300µl of DirectPCR tail-lysis 
buffer (Viagen Biotech; Los Angeles, USA) and 30µg Proteinase K (Roth) (3µl) in a TermoMixer 
(Eppendorf; Hamburg, Germany) at 1400rpm and 55°C for 3h and then inactivated at 85°C for 
25 minutes.  
Primers used for the PCR were: 
− APP (3’:  AATTCCGACATGACTCAGG, 5’: GTTCTGCTGCATCTTGGACA) 
− PS1 (5’: AATAGAGAACGGCAGGAGCA, 3’:GCCATGAGGGCACTAATCAT) 
Then, the PCR was performed mixing the PCR master mix and DNA samples according to the 
table 3.1 and using the Cycler according to table 3.2. Genotypes were checked via gel 
electrophoresis on 1.5% agarose gel containing 0.1% ethidium bromide. The gel was run for 
45-90 minutes at 70-130V on TAE 1x buffer. DNA bands were detected using a UV light device 
and observing the bands under 300nm illumination.  
During the last months, a second protocol with a safer and non-carcinogenic DNA stain was 
used. Samples were evaluated via 1.5% agarose gel containing 0.06µl/ml Midori green (Takara 
Clone Tech; Japan) and bands were detected using the FAS V Gel Documentation System 
(Nippon genetics; Japan). 
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A Parents
wt wtwt  (wt  x  wt)
wt tgwt  (tg  x  wt)
tg tgwt   (tg  x  wt)
wt wttg  (wt  x  tg)
tg wttg   (wt  x  tg)
3-month
B Parents
wt wtwt  (wt  x  wt)
wg tgwt  (tg  x  wt)
tg tgwt   (tg  x  wt)
tg tgwt  (tg  x  wt)
tg wttg   (wt  x  tg)
9-month
MATERIALS AND METHODS
Table 3.1. PCR master mix for genotyping. 
Table 3.2. PCR for APP and PS1 genotyping 
3.1.4.Dissection of the brain, and extraction of blood and sperm 
Mice were sacrificed one week (offspring project) and one month (aging project) after the 
behavioral battery using an overdose of Ketamine/Xylazine. The dose used per each mouse was 
0.3µl of the combination of 20µl of Ketamine, 150µl of Xylazine and 30µl 0.9% NaCl. 
After death confirmation, the abdominal cavity was carefully opened, a needle with a syringe (22 
gauges/ 1ml syringe) was inserted into the heart, and then the blood was extracted and collected 
in a specific RNAprotect Animal Blood Tubes (Qiagen; Hilden, Germany). After this step, a small 










Primer APP 5’ 0.25 µl
Primer APP 3’ 0.25 µl
Primer PS1 5’ 0.13 µl




Step Temp. (ºC) Time 
Denaturing 95 2 min
Amplification 




Elongation 72 5 min
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3.1.4.1.Extraction of the blood extraction and dissection of the liver  
After death confirmation, the abdominal cavity was carefully opened, a needle with a 
syringe (22 gauges/ 1ml syringe) was inserted into the heart, and then the blood was 
extracted and collected in a specific RNAprotect Animal Blood Tubes (Qiagen; Hilden, 
Germany). After this step, a small piece of liver was cut. Both samples were directly 
frozen with liquid nitrogen. 
3.1.4.2.Dissection of the hippocampal subregions 
To remove the brain, the scalp was opened; the skull was carefully cut on the middle incision, 
laterals and the most anterior part between the eyes; and then the brain was placed into a metal 
plate on ice to cool down the brain immediately.  
For the hippocampal subregions, the brain was inserted inside a cold PBS Petri dish and cut 
along the medial longitudinal fissure and the cerebral hemisphere was medial sided up. The 
Dentate Gyrus (DG) was dissected from the hippocampus by detaching its borders sliding 
superficially with a needle. The remaining hippocampal parts were pulled off the cortex using a 
surgical scoop and split into Cornu Ammonis 1 (CA1) and 3 (CA3). All the dissection steps were 
performed using a stereoscope.  
3.1.4.3.Extraction of sperm 
For the sperm extraction, cauda epididymis was cut from the mice, placed in a Petri dish with 
1ml of PBS and cut it in several parts. To allow the sperm to swim out, the sample was incubated 
at 37°C and 5% CO2 for 15 minutes.  PBS with the spermatozoids was transferred to a new 
tube and centrifuged at 13000 rpm for 15 minutes at 4°C.   
All dissected regions and extractions were directly frozen in liquid nitrogen and afterward stored 
at -80°C freezer until the tissue is ready for processing.  
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3.2.Behavioral experiments  
Mice from both projects were subjected to a battery of behavioral tests. For the offspring project, 
both females and males were used for behavioral testing. Behavioral experiments were carried 
out by an experimenter blinded to treatment and always by the same experimenter. All tests 
were recorded using a camera setup and Videomot2 tracking system (Version 7.02, TSE 
monitoring system; Bad Homburg, Germany). All behavior devices were cleaned with 70% 
ethanol before every experimental test.  
3.2.1.Open field test 
Open Field (OF) test is a common behavioral test to evaluate exploratory behavior, anxiety 
levels and general motor abilities. This test consists of an open arena (50x50cm) with 
surrounding walls (20cm high walls) that prevent the mouse from escaping. A mouse was placed 
into the central area and was allowed to explore the arena for 5 minutes freely. Time and 
distance spent in the center and periphery, average speed and the total distance were recorded. 
For the data analysis, the open field was virtually divided into 9 identical squares.  
3.2.2.Morris water maze 
Richard G. Morris first established Morris Water Maze test in 1981 to test hippocampal-
dependent spatial learning and memory (R., 1981). This test consists of a circular pool (1.2m in 
diameter) filled with opaque water at 22°C, a submerged platform (10x10cm) and four signs 
around the pool. The pool was virtually divided into 4 equally sections and the platform was 
located in the center of one of the quadrants and right underneath the water surface (1cm). Each 
mouse was placed inside the pool four times every training day for 1 minute, every time from a 
different position. Mice that did not find the platform were guided to the platform and let stay 
there for 15 seconds. During training days, the time and distance (latency) to find the platform 
every day was recorded. During the probe trials (PT), the platform was removed from the pool 
and mouse was placed inside the pool from the opposite side of the original platform position for 
1 minute. Percentage of time and distance spent in the target quadrant, percentage of time and 
distance spent in the control region, average/cumulative distance to the platform, number of 
visits to the platform position and average speed were quantified. Mice that require 55 seconds 
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or more to find the platform during 3 or more training days or with speed less of 3 a.u./sec during 
both probe tests were removed from the analysis. 
3.2.3.Contextual fear conditioning 
Fear conditioning (FC) is a standard test used to study an animal ability to learn basic 
associations. This test consists of a chamber protected from the external sound (58 cm x 30 cm 
x 27 cm) with white noise, white light and a grid on the floor. NIR Video Fear Conditioning 
software controlled the light, noise and video record. During the training day, mice were 
introduced inside the chamber and were allowed to explore the novel context for 3 minutes till 
the last two seconds when they received a foot-shock (0.5mV, during 2 seconds) and then were 
returned to the standard cage. After 24hours (recalling day), mice were introduced inside the 
same chamber, but without receiving any shock. The percentage freezing during training and 
test days was automatically tracked, considering freezing if the motion index was below a 
threshold of 50 for at least 30 frames. The complete equipment and analysis system used was 
from Med Associates; St. Albans, USA. 
3.2.4.Barnes Maze 
Barnes Maze was established by Carol Barnes for testing spatial learning and memory in 1979 
(C. A. Barnes, 1979). This maze consists of a circular open surface with 20 possible escape 
holes symmetrically distributed around the perimeter of the circle and 4 visual cues. Only one of 
the holes has an escape box below. A bright light and different white noises were used to 
stimulate the mouse to enter the escape cage. This test was performed according to Attar with 
some modifications (Attar et al., 2013). On the habituation day, a mouse was placed in the 
middle of the maze underneath a clear glass beaker for 30 seconds while the light was switched 
on. Then, the mouse was guided to the target hole, where it was allowed to enter the escape 
cage and stayed inside for a 1 minute. During training days, the mouse was placed inside an 
opaque plastic cylinder in the center for 15 seconds. Then, it was allowed to explore for 2 
minutes freely. In case that the mouse entered the dark chamber, it was allowed to stay inside 
for 1 minute and then returned to the regular cage. Mice that did not enter the dark chamber 
were guided to the target hole using a glass beaker and were let them enter in the next 3 
minutes. If they did not enter the escape cage during the 3 minutes, they were nudged with the 
beaker until they entered the cage and were allowed to stay 1 minute inside the cage. On the 
probe test day, the escape cage was removed and mouse was placed in the middle underneath 
the opaque cylinder for 15 seconds. Then, each mouse was allowed to move for 2 minutes 
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freely. The time spent in the target quadrant and control region were recorded. During each 
training and test days, type of white noise was changed. First training day only an extremely 
bright switched was switched on. Further training and test days, the light was switched on and 




3.3.1.RNA isolation from brain 
The method selected for RNA isolation was an organic extraction method. All protocol was done 
in a sterile fume hood and all the equipment used was previously cleaned with 70% ethanol and 
RNaseZap to avoid contamination of the samples. Brain tissue was defrosted and kept on ice 
during all the protocol to avoid degradation of samples. Brain samples were homogenized in 
TRIzol Reagent (Sigma-Aldrich; St. Louis, USA) (400µl for CA and 200µl for DG) using 10 
ceramic beads and the Omni Bead-Ruptor 24 (Omni International; Kennesaw, USA) at a speed 
of 2.6 for 5 seconds. The same amount of TRIzol was added for the second time and samples 
were incubated at room temperature (RT) for 5 minutes to lyse the tissue and then were shortly 
vortexed.  
The solution was separated into an aqueous phase and an organic phase, chloroform was 
added (160µl for CA and 80µl for DG), tubes were shaken manually for 15 seconds and were 
incubated at RT for 15 minutes. The aqueous phase, which contains the RNA, was transferred to 
a fresh tube and the interphase (DNA) and organic phase (proteins and phenol) were kept for 
future experiments. The RNA was obtained from the aqueous phase by precipitation adding 
500µl of isopropanol for 1ml TRIzol reagent and 1µl of GlycoBlue (Thermo Fischer Scientific; 
Waltham, USA), vortexing the tube and incubating at -20°C overnight. To obtain the pellet of 
RNA, samples were shortly vortex and centrifugated at 12000rpm for 30 minutes at 4°C. Then 
the supernatant was discarded.  
To remove any residual contaminating DNA and ensure a high quality of RNA, RNA was treated 
with 1µl DNaseI (Invitrogen) (10U/µl), 5µl of 10x Incubation Buffer (Thermo Fischer Scientific; 
Waltham, USA), 0.5µl of RNase OUT (40U/µl) (Thermo Fischer Scientific; Waltham, USA) and 
43.5µl RNase free water; and was incubated for 20 minutes at 37°C. RNA was purified by 
adding 1 volume (200µl) of phenol/chloroform/isoamyl alcohol (25:24:1) and 150µl RNase free 
water, vortexing and centrifuging at 13000rpm for 2 minutes at RT. Then, the aqueous phase 
with RNA was transferred to a new tube and the RNA was precipitated by including 1/10 of the 
volume of the aqueous phase 3M Na-acetate pH 4.8, 1 volume of isopropyl alcohol and 1µl of 
GlycoBlue (Thermo Fischer Scientific; Waltham, USA); vortexing and centrifuging samples at 
13000rpm for 30 minutes at 4°C.  
For the washing steps, the supernatant from the samples was removed, 1ml of 75% ethanol was 
added and the sample was centrifuged at 13000rpm for 5 minutes at 4°C three times. 
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To dissolve the RNA, the supernatant was removed, samples were air-dried for 10 minutes to 
clean the RNA from ethanol, the pellet of RNA was redissolved in 50-100µl RNase free water 
and mixed it with the thermomixer at 42°C for 10 minutes.  
RNA concentration and purity were measured using Nanodrop 2000 (Thermo Fischer Scientific; 
Waltham, USA) and the integrity was checked by using Agilent 2100 Bioanalyzer (Agilent 
Technologies; Santa Clara, USA). Samples with a lower value of 1.8 for 260/280 ratio of 
absorbance or an RNA integrity number (RIN) below 8.0 were treated again with DNase 
treatment and re-purified following previous steps described. 
3.3.2.RNA isolation from the sperm 
The spermatozoa-containing solution was treated with a hypotonic buffer and a somatic cell lysis 
buffer (SCLB; 0.1% SDS, 0.5% Triton X; 100% solved in deionized water) to remove remaining 
somatic cells. This procedure was based on the method previously described by Goodrich 
(Goodrich, Johnson, & Krawetz, 2007). Sperm pellet was thawed and was resuspended by 
adding 1 ml SCLB and pipetting. 4 ml more of SCLB were added before incubation on ice for 30 
minutes. The sample was centrifuged at 600rpm for 15 minutes at 4°C. To remove traces of 
SCLB, the supernatant was removed and washed twice by adding 1ml PBS and centrifuging at 
600rpm for 5 minutes at 4°C. To isolate the RNA from the sperm, the standard protocol of RNA 
isolation explained above was followed.  
3.3.3.RNA isolation from the blood 
RNA from the blood was extracted using the RNeasy Protect Animal Blood Kit (RNeasy silica-
membrane technology) from Qiagen (Hilden, Germany). RNAprotect blood tubes were incubated 
at least for 2h at RT to ensure complete lysis of blood cells.  
Afterward, these tubes were centrifuged at 5000rpm at RT for 3 minutes and the supernatant 
was removed by decanting or pipetting. RNA pellet was dissolved by adding 1ml of RNase free 
water, vortexing and centrifuging at 5000rpm for 3 minutes at RT. To resuspend the pellet, the 
supernatant was removed, 240µl of RSB (resuspension buffer) were added, and then everything 
was vortexed till the pellet was dissolved and transferred to a fresh tube. Blood samples were 
digested using 200µl of RBT (binding buffer) and 20µl of proteinase K, mixing shortly by 
vortexing for 5 seconds and incubating in a shaker-incubator at 400-1400rpm for 10 minutes at 
55°C. Samples were homogenized by pipetting the product to a QIAshredder spin column 
placed in a 2ml collection tube and centrifuge at 19000rpm for 3 minutes at RT. Then the 
supernatant was placed to a new 1.5ml collection tube without touching the pellet, 1.5 volume 
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(generally 690µl) of 100% ethanol was added (to optimize binding conditions) and was mixed by 
vortexing. RNA was pipetted into an RNeasy MinElute spin column placed in 2ml collection tube 
and centrifuge at 10000rpm for 1 minute at RT. The RNA was bound to the silica membrane and 
the supernatant was removed.  
To remove the genomic DNA contamination, 350µl of RWT buffer was added, centrifuged at 
10000rpm for 15 seconds, discarded the flow-through, treated with 80µl of DNaseI incubation 
mix (10µl of DNaseI and 70µl buffer RDD) and incubated on the benchtop for 15 minutes at RT. 
Then, 350µl of RWT buffer was added again, centrifuged at 10000rpm for 15 seconds and 
discarded the flow-through.  The RNA was washed with 500µl RPE buffer (wash buffer 
concentrate), centrifuged at 10000rpm for 15 seconds and discarded the flow-through. 
Afterward, 500µl of 80% ethanol was added and centrifuged at 10000rpm for 2 minutes. The 
spin column was placed in a new 2ml tube, opened centrifuged at full speed for 5 minutes and 
discarded the flow-through and the tube. 
To elute the RNA, the column was placed in a new 1.5ml tube, pipetted 14-30µl REB buffer 
(elution buffer), centrifuged at 10000rpm for 1 minute, incubated the RNA for 5 minutes at 65°C 
in the shaker-incubator without shaking and chilled immediately on ice.  
RNA concentration and purity were quantified using Nanodrop 2000 (Thermo Fischer Scientific; 
Waltham, USA) and the integrity was tested by using Agilent 2100 Bioanalyzer (Agilent 
Technologies; Santa Clara, USA). 
3.3.4.RNA concentration and quality 
The RNA quantity and purity were controlled with Nanodrop 2000 (Thermo Scientific).  Nanodrop 
2000 is a microvolume UV-Vis spectrophotometer that allows the measurement of the RNA 
concentration and purity. Previous to sample measurement, settings were adjusted for RNA 
samples, and the blank (RNase free water) was measured. RNA quantity and purity were 
checked by adding 1µl of the sample onto the pedestal, closing the arm and measuring by 
clicking measure. The absorbance was measured.   
The concentration is based on 260nm absorbance. The purity of DNA and RNA are evaluated 
observing the ratio 260/280 nm. The DNA is pure when the value of 260/280 nm ratio is around 
1.8. The RNA is pure when the value of 260/280 nm ratio is around 2.0. A low ratio might be an 




RNA integration is analyzed using Agilent Bioanalyzer. This equipment allows confirming that the 
ratio of 18S:28S RNA is closed to the theoretical maximum of 2.5 using electrophoretic 
separation and subsequent detection via laser-induced fluorescence and representation in an 
electropherogram. The electropherogram allows the detection of the quality of an RNA sample. 
Profiles generated on the Agilent 2100 Bioanalyzer provide information about the concentration 
and the RNA integrity. The RNA Integrity Number (RIN) is used to screen the integrity of the total 
RNA and is ranged from 1 to 10, from more to less degraded, respectively.  
Previous to the measurement, electrodes were cleaned with RNase free water and RNaseZap 
and the priming station and the program were set for RNA measuring. A new RNA Nano LabChip 
was introduced on the chip priming station. 9µl of gel-dye (previously prepare the mix of 1µl of 
RNA dye concentrate and 65µl of filtered gel, vortexing and centrifuging at 13000rpm at RT for 
10 minutes) was added in a specific well marked with white G and the plunger was pushed until 
it was subjected by the clip for 30 seconds and then it was released for 5 seconds. 9µl of gel-dye 
was also added in two wells marked with black G.  
The loading RNA marker was added in all 12 samples, 1µl of the prepared ladder was pipetted 
in its specific place and 1µl of samples were pipetted in each of the 12 sample wells. The chip 
was vortexed in the IKA vortexer at 2400rpm for 1 minute, it was inserted inside the Bioanalyzer 
and the program was run. Results were analyzed on the computer. Samples with an RNA 
integrity number (RIN) below 8.0 were treated again with DNase treatment and re-purified as 
described. Samples with RIN below 6.0 were not used for further analysis. 
3.3.6.cDNA preparation for RNA detection 
The complementary DNA (cDNA) was prepared using the reverse transcription protocol from 
Roche, Transcriptor First Strand cDNA Synthesis Kit (Roche; Basel, Switzerland).  
RNA concentrations were measured with the Nanodrop and all samples were equally balanced 
at the same concentration adding RNase free water (Table 3.3). RNA samples were mixed with 
primers and RNase free water (Table 3.4). The mixer was denaturated by incubating for 10 
minutes at 65°C in a PCR cycler. Afterward, the concentration of cDNA was diluted to 3-5ng/µl. 
The qPCR mixture and template-primer mix were combined and incubated as described in the 
PCR cycler (Table 3.5). 
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Table 3.3. Balanced of RNA samples 
Table 3.4. Master mix for cDNA preparation 
Table 3.5. cDNA preparation protocol 
3.3.7.Primer design 
PCR primer design depends heavily on several factors, including melting temperature (Tm), 
length, GC content, secondary structure and specificity. A good primer contains from 18-22 
bases, 50-55% GC content and similar melting temperature between both primers.  
Primers for qPCR were designed using the “UPL Assay Design Center”(http://
www.universalprobelibrary.com) from Roche and ordered from Sigma Aldrich (St. Louis, USA). 
Component 11μl 5.5μl
Random hexamer primer (0.6mM) 2μl 1μl
Template RNA (500ng) xμl xμl
RNase free water 11- xμl 5.5 - xμl
Component 11μl 5.5μl
5x Reaction buffer 4μl 2μl
RNase Inhibitor (40U/μl) 0.5μl 0.25μl
dNTP Mix (10mM each) 0.5μl 0.25μl
Reverse Transcriptase 2µl 1µl








3.3.8.Quantitative real time PCR to quantify mRNA levels 
The LightCycler 480 instrument (Roche; Basel, Switzerland) is a quantitative real-time PCR 
(qPCR) and was used to quantify the expression of transcripts and microRNAs.  
3.3.9.qPCR for RNA detection 
3.3.9.1.SYBR Green qPCR 
SYBR Green I Mastermix (2x), water and primers were mixed according to the table 3.5 and 
they were added to each well from the plate. Besides, the cDNA was introduced inside the plate. 
The plate was sealed with Heat-Sealing film and was shortly centrifuged at 10000rpm at RT for 1 
minute. Afterward, the thermal cycling conditions were set as described in table 3.6, the plate 
was placed inside the real-time cycler, and the cycling program was started. 
Table 3.5.Master mix for the qPCR 
Table 3.6 qPCR cycler program 
Component Volume/reaction




cDNA sample (1:10 diluted) 1μl
Step Temp. (°C) Time
PCR initial activation step 95°C 5 min
Denaturation 95°C 10 sec
Annealing 60°C 15 sec
Extension 72°C 10 sec
Cooling 40°C 10 sec








3.4.1.Analysis of qPCR data  
The qPCR data was analyzed following the double delta Ct method (ΔΔCt) (Livak & Schmittgen, 
2001). Relative quantification of gene expression and microRNAs was expressed as a fold 
change (FC). To apply this method, control and experimental samples were tested with genes of 
interest and housekeeping genes (endogenous controls) (Hprt, Gapdh, Tubb3).  In case of 
microRNA analysis, the “housekeeping” smallRNA used is RNU6B (miScript SYBR Green PCR 
kit) and SnoRNA202 (Taqman Universal PCR Master Mix). The average of the same sample 
replicates was taken, and the CT value from the gene of interest was normalized by the CT 
values from the same sample but with the housekeeping gene.  
3.4.2.Next-Generation Sequencing data analysis 
Sequencing data was processed using software pipeline, which was customized in-house. Base 
calls from BCL were converted to FASTQ files using Illumina bcl2fastq (v1.8.4). Then the bases 
were assigned (base calling); the adapters were remove (adapter trimming) and the read 
sequence were divided (demultiplexing). Afterward, the quality of the raw sequence data was 
evaluated using FastQC (v 0.11.5).  The mouse transcriptome (Mus_musculus.GRCm38.86) 
was used to map the reads. The unmapped reads were the mapped to the mouse genome 
(mm10). RNA-STAR 2.5.2b was used for the entire mapping. All the default specifications were 
used, except for the mismatches. No mismatches for the reads <19b, one mismatch for reads 
between 20b to 39b, two mismatches for reads between 40b to 59b and so on were allowed. 
The number of aligned reads overlapping the exons for each gene was counted using HTSeq 
0.9.1(intersection-non-empty mode). The first analysis of differentially expressed genes was 
done observing changes in a scatter plot, known as volcano plot. The cluster of samples was 
evaluated using principal component analysis (PCA). 
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3.4.3.Differentially expression of genes and small RNAs 
To identify differentially expressed genes and microRNAs, the unwanted sources of variation 
(RUVs) were identified and corrected using RUVSeq (v. 1.8.0). The differential expression 
analysis was performed using DESeq2 (v. 1.14.1) (Love, Huber, & Anders, 2014). For further 
analyses, significant thresholds were established according to basemean ≥1, log2FC ±0.25 and 
padj ≤0.05 (Benjamini-Hochberg). Heatmaps and Venn diagrams with these thresholds were 
generated. Bioinformatics & evolutionary genomics  (http://bioinformatics.psb.ugent.be/intranet/) 
and VennDiagrams  (http://www.venndiagrams.net/) web tools were used to measure the overlap 
of genes and generate venn diagrams.  
3.4.4.Differential exon usage 
To identify differentially expressed exons, a customized in-house software pipeline was 
designed, and DEXSeq 1.22 was performed following the standard instructions and using the 
mm10 reference genome (Anders, Reyes, & Huber, 2012). Exons with an adjusted p-value 
≤0.05  and log2FC ±0.25 were considered as significantly differentially expressed exons. The 
measurement of the overlap of gene-set and the Venn diagram illustrations were generated 
using Bioinformatics & evolutionary genomics  (http://bioinformatics.psb.ugent.be/intranet/) and 
VennDiagrams  (http://www.venndiagrams.net/) web tools. 
3.4.5.Pathway analysis 
Two different approaches were used for the functional analysis. First, Gene Set Enrichment 
Analysis (GSEA) (Subramanian et al., 2005), which allows the study of whole dataset functions 
without restricting the study to only genes with a specific threshold. This analysis was performed 
using the standard protocol and selecting following settings, permutation type: gene_set (sample 
size was lower than 7 per group); number permutations: 1000 and chip platform: 
gseaftp.broadinstitute.org://pub/gsea/annotations/GENE_SYMBOL.chip. All three GO term 
categories (biological process, molecular function and cellular component) were evaluated 
independently. The top 50 and 20 significant pathways (nominal pval ≤0.05; false discovery rate 
(FDR) ≤0.1) from each category (biological process, molecular function and cellular component) 
were selected and ranked by Normalized Enrichment Score (NES). The top 25 overrepresented 
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and underrepresented were categorized in a broader biological process and were represented in 
pie charts. GSEA was only used for the transcriptome functional analysis. 
The second approach used for the functional analysis was Cytoscape 3.0 and Cluego 2.3.3 
(Bindea et al., 2009; Shannon et al., 2003), which were used to find the significantly enriched 
pathways in differentially expressed genes, using a cut-off based on padj ≤0.05 and log2FC ± 
0.25. Significant pathways (Benjamini-Hochberg, pval ≤0.05) were displayed with Cytoscape 
plotting tool and also the top 20 were displayed in contingency bars. Up-regulated and down-
regulated genes were separated in 2 clusters. All three GO term categories (biological process, 
molecular function and cellular component) were evaluated together. This approach was used 
for the functional analysis of differentially expressed genes, exons and microRNA target mRNAs.  
3.4.6.Statistics 
Basic analysis and table preparation were done using Microsoft Excel 2010 (Microsoft; 
Redmond, USA). Statistic studies were mainly performed using Prism7 (GraphPad Software; La 
Jolla, USA). Unpaired T-test was used to analyze the significant differences between groups. To 
screened whole dataset one-way or two-way ANOVA was used. To identify outliers inside a 
group the ROUT test (Q=10%) was performed. Differences with a p-value≤0.05 were considered 
significant (*), p-values ≤0.01 (**) and p-values ≤0.001 (***). In order to evaluate the litter and 
batch effects, a linear mixed model was used. This model was specifically designed in-house to 
evaluate these parameters (random factors) using R. The treatment and gender were 






4.1.The early characteristics of Alzheimer’s disease in 
APPPS1-21 mouse model 
4.1.1.Cognitive abilities in APPPS1-21 transgenic mice at 3 months of 
age 
In order to study the cognitive abilities at early stages of Alzheimer’s disease pathology, I 
decided to employ a model for AD, namely the APPPS1-21 mice. Previous studies demonstrated 
that different mouse models of AD showed learning and memory impairments at different ages 
(Gengler et al., 2010; Radde et al., 2006; Serneels et al., 2009). However, this specific model of 
AD has not been characterized at early stages. I characterized cognitive performance in 
APPPS1-21 mice at 3 months of age as compared to wild-type (wt) controls. Moreover, I 
analyzed the parental-specific effect of the APP and PS1 mutations on behavior, testing 
APPPS1-21 transgenic mice obtained from a transgenic father (tgtgwt) or a transgenic mother 
(tgwttg) (Figure 4.1.1A). APPPS1-21 mice were tested in the following battery of behavior tests: 
open field (OF), Morris water maze (MWM) and fear conditioning (FC) (Figure 4.1.1B). Both 
female and male mice were used in the experiment and were pooled together since no 
statistically significant differences in cognitive abilities were observed between them (Appendix 
figure 1-5).  
Figure 4.1.1. Experimental groups and design.  
(A) 3 months old APPPS1-21 transgenic mice born to transgenic fathers (tgtgwt) or mothers (tgwttg) were 
compared to control wild-type mice born to wild-type parents (wtwtwt). (B) 3 months old mice were 
subjected to a battery of behavioral experiments, open field (OF), Morris water maze (MWM) and fear 
conditioning (FC). A week later, brain subregions were dissected, RNA was isolated and RNA sequence 
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I first tested mice in the open field, a commonly used task to measure exploratory behavior, 
general locomotor activity and anxiety. Total distance and speed were comparable between 
groups (Figure 4.1.2A-B), indicating no motor deficit. Moreover, both transgenic groups spent 
significantly more time and traveled longer distances exploring the central area and visited the 
center more often than wild-type mice (Figure 4.1.2C-E). These might suggest that transgenic 
mice at 3 months of age are less anxious compared to wild-type controls. 
Figure 4.1.2. Transgenic mice did not show motor impairments in the open field, but showed less 
anxiety levels at 3 months of age.  
Open field test in APPPS1-21 transgenic mice born to a transgenic father (tgtgwt, n=27) or mother (tgwttg, 
n=16) or pure wild-type mice (wtwtwt, n=34) at 3 months of age. (A and B) Total distance traveled (A) and 
average speed (B) during the open field test. (C, D and E) Percentage of time (C) and distance (D) spent 
on the central area of the field and number of visits to the center (E). Student’s two-tailed T-test, ns = no 
significant differences; **P < 0.01; ***P < 0.001; ****P < 0.0001. Error bars indicated SEM.  
Next, I tested mice for spatial memory in the Morris water maze (MWM). MWM consists of 2 
parts. The first part is the training period, where mice are trained to navigate a pool to find an 
escape platform submerged under water. The second part is the test period, where the mice’ 
memory abilities are evaluated by removing the platform and recording the time mice spend 
searching for the platform in the quadrant where the platform was previously located (the target 
quadrant), indicating their ability to navigate through the maze and recall the target position. 
During the training phase, APPPS1-21 transgenic mice from a mutant father (tgtgwt) or mother 
(tgwttg) required significantly more time to find the platform than controls (wtwtwt) at 3 months of 
age, which was reflected both in the repeated measures ANOVA and the areas under the latency 
curve (AUC) analysis (Figure 4.1.3A-C). AUC in this data represents the total latency time over 
the training days and it is measured by the trapezoidal rule (Bailer, 1988; Gagnon & Peterson, 
1998; Jaki & Wolfsegger, 2009). Nevertheless, all groups presented a daily learning 
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Figure 4.1.3. APPPS1-21 tg mice showed difficulties to learn a spatial task at 3 months of 
age.  
Morris water maze (MWM) in APPPS1-21 transgenic mice born to a transgenic father (tgtgwt, n=25) or 
mother (tgwttg, n=17) and control wild-type mice (wtwtwt, n=30) at 3 months of age. (A and B) tgtgwt vs. wtwtwt 
(A) and tgwttg vs. wtwtwt (B) group-average time to find the target platform on each consecutive training day 
(Day 1-8). Two-way ANOVA after Sidak correction, *P < 0.05; **P < 0.01. The dashed line represents the 
chance level of 25%. First probe trial (PT1, day 6) and second probe trial (PT2, day 10). (C) Comparison 
of transgenic mice (tgtgwt and tgwttg) vs. wild-type mice (wtwtwt) analyzing the areas under the learning 
curves (AUC) of escape latency for each group. Student’s two-tailed T-test, ns = no significant differences; 
*P < 0.05; **P < 0.01. Error bars indicated SEM. 
I carried out 2 probe tests to analyze spatial memory. Probe test 1 (PT1) was performed after 5 
days of training and showed that after these days of training none of the mice in any group had 
learned the task. This suggests that 5 days were not enough to consolidate the platform’s 
position in this mouse model and with this specific protocol. None of the mice in any group spent 
significantly more than 25% of the time and traveled distance in the target quadrant. Despite 
this, wild-type control mice (wtwtwt) showed a clear preference for and traveled longer distances 
in the target quadrant than both APPPS1-21 transgenic groups (tgtgwt and tgwttg) (Figure 4.1.4A-
C). 
Based on these results, I trained the mice for 3 additional days before I subjected them to a 
second probe test (PT2) after 8 total days of training. At this point, wtwtwt mice spent more than 
25% of the time and traveled distance in the target quadrant meaning that they had learned the 
task, whereas both transgenic groups spent similar amounts of time and traveled distance in the 
target and other quadrants. These results indicate that APPPS1-21 transgenic groups did not 
learn the position of the platform at 3 months of age. It is interesting to note, that although the 
learning impairment was apparent for both transgenic groups, the direct comparison for time, 
distance and platform visits of wtwtwt vs. tgwttg mice did not reach significance. This probably 
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indicates a slightly less severe manifestation of the behavioral phenotype in Morris water maze 
(MWM) in mice born to a transgenic mother (Figure 4.1.4D-F).  
As a refinement to the classical MWM memory parameters, I included a more sensitive analysis 
consisting of recording the distance between the position of the mouse and the position of the 
platform during the PT every two seconds. This parameter confirms the significant difference in 
performance between groups during first probe trial for both tgtgwt and tgwttg mice (Figure 4.1.4G-


























































































































































































































































































Figure 4.1.4. Transgenic mice showed spatial memory impairments at 3 months of age.  
Morris water maze (MWM) test in APPPS1-21 transgenic mice born to a transgenic father (tgtgwt, n=25) or 
mother (tgwttg, n=17) and control wild-type mice (wtwtwt, n=30) at 3 months of age. (A-F) Percentage of time 
(A) and distance (B) spent in the target quadrant (T) vs. average of other quadrants (O) and number of 
visits to the platform(C) during first probe trial (PT1, day 6) (A-C) and second probe trial (PT2, day 10) (D-
F). Student’s two-tailed T-test,	  ns = no significant differences; *P < 0.05; **P < 0.01; ***P < 0.001. The 
dashed line represents the chance level of 25%. (G-J) The distance between mouse and the platform 
position every two seconds during PT1 (G) and PT2 (I) and the average of total distance during PT1 (H) 
and PT2 (J). Two-way ANOVA after Sidak correction and student’s two-tailed T-test, *P < 0.05; **P < 0.01; 
***P < 0.001; ****P < 0.0001. Error bars indicated SEM. 
Importantly, none of the mice in any group presented a reduction of the motor skills during all 
training and test phases. During the first day of training and the first probe trial (PT1) all mice 
swam at similar speeds (Figure 4.1.5A-B). Only during the last probe trial (PT2), transgenic mice 
























































































































































































































































































Figure 4.1.5. Transgenic mice did not show swimming difficulties at 3 months of age in the Morris 
water maze (MWM) spatial task. 
Morris water maze (MWM) test in APPPS1-21 transgenic mice born to a transgenic father (tgtgwt, n=25) or 
mother (tgwttg, n=17) and control wild-type mice (wtwtwt, n=30) at 3 months of age. (A) Average speed 
during the first training day of the MWM. (B and C) Average speed during the first probe trial (PT1) (B) 
and second probe trial (PT2) (C). Student’s two-tailed T-test, ns = no significant differences; *P < 0.05. 
Error bars indicated SEM.  
Together, these results confirm that transgenic APPPS1-21 mice exhibit memory impairment 
already at 3 months of age. This effect is comparatively stronger in case of a transgenic father 
(tgtgwt), whereas APPPS1-21 offspring from a transgenic mother (tgwttg) show a milder – yet 
significant – impairment. These impairments in APPPS1-21 offspring are not associated with one 
gender since there were no remarkable gender-dependent differences in the MWM in any group 
(Appendix figure 2 and 3). 
Finally, I tested mice in the contextual fear-conditioning (FC) paradigm, a test for associative 
memory. During the training day, wild-type and tgwttg mice showed similar levels of motility. Only 
tgtgwt mice presented significantly lower motility and significantly higher levels of freezing (Figure 
4.1.6A). During the test, all groups showed similar levels of freezing (Figure 4.1.6B-C). These 
data suggest that at 3 months of age there is no obvious effect of the APP and PS1 transgene 
on contextual associative memory. This reduction of the motility was not associated to one 
gender, since there were no remarkable gender-dependent differences in any of the groups in 


















































wt wtwt tg tgwt tg wttg
A B C
RESULTS
Figure 4.1.6. APPPS1-21 tg mice did not show deficits of contextual associative memory  
at 3 months of age.  
Fear conditioning in APPPS1-21 transgenic mice born to a transgenic father (tgtgwt, n=28) or mother (tgwttg, 
n=19) and control wild-type mice (wtwtwt, n=34) at 3 months of age. (A) Average of motion during the 
training day. (B and C) Percentage of time (B) and time (C) freezing during training (first column) and 
testing day (second column). PS= pre-shock. T= test (24h later). Student’s two-tailed T-test, ns = no 
significant differences; *P < 0.05; **P < 0.01. Error bars indicated SEM. 
4.1.2.Transcriptional profiling and functional pathway analysis in 
APPPS1-21 mice at 3 m 
So far, I have established that APPPS1-21 transgenic mice show spatial cognitive deficits 
already at 3 months of age. I also identified that there are differences in the cognitive 
performance of APPPS1-21 transgenic mice depending on whether they come from a mutant 
mother or father. These data suggest that APPPS1-21 transgenic mice might present changes in 
the cellular state at 3 months of age. Thus, I decided to use the transcriptome as a readout of 
the cellular state and wondered whether I would be able to dissect molecular pathways already 
affected at 3 months of age.  
4.1.2.1.Transcriptional profiling of APPPS1-21 transgenic mice at 3 months of age 
I first concentrated on the analysis of spatial-memory relevant regions of APPPS1-21 transgenic 
mice that originated from an APPPS1-21 tg father or mother (tgtgwt and tgwttg) at 3 months of age.  
Specifically, I analyzed two specific subregions of the hippocampus, the Cornu Ammonis (CA1) 
and the Dentate Gyrus (DG). Both of these regions were involved in spatial memory and were 
one the first regions affected in APPPS1-21 tg mice, by the deposition of amyloid plaques, DG at 
3 months and CA1 at 5 months of age (Radde et al., 2006). I compared the CA1 and DG 
transcriptome from tgtgwt and tgwttg mice to that of control wt mice (wtwtwt). I also stratified samples 
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from male and female APPPS1-21 tg mice. Although I previously defined no significant gender-
associated differences in the cognitive performance for these groups (Appendix figure 1-5), I 
wondered whether there would be gender-specific differences at the transcriptomic levels as 
there are gene expression regulatory mechanisms that are known to be gender-specific (Khor, 
Tong, Qian, & Song, 2008; Manoli & Tollkuhn, 2018). The quality of CA1 female samples was 
rather poor and thus results from these samples will be omitted in this report.  
As seen previously, tg mice born to APPPS1-21 tg fathers (tgtgwt) showed strong spatial cognitive 
deficits. These deficits were also observed in tg mice born to APPPS1-21 tg mother (tgwttg), albeit 
in a milder form. Despite the mild cognitive differences, tgtgwt and tgwttg were mostly 
undistinguishable at transcriptomic level, so they were combined in order to identify stronger 
effects linked to the APPPS1-21 phenotype. At the transcriptomic level, the variability of tgtgwt vs. 
tgwttg mice (0.4% for DGm, 0.06% for DGf and 0.05% for CA1m) was almost negligible compared 
to the combination of APPPS1-21 tg groups vs. control wtwtwt (2.8% for DGm, 3.3% for DGf and 
0.11 for CA1m) (Appendix table 2).  
The transcriptomic profile was evaluated based on significant differentially expressed genes 
(padj ≤ 0.05) and observing level of changes defined by log2FC cutoff as severe (± 1.00), 
medium (± 0.50) and mild (± 0.25) (Figure 4.1.7A). The majority of genes fell into mild to medium 
changes in APPPS1-21 tg mice, indicating a moderate alteration of the transcriptome, maybe 
affected by certain compensatory mechanisms. Because the main changes in the transcriptome 
were observed for genes at the mild level (padj ≤ 0.05; log2FC ± 0.25), further differentially 
expressed and signaling pathway analyses were focused on these genes.  
Analyzing specifically genes associated with mild changes, around 54-60% of total genes were 
up-regulated in all three regions of the hippocampus of APPPS1-21 transgenic mice.  Compared 
to DG from males and females (1374 for DG from males and 1595 for DG from females), the 
CA1 region from APPPS1-21 tg males was only mildly affected regarding gene expression all 
compared to wild-type controls (wtwtwt) (only 55 for CA1 from males) (Figure 4.1.7A-B and D-F). 
This might be connected to the fact that at 3 months of age only DG and neocortex were 
affected by plaque formation, whereas CA1 will not be affected until 2 or 3 months later in this 
model of AD (Radde et al., 2006). From the total number of significant differentially expressed 
genes (padj ≤ 0.05 and log2FC ± 0.25) in transgenic mice, around 25% of genes overlapped 
between male and female mice in DG regions (Figure 4.1.7C). This percentage suggests that 
male and female tg mice exhibited different transcriptomic profile, although cognitive 
performance was similar between both genders. Thus, as I hypothesized, there were in fact 
gender-specific transcriptomic states despite similar behavioral output. 75% of genes affected by 
the double mutation depend on the gender. These differences might indicate a gender-




Figure 4.1.7. Mild to medium transcriptional differences in APPPS1-21 transgenic mice at 3 months 
of age. 
(A) Number of significant differentially expressed genes with different level of changes (severe (± 1.00), 
medium (± 0.50) and mild (± 0.25), established by the log2FC) between transgenic (tg= tgtgwt + tgwttg) and 
control wild-type (wtwtwt) mice. Padj, P value adjusted and log2FC, logarithm base 2 of Fold Change. (B) 
Number of significant differentially expressed up- and down-regulated genes for DG males (DGm), DG 
females (DGf) and CA1 males (CA1m) in tg vs. wtwtwt comparison. Padj ≤ 0.05, log2FC ± 0.25. (C) Venn 
diagram showing overlap between significant genes in different subregions (DGm, DGf and CA1m). Padj ≤ 
0.05, log2FC ± 0.25. (D-F) Heatmaps of differentially expressed genes in 3 months old tg vs. wtwtwt. High 
expression is indicated by the red color spectrum and low expression by the blue color spectrum. Padj ≤ 
0.05, log2FC ± 0.25. For DG males: transgenic tg n = 4 and wtwtwt n= 5; for DG females tg n=7 and wtwtwt 
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4.1.2.2.Functional pathway analysis of APPPS1-21 transgenic mice at 3 months of 
age 
Having established the transcriptomic signature of transgenic APPPS1-21 mice in DG and CA1 
at 3 months of age, I next focused on the functional pathways linked with those genes. For that, I 
used the analytical method called Gene Set Enrichment Analysis (GSEA) (Mootha et al., 2003; 
Subramanian et al., 2005) that allows me to study the whole dataset functions without restricting 
the study to only genes with a specific threshold.   
In order to further investigate the molecular state in DG and CA1 of transgenic mice at 3 months 
of age, I ran the full list of normalized counts in control wt mice (wtwtwt) and APPPS1-21 tg mice 
through GSEA. To obtain a first idea of the mechanisms involved, I selected the top 50 
significant pathways (nominal pval ≤ 0.05; FDR ≤ 0.1) from each category (biological process, 
molecular function and cellular component) ranked by Normalized Enrichment Score (NES). The 
NES indicates the level to which a group of genes is represented in the upper or lower part of 
the ranked list of genes in the expression dataset (Subramanian et al., 2005). Positive pathways 
mean enrichment in wild-type mice, whereas negative pathways are enriched in transgenic mice. 
From these top 50 pathways, I screened in detail which broader term could be used to 
summarize the pathways, in order to get a first idea of the most important mechanisms 
associated with tg mice at 3 months of age. 
Analyzing the broader biological processes associated with the top 50 preselected pathways, 
similar functions were affected in male and female DG regions (Figure 4.1.8B, C, E and F). Even 
though these regions shared only 25% of common genes; similar functional pathways were 
affected in both genders. The majority of enriched GO terms in DG of APPPS1-21 tg mice were 
linked to synapse and nervous system development, an expected finding since DG is an 
important area of adult neurogenesis (Ming & Song, 2011) (Figure 4.1.8A, C ,D and F). On the 
contrary, pathways related to metabolic process, mitochondria complex and respiratory chain, 
localization, transport and translation were underrepresented in APPPS1-21 tg mice (Figure 
4.1.8A, B, D and E). Taking into account that APPPS1-21 tg mice previously manifested spatial 
cognitive impairments, this overrepresentation of genes related to behavior, synapse or nervous 
system development might be part of a compensatory network that counteract acted AD 
pathology changes. Apart from these similar categories in male and female DG regions, there 
were gender-specific changes in certain gene-sets. In DG from males, several genes were 
involved in RNA metabolism and cellular component biogenesis (Figure 4.1.8A-C), whereas in 




In the CA1 male region of APPPS1-21 transgenic mice, genes related to metabolic processes, 
mitochondria complex and respiratory chain, synapse, transport and localization were altered 
similarly as in male and female DG regions (Figure 4.1.8G-I). However, pathways linked to lipid 
metabolism, secretion, inflammation and coagulation were exclusively affected in the CA1 
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Figure 4.1.8. Biological processes are affected in APPPS1-21 transgenic brain subregions at 3 
months of age.  
(A, D and G) Top 10 preselected biological processes over or underrepresented within the whole dataset 
of genes in tg or control (wtwtwt) brain subregions. DGm (A), DGf (D) and CA1m (G). NES= Normalized 
Enrichment Score. Positive NES means underrepresentation in tg mice, whereas negative NES means 
overrepresentation in tg mice. (B, C, E, F, H and I) Broader term summary of the top 25 overrepresented 
(C, F and I) and 25 underrepresented (B, E and F) pathways in transgenic brain subregions. Nominal pval 
≤ 0.05; FDR ≤ 0.25. For DG males: transgenic tg n = 4 and wtwtwt n= 5; for DG females tg n=7 and wtwtwt 
n=5 and for CA1 males transgenic tg n=6 and wtwtwt n=6. 
Interestingly, genes associated with the top 50 significant molecular function ontologies were 
highly compatible with the observations in the biological process ontology. Genes associated 
with oxidoreductase activity, a critical activity in the mitochondrial complex, were altered in CA1 
and DG regions of APPPS1-21 tg mice. Moreover, genes associated with transcription regulatory 
activity, an activity essential for signal transduction, were as well altered in the CA1 and DG 
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Figure 4.1.9. Molecular functions are affected in APPPS1-21 transgenic brain subregions at 3 
months of age.  
(A, D and G) Top 10 preselected molecular functions over/underrepresented within the whole dataset of 
genes in tg or control (wtwtwt) brain subregions: DGm (A), DGf (D) and CA1m (G). NES= Normalized 
Enrichment Score. Positive NES means underrepresentation in tg mice, whereas negative NES means 
overrepresentation in tg mice. (B, C, E, F, H and I) Broader term summary of the top 25 overrepresented 
(C, F and I) and 25 underrepresented (B, E and F) pathways in transgenic brain subregions. Nominal pval 
≤ 0.05; FDR ≤ 0.25. For DG males: transgenic tg n = 4 and wtwtwt n= 5; for DG females tg n=7 and wtwtwt 
n=5 and for CA1 males transgenic tg n=6 and wtwtwt n=6. 
The cellular component ontology revealed genes related to synapse, ribosome and mitochondria 
in DG and CA1 regions of APPPS1-21 tg mice compared to control wt mice (Figure 4.1.8A-I). In 
DG from males and females and CA1 from males, cellular components associated with 
mitochondria complex, respiratory chain, ribosome and splicing were underrepresented in 
APPPS1-21 tg mice (Figure 4.1.10A, B, D, E, G and H). In contrast, genes linked to synapse, 
neuronal parts and cytoskeleton were up-regulated in APPPS1-21 tg mice (Figure 4.1.10A, C, D, 
F, G and I). This data from the cellular components is in agreement with the previous results 
seen for biological process and molecular functions (Figure 4.1.8A-I and Figure 4.1.9A-I). 
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Figure 4.1.10. Cellular components are affected in APPPS1-21 transgenic brain subregions at 3 
months of age.  
(A, D and G) Top 10 preselected cellular components over/underrepresented within the whole dataset of 
genes in tg or control (wtwtwt) brain subregions: DGm (A), DGf (D) and CA1m (G). NES= Normalized 
Enrichment Score. Positive NES means underrepresentation in tg mice, whereas negative NES means 
overrepresentation in tg mice. (B, C, E, F, H and I) Broader term summary of the top 25 overrepresented 
(C, F and I) and 25 underrepresented (B, E and F) pathways in transgenic brain subregions. Nominal pval 
≤ 0.05; FDR ≤ 0.25. For DG males: transgenic tg n = 4 and wtwtwt n= 5; for DG females tg n=7 and wtwtwt 
n=5 and for CA1 males transgenic tg n=6 and wtwtwt n=6.  
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Taken together, these data indicate that APPPS1-21 transgenic mice show moderate but 
consistent changes in gene expression variation that accompany cognitive deficits already at 3 
months of age. These findings confirm that the genetic alteration from transgenic offspring 
promotes changes at the global molecular state of the hippocampus of these mice, affecting 
networks linked to synapse, nervous system development, energy metabolism and protein 
biosynthesis.  
As an alternative method to find significantly enriched pathways in differentially expressed genes 
in APPPS1-21 transgenic vs. control wild-type mice, I used a cutoff-based approach. In contrast 
to GSEA analyses, classical Gene Ontology (GO) analyses make use of only a partial set of the 
dataset, usually genes that show significant deregulation at a certain cutoff. I screened 
exclusively the differentially expressed genes (padj ≤ 0.05; log2FC ±0.25) for GO terms using a 
tool called ClueGO that uses Cytoscape to represent associated networks (Bindea et al., 2009; 
Shannon et al., 2003). All pathways represented in figure 4.1.11 exhibited a significant pvalue of 
≤ 0.05. A substantial shift towards pathways related to up-regulated genes can be observed in all 
three regions (Figure 4.1.11A-C).  
The most significantly affected pathways in DG regions, indicated by an intense red or blue color 
in figure 4.1.11A-B, are linked to nervous system development, synapse, RNA metabolic 
process, mitochondrial complex and ion transport. In particular, analyzing only the top 20 
significant pathways, around 75% of the pathways were related to nervous system development 
and neurogenesis (Figure 4.1.11A-B and D-E).  Interestingly transgenic mice showed strong 
changes in one of the most relevant functions of the DG, neurogenesis process (Ming & Song, 
2011). To a lesser extent, pathways related to signal transduction, metabolic process, cell-cell 
adhesion, component biogenesis, chromatin modification and regulation membrane potential 
were altered in transgenic mice (Figure 4.1.11A-B and D-E). Interestingly, several biological 
processes were shared between males and females, in agreement with the results previously 
seen in the GSEA analysis (Figure 4.1.11A-B and D-E). Particularly, in CA1 from male mice only 
cell-cell adhesion and cell projection, pathways associated with up-regulated genes, were 
significantly different (Figure 4.1.8C and F). These results confirm that the CA1 transcriptome is 
almost not altered compared to the DG region at 3 months of age in this model of AD.  
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Figure 4.1.11. Functional pathways affected in APPPS1-21 transgenic mice, specifically in DG from 
males and females.  
(A-C) Network of functional categories (biological process, molecular function and cellular component 
ontologies) of significant differentially expressed genes in brain subregions of transgenic APPPS1-21 
mice. The size of the nodes correlates inversely with statistical significance. Categories with a red color 
spectrum correspond to up-regulated genes in tg mice and blue correspond to down-regulated genes. 
Categories that shared up- and down-regulated genes are represented in grey. Genes, padj ≤ 0.05; 
log2FC ±0.25 and pathways, pval < 0.05. (D-F) Top 20 significant functional pathways ranked by -log pVal 
after Benjamini-Hochberg correction of significant differentially expressed genes in brain subregions of 
wttgwt vs. wtwtwt mice. Genes, padj ≤ 0.05; log2FC ± 0.25 and pathways, pval < 0.05. 
These findings with ClueGO/Cytoscape are in agreement with GSEA data and reflect the 
important role that genes linked to synapse, nervous system development, cell-cell adhesion, 
protein localization, metabolism and gene expression play on the molecular state of transgenic 
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4.1.3.Alternative exon usage and functional pathway analysis in 
APPPS1-21 transgenic mice at 3m 
So far, I have analyzed the variability concerning cognitive performance and transcriptome from 
APPPS1-21 transgenic mice at 3 months of age compared to control wt mice. I used the 
transcriptome as a readout of cellular state of APPPS1-21 tg mice, and I was able to identify 
different functional pathways associated with the APP/PS1 transgene. And I found that pathways 
related to splicing were altered in tg mice.  Thus, I decided to study the alternative exon usage in 
APPPS1-21 tg mice. 
4.1.3.1.Alternative exon usage in APPPS1-21 transgenic mice  
To analyze the differences of exon usage between transgenic and control wild-type mice, I 
screened the alternative exon usage in previously analyzed hippocampus subregions (CA1 and 
DG) of APPPS1-21 tg mice with DEXSeq (Anders et al., 2012). Only statistically significant 
genes (padj ≤ 0.05) were evaluated and changes in levels of exon usage were analyzed by 
log2FC cutoff as severe (± 1.00), medium (± 0.50) and mild (± 0.25).  
Notably, a large number of genes showed significant (padj ≤ 0.05) alternative exon usage in CA1 
and DG from APPPS1-21 tg mice. From 150 for CA1m to 2330 for DGf genes showed severe 
changes and thousands of them (from 3659 for DGm to 9605 for DGf) showed a mild change in 
tg mice (Figure 4.1.12A), indicating a strong alteration of the exon usage. The CA1 region of 
APPPS1-21 tg mice was also strongly affected and a substantial shift towards the inclusion of 
exons can be observed in CA1 and DG of the experimental groups (Figure 4.1.12A-B) 
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Figure 4.44: Small alternative exon usage changes between wild-type and transgenic APPPS1-21 offspring: (A-C) 
Number of significant differentially spliced genes in DG from males (A) and females (B) and CA1 (C) from male of wtwtwt, wttgwt 
and wtwttg animals compare to tg APPPS1-21 transgenic animals. Red columns represent significant alternative inclusion exons; 
blue columns represent significant alternative exclusion exons and greys are the sum of previous two. Genes, padj ≤ 0.05; 
log2FC ±0.25  . For DG males: tg n=4; wttgwt n=7; wtwttg n=5 and wt wtwt n=5; for DG females tg n=7; wttgwt n=5; wtwttg n=4 and wt wtwt n=5 and 
for CA1 males tg n=6; wttgwt n=7; wtwttg n=8 and wt wtwt n=6.
Figure 4.43: Drastic alteration of alternative exon usage in DG and CA1 of transgenic animals: (A) Number of significant alternative 
exon usage with different levels of changes (severe, medium and mild, established by the log2FC) in tg animals compare to wt
wtwt animals. 
Exon usage, padj ≤ 0.05. (B) Number of significant included and excluded exons for DG males (DGm), DG females (DGf) and CA1 males 
(CA1m) in tg vs. wtwtwt animals. Red columns represent significant alternative included exons and blue columns represent significant alterna-
tive excluded exons. Exon usage, padj ≤ 0.05, log2FC±0.25. For DG males:  tg n=4 and wt 
wtwt n=5; for DG females tg n=7 and wt wtwt n=5 and 





























































































































Figure 4.12. Drastic alteration in the alternative exon usage in DG and CA1 of APPPS1-21 
transgenic mice.  
(A) Number of significant alternative exon usage with different levels of changes (severe (± 1.00), medium 
(± 0.50) and mild (± 0.25), established by the log2FC) in tg mice compared to wtwtwt mice. Exon usage, 
padj ≤ 0.05. (B) Number of significant included and excluded exons for DG males (DGm), DG females 
(DGf) and CA1 males (CA1m) in tg vs. wtwtwt mice. Red columns represent significant alternative included 
exons and blue columns represent significant alternative excluded exons. Exon usage, padj ≤ 0.05, 
log2FC±0.25. For DG males:  tg n=4 and wtwtwt n=5; for DG females tg n=7 and wtwtwt n=5 and for CA1 
males tg n=6 and wtwtwt n=6. 
Based on significant differential exon usage (padj ≤ 0.05), I compared DG from males and 
females and CA1 from males of APPPS1-21 tg mice, all of them compared to control wt mice 
(wtwtwt). I found that a large number of identical genes (1422) showed alternative exon usage in 
all three regions. In DG from males, this represented a 46.4% from the total alternative exon 
usage, 21.8% in DG from females and 35% in CA1 from males (Figure 4.1.13A-C).  
Figure 4.1.13.  A large number of identical genes showed alternative exon usage in DG from males 
and females and CA1 from males of genes in APPPS1-21 transgenic mice. 
(A-C) Venn diagrams illustrating overlap of spliced genes in DG from males and females and CA1 from 
males in tg vs. wtwtwt comparison. Genes, padj ≤ 0.05; log2FC ± 0.25. For DG males: tg n=4 and wtwtwt n=5; 
for DG females tg n=7 and wtwtwt n=5 and for CA1 males tg n=6 and wtwtwt n=6. 
Taken together, these results indicate that APPPS1-21 transgenic mice show more drastic 
alternative exon usage changes than transcriptomic changes in DG and CA1 regions. A large 
number of genes that had alternative exon usage were shared between CA1 and DG regions of 






























4.1.3.2.Functional pathways linked to alternative exons in APPPS1-21 transgenic 
mice at 3 months of age 
In order to further investigate the molecular state affected by alternative exon usage, I performed 
a functional analysis using ClueGO/Cytoscape (Bindea et al., 2009) (Shannon et al., 2003). I 
analyzed the genes with a significantly altered exon usage (padj ≤ 0.05 and log2FC ± 0.25) in 
APPPS1-21 tg mice compared to control wt mice (wtwtwt). Thousands of signaling pathways were 
disrupted in male and female DG and male CA1 of APPPS1-21 tg mice (2460 for DGm, 3556 for 
DGf and 2887 for CA1m). These dramatic changes suggest that the combination of inherited 
genetic and non-genetic factors promote an extreme alteration in the global translational 
processes, affecting genes associated to a very wide spectrum of functions. To focus on the 
most relevant pathways, I screened the top 20 most significantly affected biological processes 
and molecular functions ranked by corrected p-value (Benjamini-Hochberg). Differentially exon 
usage was observed in many genes involved in the system and nervous system development, 
cell and neuronal projection, signaling receptor activity, transport and localization (mainly of 
proteins) and metabolic process (mainly protein) (Figure 4.1.14A-C). 
  
Figure 4.1.14. Top 20 significant pathways affected by alternative exon usage in genes of CA1 and 
DG from APPPS1-21 transgenic mice.  
(A-C) Top 20 significant functional pathways ranked by -log pval after Benjamini-Hochberg correction of 
significant differentially expressed genes in brain subregions of tg vs. wtwtwt comparison. Genes, padj ≤ 
0.05; log2FC ± 0.25 and pathways, pval < 0.05. For DG males: tg n=4; wttgwt n=7 and wtwtwt n=5; for DG 
females tg n=7; wttgwt n=5 and wtwtwt n=5 and for CA1 males tg n=6; wttgwt n=7 and wtwtwt n=6. 
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RESULTS
 Notably, several of these biological functions were also affected in the transcriptome of 
APPPS1-21 tg mice (section), such as nervous system development, transport and localization 
and metabolic process. Thus, I wondered whether these genes affected by alternative exon 
usage corresponded to the significant differentially expressed genes in APPPS1-21 tg mice. To 
this end, I compared the up-/down-regulated and the total number of differentially expressed and 
alternatively spliced genes in APPPS1-21 tg mice compared to wt control mice. Around 30% of 
the differential expressed genes in CA1 and DG regions of tg mice also showed modifications on 
the splicing events (Figure 4.1.15A-C). These results indicate that only 30% of the transcriptome 
from APPPS1-21 tg mice is also affected by an alternative splicing process, whereas 70% of the 
differentially expressed genes in APPPS1-21 tg mice did not show an alteration of their splice 
events.   
Figure 4.1.15. Around 30% of genes were affected by differential expression and splicing in CA1 
and DG regions of APPPS1-21 transgenic mice.  
(A-C) Venn-diagrams are showing the overlap of genes affected by differentially expression and splicing in 
CA1 and DG regions of APPPS1-21 tg mice. Genes, padj ≤ 0.05; log2FC ± 0.25 and pathways, pval < 
0.05. For DG males: tg n=4 and wtwtwt n=5; for DG females tg n=7 and wtwtwt n=5 and for CA1 males tg 
n=6 and wtwtwt n=6.    
Next, I analyzed the pathways of those genes that were both differentially expressed and had an 
alternative exon usage in APPPS1-21 tg mice. Along these genes in DG from male and female 
APPPS1-21 tg mice, I could find genes related to nervous system development, embryo 
development, synapse, microtubule and cytoskeleton, cell metabolic process, chromatin 
modification, cell death, transmembrane transport, RNA metabolic process and response to 
stimulus (Figure 4.1.16A-C). Almost all pathways were associated with up-regulated genes, 
except pathways connected with mitochondria, ATPase activity and ribonucleotide metabolism, 
which were associated with down-regulated genes (Figure 4.1.16A-C). The overlap between 
differentially expressed and spliced genes in CA1 from males was too small to observe any 
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Figure 4.1.16. Several pathways were affected by those genes that were both differentially 
expressed and had an alternative exon usage in DG region of APPPS1-21 transgenic mice.  
(A-B) Network of functional categories (biological process, molecular function and cellular component 
ontologies) of significant differentially expressed and spliced genes in DG of APPPS1-21 transgenic mice. 
The size of the nodes correlates inversely with statistical significance. Categories with a red color 
spectrum correspond to pathways associated with genes with inclusion of exons and up-regulated genes 
in transgenic mice and with blue correspond to exclusion of exons and down-regulated genes. Genes, 
padj ≤ 0.05; log2FC ± 0.25 and pathways, pval < 0.05. For DG males: tg n=4 and wtwtwt n=5; for DG 
females tg n=7 and wtwtwt n=5 and for CA1 males tg n=6 and wtwtwt n=6.   
These findings suggest the existence of a clear connection between the altered expressed 
genes and the alternative exon usage in APPPS1-21 tg mice and therefore of the pathways 
associated with them. On the other hand, a high proportion of differentially expressed or 
differentially spliced genes did not overlap (around 70%), indicating alteration of distinct 
signaling pathways that directly or indirectly can be connected in similar networks associated 











































































































4.2.Intergenerational effect on wild-type mice born to an 
APPPS1-21 transgenic father or mother   
4.2.1.Cognitive abilities of wild-type mice born to APPPS1-21 
transgenic parents  
4.2.1.1.Cognitive abilities in wild-type mice born to APPPS1-21 transgenic fathers or 
mothers at 3 months of age               
Having established the cognitive performance, the transcriptome and the exon usage of 
APPPS1-21 tg mice, I next focused on the potential intergenerational transmission of non-
genetic factors from tg parents to their wild-type offspring. This paternal transmission might 
impact on memory function. Several studies have shown a substantial effect of parental lifestyle 
on offspring phenotypes via epigenetic inheritance (Anway et al., 2005; Rodgers et al., 2015; 
Siklenka et al., 2015; Wei et al., 2014). I wondered whether a genetic factor, such as a specific 
genotypic composition, could also influence the next generation through non-genetic 
mechanisms. Concretely, I posed the question of whether wt offspring from APPPS1-21 tg 
parents would show any cognitive differences as compared to control wild-type mice born to two 
wt parents, i.e. whether there is any non-genetic trace of the parent’s genotype that gets 
transmitted to the next generation.  To study this idea, I tested the following groups: wt mice born 
to an APPPS1-21 tg father and a wt mother (wtgwt), wt mice born to a wt father and an 
APPPS1-21 tg mother (wtwttg), as the main experimental groups. As control groups I used wt 
mice born to wt parents (wtwtwt), as well as tg mice born to a tg father (tgtgwt), and tg mice born to 
a tg mother (tgwttg) (Figure 4.2.1A). Both male and female were evaluated together since 
independently did not show statistically significant differences in learning tasks (Appendix figure 
1-5). Both gender offspring were tested through the same behavioral battery delineated earlier: 
open field (OF), Morris water maze (MWM) and fear conditioning (FC) (Figure 4.2.1B). I always 
carried out two groups of comparisons. First, I compared wttgwt mice to control wt (wtwtwt) mice 




Figure 4.2.1. Experimental groups and design.  
(A) 3-month old APPPS1-21 wild-type or transgenic mice born to transgenic fathers (wttgwt and tgtgwt) or 
mothers (wtwttg and tgwttg) vs. control wild-type mice born to wild-type parents (wtwtwt). (B) Mice were 
subjected to a battery of behavioral experiments, open field (OF), Morris water maze (MWM) and fear 
conditioning (FC). A week later, brain subregions were dissected, RNA was isolated and RNA sequence 
was ran and analyzed.  
I first tested mice in the open field test (OF). Wt and tg mice born to an APPPS1-21 tg father did 
not show any differences in distance or speed in the OF test, indicating no motor impairments or 
apathy (Figure 4.2.2A-B). In contrast, wtwttg mice showed a mild but significant reduction in the 
speed and traveled distance (Figure 4.2.2F-G). This reduction is probably due to an increase of 
apathy more than an impairment of their motor abilities, since wtwttg also traveled more distance 
in the center compared to control wt mice (Figure 4.2.2I). Importantly, wttgwt did not show the 
decrease anxiety phenotype described for tgtgwt (Figure 4.2.2C-E). Thus, wttgwt resembled control 
wt mice more than they did tg mice in the open field parameters. For wtwttg, the situation was 
similar, although there was a slight trend towards tgwttg showing a slightly less anxious phenotype 
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Figure 4.2.2. Wild-type mice born to APPPS1-21 transgenic fathers (wttgwt) did not show motor 
impairments, an increase of apathy or levels of anxiety, whereas wild-type born to APPPS1-21 
transgenic mothers (wtwttg) showed a slight increase of apathy and reduction of anxiety levels in 
the open field test at 3 months of age.  
Open field test in APPPS1-21 wild-type and transgenic mice born to transgenic father (wttgwt, n=32; tgtgwt, 
n=27) or mother (wtwttg, n=24; tgwttg, n=16) and control wild-type mice (wtwtwt, n=34) at 3 months of age: (A 
and B) Total traveled distance (A) and average speed (B) during the open field test. (C-E) Percentage of 
time (C) and distance (D) spent in the central area of the field and number of visits center (E). Student’s 
two-tailed T-test, ns = no significant differences; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. Error 
bars indicated SEM. 
In conclusion, OF revealed no major motor impairments in wild-type mice born to either 
APPPS1-21 tg mothers or fathers and indicated no overall significant differences in anxiety 
behavior. 
Next, I tested spatial memory in the Morris water maze (MWM). During the spatial learning 
process in MWM task, wild-type born to APPPS1-21 transgenic fathers (wttgwt) presented 
different spatial behavior compared to wild-type controls (wtwtwt). Wttgwt required significantly 
more time than wtwtwt to find the platform each day and overall during the total training process 
(Figure 4.2.3A-B). Thus, their cognitive performance resembles that of tgtgwt, indicating that there 
is in fact a non-genetic inheritance or trace of the genetic makeup of the male parent. On the 
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RESULTS
platform (Figure 4.2.3C-D). This is in line with the previous observation that tgwttg mice show a 
milder cognitive impairment as compared to that of tgtgwt (Figure 4.1.4I-J). 
Figure 4.2.3. Only wild-type mice born to an APPPS1-21 transgenic father showed difficulties to 
learn a spatial task at 3 months of age. 
 Morris water maze (MWM) test in APPPS1-21 wild-type and transgenic mice born to a transgenic father 
(wttgwt, n= 30; tgtgwt, n=25) or mother (wtwttg, n=18; tgwttg, n=17) and control wild-type mice (wtwtwt, n=30) at 
3 months of age. (A and B) wttgwt vs. wtwtwt and tgtgwt (A) and wtwttg vs. wtwtwt and tgwttg (B) group-average 
time to find the target platform on each consecutive training day (Day 1-8). Two-way ANOVA after Sidak 
correction, ns = no significant differences; **P < 0.01. The dashed line represents the chance level of 
25%. First probe trial (PT1, day 6) and second probe trial (PT2, day 10). (C) Comparison of wild-type 
experimental groups (wttgwt and wtwttg) vs. wild-type controls (wtwtwt) and transgenic groups (tgtgwt and tgwttg) 
analyzing the areas under the learning curves (AUC) of escape latency for each group. Student’s two-
tailed T-test, ns = no significant differences; **P < 0.01; ***P < 0.001. Error bars indicated SEM. 
Similarly to the tests presented for APPPS1-21 transgenic mice, I carried out a first probe test 
after 5 days of training (PT1). None of the control wild-type and experimental mice spent 
significantly more time in the target quadrant than in the rest of the pool. So, I conclude that for 
this specific colony and this specific protocol, 5 days of training were not enough to learn the 
task (Figure 4.2.4A-F). 
I then performed a second probe trial (PT2) after 3 additional days of training, at day 8. At this 
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target quadrant than in the other quadrants. Wtwtwt spent more than 25% of the traveled time and 
distance in the target quadrant, indicating a solid memory for the platform location (Figure 
4.2.4G-H and J-K). In contrast, neither wttgwt nor tgtgwt showed a preference for the target 
quadrant (Figure 4.2.4G-H). Wtwtwt visited the platform more often than the other wild-type 
groups, although these differences failed to reach statistical significance (Figure 4.2.4I and L). 
Taken together, these results support my initial observation during training that wt mice born to 
an APPPS1-21 tg father behaviorally resembled a tg mice more than they do wt mice (Figure 
4.2.3A-B). This supports a non-genetic form of inheritance of a cognitive deficit or a 
predisposition to perform worse than control wt counterparts. In contrast to this and in 
agreement with PT1, wtwttg behaved more similarly to wtwtwt and showed borderline memory for 
the platform location (Figure 4.2.4D-F and J-L). 
As before, checking the distance between the mouse’s trajectory and that of the platform every 
two seconds during the test greatly accentuated the differences between the groups. As can be 
observed in figure 4.2.4M, O, Q and R there were big differences between wttgwt and control wt 
controls in the distance per time and in the global distance parameters. These effects were 
detected in both probe trials, PT1 and PT2 (Figure 4.1.10M, O, Q and R). In contrast, wtwttg mice 
traveled a similar distance to control mice during both probe trials, although there was a clear 
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Figure 4.2.4. Only wild-type mice born to APPPS1-21 transgenic father (wttgwt) showed spatial 
memory impairments at 3 months of age.  
Morris water maze (MWM) test in APPPS1-21 wild-type and transgenic mice born to a transgenic father 
(wttgwt, n= 30; tgtgwt, n=25) or mother (wtwttg, n=18; tgwttg, n=17) and control wild-type mice (wtwtwt, n=30) at 
3 months of age. (A-L) Percentage of time (A, D, G and J) and distance (B, E, H and K) spent in the 
target quadrant (T) vs. average other quadrants (O) and number of visits to the platform (C, F, I and L) 
during first probe trial (PT1, day 6) (A-F) and second probe trial (PT2, day 10) (G-L). Student’s two-tailed 
T-test, ns = no significant differences; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. Column 
statistics, one-sample T-test, hypothetical value 25. ns = no significant differences; $P < 0.05. The dashed 
line represents the chance level of 25%. (M-T) The distance between mouse and the platform position 
every two seconds during PT1 (M and N) and PT2 (O and P) and the average of total distance during PT1 
(Q and S) and PT2 (R and T). Two-way ANOVA after Sidak correction and student’s two-tailed T-test, *P < 
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Importantly, the swimming speed did not differ between groups during the first day of training 
and during the probe tests. All wild-type mice swam at similar speeds, and none of them 
presented alterations of the motor functions (Figure 4.2.5A-F). 
 
Figure 4.2.5. Wild-type mice from APPPS1-21 parents did not show motor impairments at 3 months 
of age in the Morris water maze task (MWM). 
Morris water maze (MWM) test in APPPS1-21 wild-type and transgenic mice born to a transgenic father 
(wttgwt, n= 30; tgtgwt, n=25) or mother (wtwttg, n=18; tgwttg, n=17) and control wild-type mice (wtwtwt, n=30) at 
3 months of age. (A and D) Average speed during first training day of MWM task. (B, C, E and F) Average 
speed during first probe trial (PT1) (B and E) and second probe trial (PT2) (C and F). Student’s two-tailed 
T-test, ns = no significant differences; *P < 0.05. Error bars indicated SEM. 
These results suggest that the parenteral genotype indeed has an impact on the performance of 
their offspring (wild-type or transgenic mice), even if the genotype itself is not transmitted as in 
the case of wild-type offspring. Mice from parents with distinct genotypes presented different 
cognitive abilities in a spatial memory task despite having the same genotype. Specifically, wild-
type mice from APPPS1-21 transgenic fathers (wttgwt) showed spatial learning and memory 
impairments that were similar to transgenic mice (tgtgwt). This parental influence seems to have a 
strong effect when the transgene of APP and PS1 comes from the father and a milder when it 
comes from the mother suggesting that a factor transmitted via sperm could be causative for the 
observed phenotype. Wild-type mice from transgenic mother (wtwttg) performed similarly to wild-
type mice from wild-type parents (wtwtwt) at 3 months of age. These similarities and dissimilarities 
were observed at a similar level in males and females (Appendix figure 1-4). 
Finally, I also tested mice in the fear-conditioning paradigm. During the training day, all wild-type 
groups presented similar average mobility (Figure 4.2.6A and D). During the test, all groups 








































































































wt wtwt wt tgwt tg tgwt wt wttg tg wttg
RESULTS
control group, around 40% (Figure 4.2.6B-C and E-F). This data suggests that at 3 months of 
age all wild-type groups (wtwtwt, wttgwt and wtwttg) can acquire the associative memory for the 
aversive context regardless of the genetic background of the parents. Thus, the 
intergenerational non-genetic inheritance of cognitive deficits seems to be restricted to spatial 
navigation tasks. 
Figure 4.2.6. APPPS1-21 wild-type mice groups did not show deficits of contextual associative 
memory at 3 months of age.  
Fear-conditioning in APPPS1-21 wild-type and transgenic mice born to a transgenic father (wttgwt, n= 35; 
tgtgwt, n=28) or mother (wtwttg, n=24; tgwttg, n=19) and control wild-type mice (wtwtwt, n=34) at 3 months of 
age. (A and D) Average of motion during the training day. (B, C, E and F) Percentage of time (B and E) 
and time (C and F) freezing during training (first column) and testing day (second column). PS= pre-
shock. T= test (24h later). Student’s two-tailed T-test, ns = no significant differences; **P < 0.01. Error bars 
indicated SEM.  
4.2.1.2.Persistence of cognitive decline in wild-type and transgenic mice born to 
APPPS1-21 transgenic fathers or mothers at 9 months of age 
Previously, I characterized the cognitive performance of transgenic and wild-type mice born to 
APPPS1-21 tg parents at 3 months of age, showing restricted cognitive deficits to spatial 
behavior tasks. Interestingly, tg and wt mice born to APPPS1-21 tg fathers showed a more 
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RESULTS
the idea that the factor transmitted via sperm could be causative for the observed phenotype. 
Previous findings showed that intergenerational phenotypes could persist into later adulthood 
(Dias & Ressler, 2014b; Vassoler et al., 2013; S. Zhang et al., 2017). I posed the question of 
whether wt offspring born to APPPS1-21 tg parents would show cognitive differences as 
compared to control wt mice at late adulthood. Moreover, I evaluated the cognitive decline 
progression linked to AD pathology, from 3 to 9 months of age, in this mouse model of AD. To 
test these ideas, wt and tg mice born to APPPS1-21 tg parents at 9 months of age were tested 
through the same behavioral battery delineated earlier: open field (OF), Morris water maze 
(MWM) and fear conditioning (FC) (Figure 4.2.7B). To avoid the effect of previous memories, 
new batches of mice were used in this section. I carried out the behavior tests to the next 
comparisons: control wt (wtwtwt) vs. wt born to a tg father (wttgwt) vs. tg born to a tg father (tgtgwt); 
and wtwtwt vs. wt born to a tg mother (wtwttg) vs. tg born to a tg mother (tgwttg) (Figure 4.2.7A). 
Both female and male mice were used in the experiment and were pooled together since no 
statistically significant differences in cognitive abilities were observed between them (Appendix 
figure 6-9). 
Figure 4.2.7. Experimental groups and design. 
(A) 9-month old APPPS1-21 wild-type or transgenic mice born to transgenic fathers (wttgwt and tgtgwt) or 
mothers (wtwttg and tgwttg) vs. control wild-type mice born to wild-type parents (wtwtwt). (B) Mice were 
subjected to a battery of behavioral experiments, Open field (OF), Morris Water Maze (MWM) and Fear 
Conditioning (FC). A week later, brain subregions were dissected, RNA was isolated and RNA sequence 
was ran and analyzed.  
I first tested wt and tg mice born to APPPS1-21 parents in the open field (OF). None of the 
offspring mice born to a tg mother (wtwttg and tgwttg) showed motor deficits (Figure 4.2.8F-G). In 
contrast, wt and tg offspring from tg father (wttgwt and tgtgwt) showed a clearly decreased of the 
speed and mild reduction of the total traveled distance, indicating a reduction of their motor 
abilities (Figure 4.2.8A-B). Importantly, both offspring from tg father (wttgwt and tgtgwt) and tgwttg 
mice did not show alteration of anxiety levels. In contrast, wt mice born to an APPPS1-21 tg 
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at 3 months of age (Figure 4.2.8C-D and H-J). Thus, wt born to an APPPS1-21 tg father (wttgwt) 
at 9 months of age resembled tg mice more than they did wt control mice in the open field 
parameters. 
Figure 4.2.8. Wild-type and transgenic mice born to APPPS1-21 transgenic fathers showed a 
reduction of their motor abilities and only wild-type mice born to APPPS1-21 tg mother (wtwttg) 
showed an increase of anxiety levels opposite to what they showed at 9 months of age.  
Open field test in APPPS1-21 wild-type and transgenic mice born to a transgenic father (wttgwt, n= 31; 
tgtgwt, n=22) or mother (wtwttg, n=7; tgwttg, n=4) and control wild-type mice (wtwtwt, n=31) at 9 months of age. 
(A and B) Total traveled distance (A and F) and average speed (B and G) during the open field test. (C-E 
and H-J) Percentage of time (C and H) and traveled distance (D and I) spent on the central area of the 
field and number of visits center (E and J). Student’s two-tailed T-test, ns = no significant differences; *P < 
0.05; **P < 0.01. Error bars indicated SEM. 
Next, I trained all groups for spatial memory in Morris water maze (MWM). During the training 
phase, none of the wild-type mice born to one transgenic parent (wttgwt and wtwttg) showed 
differences in the time traveled to find the platform compared to control wt mice (wtwtwt). In 
contrast, tgtgwt and tgwttg showed more difficulties to learn the spatial task, spending more time to 
daily reach the platform (Figure 4.2.9A-D). 
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Figure 4.2.9. Only APPPS1-21 transgenic mice showed difficulties to learn the spatial task at 9 
months of age.  
Morris water maze (MWM) test in APPPS1-21 wild-type and transgenic mice born to a transgenic father 
(wttgwt, n=26; tgtgwt, n=20) or mother (wtwttg, n=6; tgwttg, n=4) and control wild-type mice (wtwtwt, n=26) at 9 
months of age. (A and C) Wttgwt vs. wtwtwt and tgtgwt (A) and wtwttg vs. wtwtwt and tgwttg (C) group-average 
time to find the target platform on each consecutive training day (Day 1-8). Two-way ANOVA after Sidak 
correction, ns = no significant differences; *P < 0.05. The dashed line represents the chance level of 25%. 
First probe trial (PT1, day 6) and second probe trial (PT2, day 10). (B and D) Comparison of wttgwt vs. 
wtwtwt and tgtgwt (B) and wtwttg vs. wtwtwt and tgwttg (D) analyzing the areas under the learning curves (AUC) 
of escape latency for each group. Student’s two-tailed T-test, ns = no significant differences; *P < 0.05; **P 
< 0.01. Error bars indicated SEM. 
I carried out a first probe test after 5 days of training (PT1). Similarly to the tests presented for 
mice at 3 months of age, none of the mice in any group learn the task during the first probe test 
1 (PT1), spending less than 25% of the time and traveled distance in the target quadrant (Figure 
4.2.10A-F). Despite this, wttgwt and wtwttg mice showed a certain preference for travel longer 
distances in the target quadrant than both tg groups (Figure 4.2.10A-F). However, this tendency 
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was not observed during the second probe test (Figure 4.2.10G-L). Probably the preference for 
the target quadrant during the first PT was a random swim traveling rather than a learning 
preference.  
I then performed a second probe trial (PT2) after 3 additional days of training, i.e. at day 8. At 
this point, wtwtwt spent more time traveling in the target quadrant than the other quadrants 
compared to other groups, although these differences were borderline (pval=0.0521). In 
contrast, neither wt nor tg born to APPPS1-21 tg parents showed a preference for the target 
quadrant (Figure 4.2.10G-L). There were no remarkable gender-dependent differences in spatial 
cognitive performance in any of the groups (Appendix figure 7 and 8).  
As before, I included a more sensitive analysis consisting of recording the distance between the 
position of the mouse and the platform position during the PT every two seconds. In PT1, none 
of the APPPS1-21 offspring showed differences compared to controls (Figure 4.2.10M and N). In 
PT2, wt and tg mice born to APPPS1-21 tg fathers (wttgwt and tgtgwt) showed significant 
differences (p<0.05 and p=0.063) compared to controls, whereas wtwttg traveled similar distance 
than controls (Figure 4.2.10O and P). Wild-type mice born to APPPS1-21 tg fathers (wttgwt) 
showed spatial learning and memory impairments that were similar to transgenic mice (tgtgwt) as 











































































































































































































































Figure 4.2.10. Wild-type and transgenic mice born to APPPS1-21 transgenic fathers, and 
transgenic mice born to APPPS1-21 tg mother showed spatial memory impairments at 9 months of 
age. 
Morris water maze (MWM) test in APPPS1-21 wild-type and transgenic mice born to a transgenic father 
(wttgwt, n=26; tgtgwt, n=20) or mother (wtwttg, n=6; tgwttg, n=4) and control wild-type mice (wtwtwt, n=26) at 9 
months of age. (A-L) Percentage of time (A, D, G and J) and distance (B, E, H and K) spent on the target 
quadrant (T) vs. average other quadrants (O) and number of visits to the platform (C, F, I and L) during 
first probe trial (PT1, day 6) (A-F) and second probe trial (PT2, day 10) (G-L). Student’s two-tailed T-test, 
ns = no significant differences; *P < 0.05; **P < 0.01. The dashed line represents the chance level of 25%. 
(M-T) The distance between mouse and the platform position every two seconds during PT1 (M and N) 
and PT2 (O and P) and the average of total distance during PT1 (Q and S) and PT2 (R and T). Two-way 
ANOVA after Sidak correction and student’s two-tailed T-test, ns = no significant differences; *P < 0.05. 
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RESULTS
Interestingly, the swimming speed was only reduced in wt and tg mice born to APPPS1-21 tg 
fathers (wttgwt and tgtgwt) during the first day of training, similarly to the open field test (Figure 
4.2.11A). Although a motor impairment was apparent for both groups during day 1, wttgwt and 
tgtgwt swam at similar speeds than control wt mice during both probe trials, indicating a mild 
impairment of their motor abilities (Figure 4.2.11B-C). Wt and tg mice born to a tg mother (wtwttg 
and tgwttg) did not present motor impairments (Figure 4.2.11D-F). 
Figure 4.2.11. Wild-type and transgenic mice born to an APPPS1-21 transgenic father showed mild 
motor impairments.  
Morris water maze (MWM) test in APPPS1-21 wild-type and transgenic mice born to a transgenic father 
(wttgwt, n=26; tgtgwt, n=20) or mother (wtwttg, n=6; tgwttg, n=4) and control wild-type mice (wtwtwt, n=26) at 9 
months of age. (A and D) Average speed during first training day of MWM. (B,C, E and F) Average speed 
during first probe trial (PT1) (B and E) and second probe trial (PT2) (C and F). Student’s two-tailed T-test, 
ns = no significant differences; *P < 0.05; **P < 0.01; ****P < 0.0001. Error bars indicated SEM.  
These results suggest that all old mice show more difficulties to learn a spatial task. While 
control wild-type mice managed to learn the task, wt and tg mice born to APPPS1-21 tg fathers 
and transgenic mice born to APPPS-21 tg mothers showed learning and memory impairments. 
This data confirms that the parental genotype indeed has an impact on the performance of their 
offspring, which persist in late adulthood. It is important to highlight that the number of tgwttg mice 
was limited and the results for this specific group are to be interpreted with caution. 
Finally, mice were subjected to fear conditioning paradigm. During the training day, tgtgwt and 
wttgwt showed a reduction of their mobility, as I previously described for OF and MWM tasks 
(Figure 4.2.12A and D). During the test, wt and tg mice born to an APPPS1-21 tg mother did not 
show alterations of associative memory, whereas wt and tg mice born to an APPPS1-21 
transgenic father showed an increase of freezing levels. This could have two meanings, first that 
they have a better associative memory than control wt mice. Second, this could mean that their 
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reduction of mobility is translated as freezing periods, giving a high number of freezing events at 
the end of the test. Since these groups showed previously motor impairments in open field, 
Morris water maze and average motion during the training day, I assumed that the percentage of 
freezing is an artifact from their motor impairments. In order to use next time this test for this 
mouse line, I will need to change the analyses and extract more sensitive parameters.  
Figure 4.2.12. Fear conditioning in wild-type and transgenic mice born to APPPS-21 transgenic 
parents at 9 months of age.  
Fear conditioning (FC) in APPPS1-21 wild-type and transgenic mice born to a transgenic father (wttgwt, n= 
31; tgtgwt, n=18) or mother (wtwttg, n=7; tgwttg, n=4) and control wild-type mice (wtwtwt, n=29) at 9 months of 
age. (A and D) Average of motion during the training day. (B, C, E and F) Percentage of time (B and E) 
and time (C and F) freezing during training (first column) and testing day (second column). PS= pre-
shock. T= test (24h later). Student’s two-tailed T-test, ns = no significant differences; *P < 0.05; **P < 0.01. 
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RESULTS
4.2.1.3.Progressive cognitive and motor decline in wild-type and transgenic mice 
born to APPPS1-21 transgenic fathers or mothers 
In order to study differences between young and older mice, I analyzed the previous data 
together for all groups of offsprings and looked for young (3 months) vs. old (9 months) 
differences in the open field (OF), Morris water maze (MWM) and fear conditioning (FC) 
behavior tasks.   
During the OF, old mice, in general, showed an evident reduction in the total distance and 
speed, even controls groups, reflecting a slight decrease of their motor functions associated with 
aging. The only exception was wtwttg, traveling similar distances and with speed at both ages 
(Figure 4.1.22A-B). While the vast majority of groups showed a decrease of anxiety 
corresponding with aging, wild-type (wt) and transgenic (tg) mice born to APPPS1-21 tg mothers 
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Figure 4.2.13. Mild reduction of locomotor abilities and increased of anxiety levels with aging in all 
groups, except in wtwttg and tgwttg.  
Open field test in APPPS1-21 wild-type and transgenic mice born to a transgenic father (wttgwt 3m n= 32, 
9m n=31; tgtgwt, 3m n=27, 9m n=22) or mother (wtwttg 3m n=24, 9m n=7; tgwttg 3m n=16, 9m n=4) and 
control wild-type mice (wtwtwt 3m n=34, 9m n=) at 3 and 9 months of age. (A and B) Total distance traveled 
(A) and average speed (B) during open field test. (C-E) Percentage of time (C) and distance (D) spent on 
the central area of the field and number of visits to the center (E). Y = young (3-months) and O = old (9-
months). Student’s two-tailed T-test, ns = no significant differences; **P < 0.01; ***P < 0.001; ****P < 
0.0001. Error bars indicated SEM. 
In the MWM, all 5 groups of old mice showed difficulties to learn the spatial task, requiring 
significantly more time to find the platform, which was reflected in the repeated measures 
ANOVA and the areas under the curve (AUC) (Figure 4.2.14A-J). 
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Figure 4.2.14. Learning spatial task is impaired with age in all offspring groups.  
Morris water maze (MWM) test in APPPS1-21 wild-type and transgenic mice born to a transgenic father 
(wttgwt 3m n=30, 9m n=26; tgtgwt 3m n=25, 9m n=20) or mother (wtwttg 3m n=18, 9m n=6; tgwttg 3m n=17, 
9m n=4) and control wild-type mice (wtwtwt 3m n=30, 9m n=26) at 3 and 9 months of age. (A-E) Young vs. 
old group-average time to find the target platform on each consecutive training day (Day 1-8). Two-way 
ANOVA after Sidak correction, ns = no significant differences; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 
0.0001. The dashed line represents the chance level of 25%. First probe trial (PT1, day 6) and second 
probe trial (PT2, day 10). (G-J) Comparison of young and old group equivalents analyzing the areas under 
the learning curves (AUC) of escape latency for each group. Y = young (3-months) and O = old (9-
months). Student’s two-tailed T-test, ns = no significant differences; **P < 0.05; **P < 0.01; ***P < 0.001; 
****P < 0.0001. Error bars indicated SEM. 
Not many changes were observed during both probe trials (PT) between the two age periods. 
During the first probe trial (PT1), none of the mice in any group learned the position of the 
platform (Figure 4.2.15A-B). During the second probe trial (PT2), only young wt controls and wt 
from tg mother (wtwttg) showed a preference for the target quadrant confirming the close 
similarity between these groups (Figure 4.2.15C-D). 
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Figure 4.2.15. Only young control wild-type mice (wtwtwt) and young wtwttg mice showed a 
preference for the target quadrant.  
Morris Water Maze (MWM) test in APPPS1-21 wild-type and transgenic mice born to a transgenic father 
(wttgwt 3m n=30, 9m n=26; tgtgwt 3m n=25, 9m n=20) or mother (wtwttg 3m n=18, 9m n=6; tgwttg 3m n=17, 9m 
n=4) and control wild-type mice (wtwtwt 3m n=30, 9m n=26) at 3 and 9 months of age. (A-D) Percentage of 
time (A and C) and distance (B and D) spent on the target quadrant between young (Y) and old (O) mice 
during first probe trial (PT1, day 6) (A and B) and second probe trial (PT2, day 10) (C and D). Y = young 
(3-months) and O = old (9-months). Student’s two-tailed T-test, ns = no significant differences; *P < 0.05; 
**P < 0.01. The dashed line represents the chance level of 25%.  
As before, checking the distance between the position of the mouse and platform 
position, every two seconds during both probe trials (PT1 and 2) revealed the differences 
between old and young mice. While none of the young and old mice learned the task 
during PT1, old mice from all experimental groups and controls significantly differed from 
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Figure 4.2.16. All old offspring groups showed a more severe spatial cognitive impairment than 
young equivalent groups.  
Morris Water Maze (MWM) test in APPPS1-21 wild-type and transgenic mice born to a transgenic father 
(wttgwt 3m n=30, 9m n=26; tgtgwt 3m n=25, 9m n=20) or mother (wtwttg 3m n=18, 9m n=6; tgwttg 3m n=17, 
9m n=4) and control wild-type mice (wtwtwt 3m n=30, 9m n=26) at 3 and 9 months of age. (A-O) The 
distance between mouse and the platform position  every two seconds during second probe trial (PT2, day 
10) (B, E, H, K and N) and the average of total distance during PT1 (A, D, G, J and M) and PT2 (C, F, I, L 
and O). Y = young (3-months) and O = old (9-months). Two-way ANOVA after Sidak correction and 
student’s two-tailed T-test, ns = no significant differences; *P < 0.05; **P < 0.01; ***P < 0.001. Error bars 
indicated SEM.  
In contrast to open field task, only old transgenic mice born to an APPPS1-21 tg father (tgtgwt) 
showed a significant reduction of swimming speed during the first training and both probe trials 
(Figure 4.2.17A-C).  
Figure 4.2.17. Only transgenic mice born to a transgenic father showed motor impairments with 
aging during MWM task.  
Morris Water Maze (MWM) test in APPPS1-21 transgenic mice born to a transgenic father (wttgwt 3m n=30, 
9m n=26; tgtgwt 3m n=25, 9m n=20) or mother (wtwttg 3m n=18, 9m n=6; tgwttg 3m n=17, 9m n=4) and 
control wild-type mice (wtwtwt 3m n=30, 9m n=26) at 3 and 9 months of age. (A) Averaged speed during 
first training day of MWM. (B and C) Averaged speed during first probe trial (PT1) (B) and second probe 
trial (PT2) (C). Y = young (3-months) and O = old (9-months). Student’s two-tailed T-test, ns = no 
significant differences; *P < 0.05;  **P < 0.01 and  ****P < 0.0001. Error bars indicated SEM. 
Lastly, during the training day of fear conditioning I observed a significant reduction of the 
mobility of almost all studied groups (Figure 4.2.18A).  During the test, only wttgwt and tgwttg 
showed an increase of freezing with aging. Taking into account the significant reduction of their 
mobility, I assume that this increase of freezing only reaffirms their progressive degeneration of 
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Figure 4.2.18. All old groups showed a significant reduction of the average motion during the 
training day.  
Fear conditioning in APPPS1-21 wild-type and transgenic mice born to transgenic father (wttgwt 3m n=35, 
9m n=31; tgtgwt 3m n=28, 9m n=18) or mother (wtwttg 3m n=24, 9m n=7; tgwttg 3m n=19, 9m n=4) and 
control wild-type mice (wtwtwt 3m n=34, 9m n=29) at 3 and 9 months of age. (A) Average of motion during 
the training day. (B and C) Percentage of time (B) and time (C) freezing during the testing day at 3 (first 
column) and 9 (second column) months of age. Y = young (3-months) and O = old (9-months). PS= pre-
shock. T= test (24h later). Student’s two-tailed T-test, ns = no significant differences; *P < 0.05; ***P < 
0.001; ****P < 0.0001. Error bars indicated SEM.  
Taken together, this specific model of AD also showed a worsening behavior with age, similar to 
other models (Kelly et al., 2003; Sadowski et al., 2004; Van Dam et al., 2003). 9 month-old mice 
showed more severe cognitive deficits than mice at 3 months of age. To note, control wild-type 
mice born to wt parents also showed difficulties in acquiring and learning spatial task at 9 
months of age, although this age is not yet considered “old” for a wild-type mouse. Specifically, 
APPPS1-21 wild-type mice born to APPPS1-21 tg fathers (wttgwt) showed stronger alteration of 
their cognitive capabilities during aging compared to wt mice born to APPPS1-21 tg mothers 
(wtwttg). This variation could be attributed to a reduction of the motor abilities of wttgwt and tgtgwt 
mice at 9 months of age. Nonetheless, this variability in learning and motor abilities suggests 
that non-genetic inheritance of an APP/PS1 phenotype from a father or mother have a different 
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RESULTS
4.2.2.Accounting for group size, batch and litter effects  
An important technical aspect to consider in an intergenerational inheritance of any kind is group 
sizes, litter and batch effects. It is crucial to carry out behavior experiments in the offspring from 
multiple mating to verify that the effects are not litter or batch-specific. Although these factors 
have not always been accounted for (Bohacek & Mansuy, 2017), they can play critical roles in 
the final outcome of the analysis. I took great care firstly to design our mating strategy. Secondly, 
I account for litter and batch effects by using standard statistical analyses and linear mixed 
models. Mixed linear models is a statistical a take into account fixed factors (treatment and 
gender) and confounding factors (litter and batch). 
In order to use an appropriate group size, I used a large number of males and females from 
each experimental and control groups at 3 (n ≥16) and 9 (n ≥20, except in wtwttg and tgwttg) 
months of age (Table 4.2.1). Numbers of mice per groups are defined on the table 4.1.19A-B. 
Due to spatial limitations and a reduced number of births respect to other groups, the numbers 
of wild-type and transgenic mice born to APPPS1-21 tg mothers were always lower than the 
other groups (18 and 16 at 3m; 6 and 4 at 9m). Thus, behavior results from wtwttg and tgwttg at 9 
months of age are only illustrative. It is important to highlight that the number of wtwttg and tgwttg 
mice was limited and the results for this specific group are to be interpreted with caution. 
Table 4.2.1. Large group number of mice used for Morris water maze at 3 and 9 months of age.  
(A and B) Number of mice, males and females, used for behavior experiments at (A) 3 and (B) 9 months 
of age.  
In addition to a large number of mice per group, I used mice from different mating and 
statistically tested specific litter repercussion by one-way ANOVA. The numbers of mating from 
same father and mother genotype are defined in figure 4.1.20A and D. Firstly I analyzed the 
effect of different litters within each group, and no significant differences were identified for any 
litter in any experimental and control groups (Figure 4.1.20B and E). Secondly, I averaged the 
mice from the same litter and evaluated their percentage of time in the target quadrant during 
the second probe trial in the Morris water maze (MWM) task (Figure 4.1.20C and F). Similar 
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results as the ones obtained with individual mice were obtained, suggesting that the 
performance variability seen in the MWM is not litter-specific.  
Figure 4.2.19. No litter-specific effect in Morris water maze behavioral data.  
(A and B) Number of litters used to obtain enough offspring mice at (A) 3 and (B) 9 months of age to 
perform behavior experiments. (C and E) Variability between litter-specific mice at (C) 3 and (E) 9 months 
of age regarding time spent in the target quadrant during the second probe trial (PT2). One-way ANOVA 
after Tukey correction, ns = no significant differences; *P < 0.05; **P < 0.01. Error bars indicated SEM. (D 
and F) Percentage of time spent in the target quadrant (T) vs. average time spent in other quadrants (O) 
between groups of (C) 3 and (F) 9 months of age during second probe trial (PT2, day 10). All mice from 
the same litter were previously averaged. Student’s two-tailed T-test, *P < 0.05; **P < 0.01; ***P < 0.001. 
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Taking into account the large number of mice to test and the repercussion of the day cycle might 
have had on performance, behavioral experiments were conducted in different batches. 
Specifically, mice were split into 4 batches of mice at 3 months of age and 4 batches of mice at 9 
months of age. To confirm that the behavior data previously presented was not confounded by 
batch-specific effects, I performed first a standard statistical analysis between batches from each 
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Figure 4.1.20. No significant differences were observed between batches regarding the time spent 
in the target quadrant during the second probe trial (PT2) in Morris water maze.  
(A and B) Number of batches for each group at (A) 3 and (B) 9 months of age used for behavior 
experimental tests. One-way ANOVA after Tukey correction, ns = no significant differences. Error bars 
indicated SEM.    
To verify the batch- and litter-specific effect I used a more sensitive approach, the linear mixed 
model, taking into account fixed factors (treatment and gender) and confounding factors (litter 
and batch) for spatial cognitive performance (Distance to the platform during PT2). In this model, 
all wt and tg mice born to APPPS1-21 tg fathers (wttgwt and tgtgwt) and mothers (wtwttg and tgwttg) 
were compared to control wt (wtwtwt). I observed significant differences between wttgwt and tgtgwt 
mice compared to wild-type control (wtwtwt) at 3 months of age, as I previously observed using 
standard statistical analysis (Table 4.2.2). This confirms that the random factors are not affecting 
the results obtained. However, the evaluation of mice at 9 months of age did not show the spatial 
cognitive differences previously detected using standard analysis. Since the linear mixed model 
account for random factors, there is an underlying bias or potentially a litter effect, which account 
for the effect not being significant. Besides, the individual variability along aging is higher than at 
3 months of age.  
Table 4.2.2. Evaluation of batch- and litter-effect using a linear mixed model for statistical 
analysis of distance to the platform in Morris water maze (MWM) at 3 and 9 months.  
(A-B) Statistical evaluation of the distance to the platform in MWM of wild-type and transgenic 
mice born to one APPPS1-21 parent at (A) 3 and (B) 9 months of age. Fixed factors = gender and 
treatment. Confounding factors = litter and batch. ns > 0.05 *P < 0.05, **P < 0.01; ***P < 0.001. 
I am therefore confident that my results are representative of a biologically relevant factor (i.e.. 
parental origin of the transgene or even just paternal non-genetic heritage).  
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3m t-value p-value 
wttgwt 2.161580   0.0333 
wtwttg 0.303245   0.7624 
tgtgwt 3.427519   0.0009 
tgwttg 0.573621   0.5677 
A
9m t-value p-value 
wttgwt 1.136334   0.8091 
wtwttg 1.136334   0.2597 
tgtgwt 1.617813   0.1103 
tgwttg 0.582704 0.5620    
B
RESULTS
4.2.3.Intergenerational effect on transcriptional profiling and functional 
pathways 
So far, I have established that there are differences in the cognitive performance of APPPS1-21 
wild-type mice depending on whether they come from a mutant mother or father at 3 and 9 
months of age. These data suggest that there are lineage-specific non-genetic modes of 
phenotypic inheritance. Intergenerational inheritance has been associated with small non-coding 
RNAs and epigenetic-mediated transmission of acquired traits, implying mechanisms that 
promote changes at transcription level (de Castro Barbosa et al., 2016a; Herman & Sultan, 
2016). Thus, I decided to use the transcriptome as a readout of the cellular state and wondered 
whether I would be able to dissect molecular pathways associated with the parental-specific 
mode of non-genetic inheritance of the cognitive deficit. In order to obtain a cleaner signature 
and most robust effects, only 3 months mice were evaluated. Mice at 9 months of age start to 
get a mixture of aging-related effects that might confound the factor of interest that is only the 
non-genetic inheritance of a phenotype caused by a genetic mutation. 
4.2.3.1.Transcriptional profiling of wild-type mice born to an APPPS1-21 transgenic 
mother or father 
As before, I analyzed the transcriptome of two subregions of the hippocampus, CA1 and DG, 
which were involved in spatial memory. I compared the CA1 and DG transcriptome from wild-
type (wt) mice born to an APPPS1-21 tg father or mother (wttgwt and wtwttg) to the transcriptome 
of control wild-type mice (wtwtwt). The transcriptomic profile was analyzed based on significant 
differentially expressed genes (padj ≤ 0.05) with distinct levels of expression defined by the 
log2FC cutoff as severe (± 1.00), medium (± 0.50) and mild (± 0.25) (Figure 4.1.33A). 
Interestingly, only a few genes in the hippocampus subregions from wt mice born to an 
APPPS1-21 tg mother (wtwttg) differed from wtwtwt. However, the transcriptome from DG and CA1 
from wt mice born to an APPPS1-21 tg father (wttgwt) showed several changes in gene 
expression compared to control wt mice (wtwtwt), specifically in the DG from males and females 
(Figure 4.2.21A-I). This is particularly interesting since both groups are in principle wild-type 
mice grown under the same conditions. As previously described for transgenic mice, the majority 
of genes fell into mild to medium levels, and the number of differential up-regulated genes was 
higher in wttgwt than in controls (Figure 4.2.21A-D). Because the main changes in the 
transcriptome were observed for genes at the mild level of change (padj ≤ 0.05; log2FC ± 0.25), I 




Figure 4.2.21. Moderate changes in transcriptional profile in brain subregions of wild-type born to 
an APPPS1-21 transgenic father (wttgwt) at 3 months of age.  
(A and C) Number of significant differentially expressed genes with different level of changes (severe (± 
1.00), medium (± 0.50) and mild (± 0.25), established by the log2FC) in wttgwt vs. wtwtwt (A) and wtwttg vs. 
wtwtwt comparisons (C). Padj, P value adjusted and log2FC, logarithm base 2 of Fold Change. (B and D) 
Number of significant differentially expressed up- and down-regulated genes in the DG from males (DGm), 
DG from females (DGf) and CA1 from males (CA1m) in wttgwt vs. wtwtwt (B) or wtwttg vs. wtwtwt mice (D). 
Padj ≤ 0.05, log2FC ± 0.25. (E-I) Heatmaps of differentially expressed genes in 3 month-old wttgwt vs. wtwtwt 
(E-G) or wtwttg vs. wtwtwt mice (H and I). Padj ≤ 0.05, log2FC ± 0.25. For DG males: wttgwt n=7; wtwttg n=5 
and wtwtwt n=5; for DG females wttgwt n=5; wtwttg n=4 and wtwtwt n=5 and for CA1 males wttgwt n=7; wtwttg 
n=8 and wtwtwt n=6. 
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Furthermore, I compared the transcriptome of wt mice born to an APPPS1-21 tg father (wttgwt) or 
mother (wtwttg) to the transcriptome of APPPS1-21 tg mice. Previously, I described the strong 
alteration of the transcriptome signature in the hippocampal subregions of transgenic 
APPPS1-21 mice at 3 months of age compared to control wt mice (wtwtwt). Surprisingly, wt mice 
born to a tg father (wttgwt) or mother (wtwttg) showed a little amount of differentially expressed 
genes compared to APPPS1-21 tg mice. Wttgwt mice showed a maximum of 75 differentially 
expressed genes in DG region from females compared to tg mice, and wtwttg showed a maximum 
of 58 in DG region from females. These numbers suggest that wt mice born to APPPPS1-21 tg 
fathers or mothers showed minor changes in the transcriptome when they were compared to tg 
mice (Figure 4.2.22A-C).   
 
Figure 4.2.22. Little transcriptomic differences between wild-type mice born to an APPPS1-21 tg 
father (wttgwt) or mother (wtwttg) and APPPS1-21 transgenic mice.  
(A-C) Number of significant differentially expressed up- and down-regulated genes in tg vs. wtwtwt, tg vs. 
wttgwt or tg vs. wtwttg mice. Padj ≤ 0.05, log2FC ± 0.25. For DG males: tg n=4; wttgwt n=7; wtwttg n=5 and 
wtwtwt n=5; for DG females tg n=7; wttgwt n=5; wtwttg n=4 and wtwtwt n=5 and for CA1 males tg n=6; wttgwt 
n=7; wtwttg n=8 and wtwtwt n=6. 
Taken together, wt mice born to an APPPS1-21 tg father (wttgwt) exhibited a distinct transcriptome 
compared to that of wt controls (wtwtwt). Thus, their transcriptome seemed to resemble that of tg 
mice more than that of the wt control mice. On the contrary, wt mice born to an APPPS1-21 tg 
mother (wtwttg) mice, which did not show a cognitive impairment at 3 months of age, did not show 
many transcriptomic differences when compared to wtwtwt or APPPS1-21 tg mice. 
In order to investigate the level of similarity between wttgwt and tg mice, I evaluated the number 
of common genes. DG brain subregions from male and female wt born to an APPPS1-21 tg 
father (wttgwt) shared almost 52% of genes with APPPS1-21 tg mice when both were compared 
to wt control mice (wtwtwt). In the case of the CA1 region from wttgwt and tg mice, which showed 
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RESULTS
less transcriptomic changes at 3 months of age, from the 30 differentially expressed genes 
between wttgwt and wtwtwt only two were commonly expressed among wttgwt and tg mice (Figure 
4.2.23G-I). 
Additionally, only 2 in DG from males, 71 in DG from females and 8 in CA1 from males were 
statistically differentially expressed between wttgwt and tg mice (Figure 4.2.23A-I). From these 
genes, only a few were significantly different in both wt groups (wtwttg and wttgwt) comparing with 
tg mice (4 for DGm and 29 for DGf and 2 for CA1m) (Figure 4.2.23G-I). This data supports the 
conclusion that wttgwt mice indeed exhibited more transcriptional similarities with tg mice than 
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Figure 4.2.23. Around 50% of genes overlap when wild-type mice born to an APPPS1-21 transgenic 
father (wttgwt) and APPPS-21 transgenic mice were compared to wtwtwt.  
(A-I) Venn diagrams illustrating the overlap between up-/down-/total regulated genes in DG from males 
(DGm), in DG from females (DGf) and in CA1 from males (CA1m) from tg vs. wtwtwt , tg vs. wttgwt and wttgwt  
vs. wtwtwt mice. Padj ≤ 0.05, log2FC ± 0.25. For DG males: tg n=4; wttgwt n=7; wtwttg n=5 and wtwtwt n=5; for 
DG females tg n=7; wttgwt n=5; wtwttg n=4 and wtwtwt n=5 and for CA1 males tg n=6; wttgwt n=7; wtwttg n=8 
and wtwtwt n=6. 
4.2.3.2.Functional pathway analysis of wt mice originating from an APPPS1-21 
transgenic mother or father 
To further investigate the molecular state of wt mice born to APPPS1-21 tg parents I studied the 
functional pathways using first the whole dataset with GSEA (Subramanian et al., 2005) and 
then limiting to significant thresholds with ClueGO/Cytoscape (Shannon et al., 2003) (Bindea et 
al., 2009). Taking into account that the major transcriptomic changes were observed between wt 
born to an APPPS1-21 tg father (wttgwt) compared to wt control mice (wtwtwt), I next analyzed 
these in functional analyses (Figure 4.1.33A and C). Since 52% of differentially expressed genes 
were shared between wttgwt and tg mice, I expected to identify a certain overlap in the functional 
pathways affected in these mice. To achieve a first global notion of the biological processes, 
molecular functions and cellular components, I selected the top 25 most significant under and 
overrepresented pathways (nominal pvalue ≤ 0.05 and FDR ≤ 0.25) and ranked them by 
normalized enrichment score (NES). Positive pathways mean enrichment in wt controls (wtwtwt), 
whereas negative pathways are enriched in wttgwt mice. Similarly as previously presented for tg 
mice, these preselected pathways were manually reduced to main category groups.   
Regarding biological processes, enriched genes in DG regions of wttgwt males and females 
compared to wt control mice were mainly linked to tissue and nervous system development, 
synapse and cell-cell adhesion (Figure 4.2.24A, C, D and F). On the contrary, genes 
underrepresented in DG from male and female wttgwt mice were mainly associated to 
mitochondrial process and respiratory chain, metabolic process, splicing and translation (Figure 
4.2.24A, B, D and E). These were similar broader processes that were also affected in 
APPPS1-21 transgenic mice (Figure 4.1.8). Besides, several genes related to splice process 
were altered in wt mice born to an APPPS1-21 tg father (wttgwt) (Figure 4.2.24A-B). Thus, I 
decided to further investigate the alteration of splicing processing by analyzing the alternative 
exon usage in wttgwt and transgenic mice (Section 4.2.4).  
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RESULTS
In the CA1 hippocampal subregion of wttgwt mice, enriched genes were explicitly connected with 
inflammation and immune process (Figure 4.2.24G and H). In contrast, pathways associated 
with lipid metabolism and transport were underrepresented in this group (Figure 4.2.24G and I).  
Similar underrepresented pathways were found in CA1 subregion from APPPS1-21 transgenic 
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Figure 4.2.24. Biological processes are affected in the DG and CA1 regions of wild-type mice born 
to an APPPS1-21 transgenic father (wttgwt) at 3 months of age.  
(A, D and G) Top 10 preselected biological processes over or underrepresented within the whole dataset 
of genes in brain subregions of wttgwt or control (wtwtwt): DGm (A), DGf (D) and CA1m (G). NES= 
Normalized Enrichment Score. Positive NES means underrepresentation in wttgwt mice, whereas negative 
NES means overrepresentation in wttgwt mice.  (B, C, E, F, H and I) Broader term summary of the top 25 
overrepresented (C, F and I) and 25 underrepresented (B, E and F) pathways in brain subregions of wttgwt 
mice. Nominal pval ≤ 0.05; FDR ≤ 0.25. For DG males: wttgwt n=7 and wtwtwt n=5; for DG females wttgwt n=5 
and wtwtwt n=5 and for CA1 males wttgwt n=7 and wtwtwt n=6. 
Interestingly, genes associated to molecular functions showed a direct connection to the 
biological processes previously described. For example, mitochondrial complex and respiratory 
chain (oxidoreductase and hydrolase activity) or synapse (transporter and channel activity and 
receptor activity) were affected (Figure 4.2.25A-I). Other molecular functions were also 
remarkable in the DG of male and female from wt mice born to tg father (wttgwt), such as protein 
binding and transcription regulator activity (Figure 4.2.25A-F). In the CA1 region from wttgwt, only 
pathways linked to translation and peptidase and transferase activity were significantly altered  
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Figure 4.2.25. Molecular functions are affected in the DG and CA1 regions of wild-type mice born 
to an APPPS1-21 transgenic father (wttgwt ) at 3 months of age.  
(A, D and G) Top 10 preselected molecular functions over or underrepresented within the whole dataset of 
genes in brain subregions of wttgwt or control (wtwtwt): DGm (A), DGf (D) and CA1m (G). NES= Normalized 
Enrichment Score. Positive NES means underrepresentation in wttgwt mice, whereas negative NES means 
overrepresentation in wttgwt mice. (B, C, E, F, H and I) Broader term summary of the top 25 
overrepresented (C, F and I) and 25 underrepresented (B, E and F) pathways in brain subregions of wttgwt 
mice. Nominal pval ≤ 0.05; FDR ≤ 0.25. For DG males: wttgwt n=7 and wtwtwt n=5; for DG females wttgwt n=5 
and wtwtwt n=5 and for CA1 males wttgwt n=7 and wtwtwt n=6. 
Lastly, when analyzing cellular components, several genes related to components such as 
neuronal part, synapse and cytoskeletal part were enriched in DG and CA1 from male and 
females of wttgwt mice (Figure 4.2.26A, C, D, F, G and I). In contrast, genes linked to the 
ribosome, splicing and nuclear part were underrepresented in CA1 and DG of wttgwt mice (Figure 
4.2.26A, B, D, E, G and H). These results are in accordance with the molecular functions and 
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Figure 4.2.26. Cellular components are affected in DG and CA1 regions of wild-type mice born to 
an APPPS1-21 transgenic father (wttgwt) at 3 months of age.  
(A, D and G) Top 10 preselected cellular components over or underrepresented within the whole dataset 
of genes in brain subregions of wttgwt or control (wtwtwt): DGm (A), DGf (D) and CA1m (G). NES= 
Normalized Enrichment Score. Positive NES means underrepresentation in wttgwt mice, whereas negative 
NES means overrepresentation in wttgwt mice. (B, C, E, F, H and I) Broader term summary of the top 25 
overrepresented (C, F and I) and 25 underrepresented (B, E and F) pathways in brain subregions of wttgwt 
mice. Nominal pval ≤ 0.05; FDR ≤ 0.25. For DG males: wttgwt n=7 and wtwtwt n=5; for DG females wttgwt n=5 
and wtwtwt n=5 and for CA1 males wttgwt n=7 and wtwtwt n=6. 
Taken together, CA1 and DG subregions form wt mice born to APPPS1-21 tg fathers (wttgwt) 
showed moderate changes in gene expression highly linked to the cellular state earlier 
described for APPPS1-21 tg mice. CA1 and DG regions of wttgwt mice showed mainly changes in 
pathways related to nervous system development, synapse, splicing, energy metabolism, 
metabolic process and cell-cell adhesion. This data indicates that wttgwt mice present a different 
cellular state in the hippocampus than control wt mice (wtwtwt), probably due to a non-genetic 
transmission from their APPPS1-21 tg father. This is particularly interesting since both groups 
are wild-type mice.  
To validate the relevance of the previously identified pathways, I used a second method based 
on a cutoff approach (ClueGO/Cytoscape) (Bindea et al., 2009) (Shannon et al., 2003) and 
submitted only differentially expressed genes to the analysis (padj ≤ 0.05; log2FC ± 0.25). As 
previously described between tg and wtwtwt mice, the number of pathways associated with up-
regulated genes was higher compared to the pathways linked to down-regulated genes in wttgwt 
compared to wtwtwt mice (Figure 4.2.27A-C). Furthermore, the DG wttgwt from male and female 
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regulation of gene expression were altered in the CA1 (Figure 4.2.27C and F). Notably, male 
wttgwt mice were less affected than females, showing less altered pathways associated with 
significantly expressed genes. Despite this minor alteration in the DG of male wttgwt, some 
pathways in the DG region from both genders overlap with functional pathways affected in tg 
mice (Figure 4.1.11). Pathways related to nervous system development, synapse and ion 
transport were changed in both genders (Figure 4.2.27A-B and D-E). The molecular state of 
female DG was hugely affected, pathways linked to ribonucleotide metabolism, metabolic 
process, gene expression or chromatin modification were drastically affected in this region 
(Figure 4.2.27B and E). 
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Figure 4.2.27. Functions affected in CA1 and DG of wild-type mice born to APPPS1-21 transgenic 
fathers.  
(A-C) Network of functional categories (biological process, molecular function and cellular component 
ontologies) of significant differentially expressed genes in CA1 and DG from wild-type mice born to an 
APPPS1-21 transgenic father (wttgwt). The size of the nodes correlates inversely with statistical 
significance. Categories with a red color spectrum correspond to up-regulated genes in wttgwt mice and 
blue correspond to down-regulated genes. Categories that shared up- and down-regulated genes are 
represented in grey. Genes, padj ≤ 0.05; log2FC ± 0.25 and pathways, pval < 0.05. (D-F) Top 20 significant 
functional pathways ranked by -log pval after Benjamini-Hochberg correction of significant differentially 
expressed genes in brain subregions of wttgwt vs. wtwtwt mice. Genes, padj ≤ 0.05; log2FC ± 0.25 and 
pathways, pval < 0.05. For DG males:  wttgwt n=7 and wtwtwt n=5; for DG females wttgwt n=5 and wtwtwt n=5 
and for CA1 males wttgwt n=7 and wtwtwt n=6. 
These analyses reveal that several pathways defined by GSEA analysis also represented the 
top affected pathways since they also appeared in the more restrictive ClueGO/Cytoscape 
analyses (Figure 4.2.27A-F). 
In addition to the number of shared genes between DG of wttgwt and tg mice (around 52% of 
genes overlapped) (Figure 4.2.23A-F), I analyzed the proportion of common pathways between 
these two groups compared to wtwtwt mice. According to GSEA pathways, all three regions (DG 
from males and females and CA1from males) of wttgwt in almost all three GO terms categories 
showed approximately 30-40% concordance with tg mice (Figure 4.2.28A-I). Importantly, the 
overlapped pathways increased extremely when only significant differentially expressed genes 
were analyzed using Cytoscape/ClueGO, around 65% of pathways overlapped between male 
and female in DG regions from wttgwt and tg mice (Figure 4.2.29A-B). In the case of CA1 region, 
there was not any common pathway between wttgwt and tg mice (Figure 4.2.29C). It is important 
to indicate that this mechanism of overlapping pathways is limited to the name of the pathway 





Figure 4.2.28. Around 30 to 40 % of pathways overlap between wt mice born to an APPPS1-21 tg 
father (wttgwt) and APPPS1-21 tg mice when both were compared to wt control mice (wtwtwt).  
(A-I) Venn diagrams illustrating overlap of biological processes (A-C), molecular functions (D-F) and 
cellular components (G-I) in tg vs. wtwtwt and wttgwt vs. wtwtwt comparisons. Pathways, padj ≤ 0.05. For DG 
males: tg n=4; wttgwt n=7 and wtwtwt n=5; for DG females tg n=7; wttgwt n=5 and wtwtwt n=5 and for CA1 
males tg n=6; wttgwt n=7 and wtwtwt n=6.  
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Figure 4.2.29. Around 65 % of pathways overlap overlap between wt mice born to an APPPS1-21 tg 
father (wttgwt) and APPPS1-21 tg mice.  
(A-C) Venn diagrams illustrating overlap of significant pathways in tg vs. wtwtwt and wttgwt vs. wtwtwt 
comparisons. Genes, padj ≤ 0.05; log2FC ± 0.25 and pathways, pval < 0.05.  For DG males: tg n=4; wttgwt 
n=7 and wtwtwt n=5; for DG females tg n=7; wttgwt n=5 and wtwtwt n=5 and for CA1 males tg n=6; wttgwt n=7 
and wtwtwt n=6.  
Overall, wild-type mice born to an APPPS1-21 tg father (wttgwt) resembled APPPS1-21 tg mice to 
a greater extent than they did wtwtwt on cognitive performance, transcriptome and cellular state. 
Nonetheless, around 60% of whole dataset pathways (GSEA) and 40% from significant 
differentially expressed genes (ClueGO/Cytoscape) still differed between wttgwt and tg mice 
(Figure 4.1.41A-I and Figure 4.1.42A-C). Not surprisingly, hippocampus subregions from tg mice 
showed different affected pathways when compared to wttgwt and more altered pathways than 
wttgwt. This variation could be attributed to the fact that transgenic mice are affected by the direct 
genetic alteration (induced APP and PS1 mutations) and the non-genetic transmission. However, 
the wttgwt mice are only affected by non-genetic transmission. 
4.2.4.Alternative exon usage and pathway analysis in wild-type mice 
born to APPPS1-21 mice at 3m 
4.2.4.1.Alternative exon usage in wild-type mice born to an APPPS1-21 tg father or 
mother  
Having established the transcriptome of wild-type mice born to APPPS1-21 tg parents and the 
genes that had an alternative exon usage of APPPS1-21 tg mice, I next focused on genes with 
alternative exon usage in wt mice born to APPPS1-21 tg parents. Taking into account that wt 
born to tg fathers (wttgwt) showed changes in gene expression related to splicing process, I 
expected to identify significant alterations of exon usage. Thus, I analyzed the differentially 
expressed exons (padj ≤ 0.05) in wt mice born to an APPPS1-21 tg father (wttgwt) or mother 
(wtwttg) both compared to wt control mice (wtwtwt).  
The majority of exon usage changes fell into the mild (log2FC ± 0.25) to medium (log2FC ± 0.50) 
categories in wttgwt and wtwttg compared to wt control mice (wtwtwt) (Figure 4.2.30A-B). Moreover, 
some genes showed severely (log2FC ± 1.00) exon changes as well in wttgwt mice (154 (total) for 
DGm, 2280 (total) for DGf and 2 (total) for CA1m) and wtwttg mice (14 for DGm, 1329 for DGf and 
0 for CA1m) compared to wt control mice wtwttg (Figure 4.2.30A-B). Figure 4.2.30C-E shows the 
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number of genes with significant alternative exon usage that differed between control wt mice 
and experimental groups (wttgwt and wtwttg) at the mild category (padj ≤ 0.05 and log2FC ± 0.25). 
The greatest difference regarding alternative exon usage occurs in the DG from males and 
females of wt mice born to APPPS1-21 tg fathers (Figure 4.2.30A-D). Here, I found thousands of 
genes using alternative exons (1876 (total) for DG from males and 7336 (total) for DG from 
females). Changes in alternative exon usage in the CA1 of males are only 106 (total). While 
changes in wtwttg mice compared to control wt mice were mild in the DG or negligible in the CA1 
region, a vast number of alternative exon usage was observed in wttgwt, specifically in DG 
regions. These changes are mainly associated with a shift towards inclusion of exons (Figure 
4.2.30A-E). 
Figure 4.2.30. Drastic alteration in alternative exon usage in DG and CA1 of wild-type mice born to 
an APPPS1-21 transgenic father and almost negligible changes in wild-type offspring from 
APPPS1-21 transgenic mothers compared to control wild-type mice.  
(A-B) Number of significant alternative exon usage with different levels of changes (severe (± 1.00), 
medium (± 0.50) and mild (± 0.25), established by the log2FC) in wttgwt and wtwttg mice compared to wtwtwt 
mice. Exon usage, padj ≤ 0.05. (C-E) Number of significant alternative exon usage in DG from males (C) 
and females (D) and CA1 from male (E) wttgwt and wtwttg mice compared to wtwtwt mice. Red columns 
represent significant alternative inclusion exons; blue columns represent significant alternative exclusion 
exons and greys are the sums of previous two. Exons, padj ≤ 0.05; log2FC ±0.25. For DG males: wttgwt 
n=7; wtwttg n=5 and wt wtwt n=5; for DG females wttgwt n=5; wtwttg n=4 and wt wtwt n=5 and for CA1 males 
wttgwt n=7; wtwttg n=8 and wt wtwt n=6. 
In contrast, wt mice born to an APPPS1-21 tg father (wttgwt) or mother (wtwttg) showed less 
alternative exon usage variability than APPPS1-21 tg mice all of them compared to wt control 
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Figure 4.50: Drastic alteration of alternative exon usage in DG and CA1 of wild-type animals born to APPPS1-21 transgenic father 
and almost negligible changes in wild-type from transgenic mother compared to  wtwtwt animals: (A-B) Number of significant alterna-
tive exon usage with different levels of changes (severe, medium and mild, established by the log2FC) in tg animals compare to wt
wtwt 
animals. Exon usage, padj ≤ 0.05. (C-E) Number of significant alternative exon usage in DG from males (A) and females (B) and CA1 (C) 
from male wttgwt nd wtwttg animals c mpare to wtwtwt animals. Red colum s represent significant alternative inclusion exons; blue columns 
represent significant alternative exclusion exons and greys are the sum of previous two. Exons, padj ≤ 0.05; log2FC ±0.25 . For DG males: 
wttgwt n=7; wtwttg n=5 and wt wtwt n=5; for DG females wttgwt n=5; wtwttg n=4 and wt wtwt n=5 and for CA1 males wttgwt n=7; wtwttg n=8 and wt wtwt 
n=6.






























































































mice. Comparing the wttgwt males to tg mice, only a maximum of 31 differentially expressed 
exons in CA1 region were detected (Figure 4.2.31A-C). In the case of CA1 and DG regions of 
wtwttg mice, some changes in exon usage were detected, but these changes were lower than 
those between wtwtwt and tg mice in CA1 and DG regions (Figure 4.2.31A-C). 
Figure 4.2.31. Small changes alternative exon usage were identified between wt mice born to an 
APPPS1-21 tg father (wttgwt) or mother (wtwttg) and transgenic APPPS1-21 offspring.  
(A-C) Number of significant differentially spliced genes in DG from males (A) and females (B) and CA1 
from male (C) of wtwtwt, wttgwt and wtwttg mice compared to APPPS1-21 transgenic mice. Red columns 
represent significant alternative inclusion exons; blue columns represent significant alternative exclusion 
exons and greys are the sums of previous two. Genes, padj ≤ 0.05; log2FC ±0.25. For DG males: tg n=4; 
wttgwt n=7; wtwttg n=5 and wtwtwt n=5; for DG females tg n=7; wttgwt n=5; wtwttg n=4 and wtwtwt n=5 and for 
CA1 males tg n=6; wttgwt n=7; wtwttg n=8 and wtwtwt n=6. 
  
I next focused the studies on alternative exon usage in wt mice born to tg fathers, because not 
many spliced events were observed in wtwttg mice. Comparing the CA1 and DG regions among 
each other in wttgwt mice, I did not identify many common spliced genes between DG from males 
and females and CA1 from males, although several genes with alternative exon usage were 
common between DG from females and males (1172) (Figure 4.2.32C). Common genes 
between DG males and females represent 66.7% of the total genes with different spliced events 
in DG from males and 21.4% in DG from females (Figure 4.2.32A-C).   
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Figure 4.44: Small alternative exon usage changes between wild-type and transgenic APPPS1-21 offspring: (A-C) 
Number of significant differentially spliced genes in DG from males (A) and females (B) and CA1 (C) from male of wtwtwt, wttgwt 
and wtwttg animals compare to tg APPPS1-21 transgenic animals. Red columns represent significant alternative inclusion exons; 
blue columns represent significant alternative exclusion exons and greys are the sum of previous two. Genes, padj ≤ 0.05; 
log2FC ±0.25  . For DG males: tg n=4; wttgwt n=7; wtwttg n=5 and wt wtwt n=5; for DG females tg n=7; wttgwt n=5; wtwttg n=4 and wt wtwt n=5 and 
for CA1 males tg n=6; wttgwt n=7; wtwttg n=8 and wt wtwt n=6.
Figure 4.43: Drastic alteration of alternative exon usage in DG and CA1 of transgenic animals: (A) Number of significant alternative 
exon usage with different levels of changes (severe, medium and mild, established by the log2FC) in tg animals compare to wt
wtwt animals. 
Exon usage, padj ≤ 0.05. (B) Number of significant included and excluded exons for DG males (DGm), DG females (DGf) and CA1 males 
(CA1m) in tg vs. wtwtwt animals. Red columns represent significant alternative included exons and blue columns represent significant alterna-
tive excluded exons. Exon usage, padj ≤ 0.05, log2FC±0.25. For DG males:  tg n=4 and wt 
wtwt n=5; for DG females tg n=7 and wt wtwt n=5 and 























































































































































Figure 4.2.32. A large number of identical genes showed alternative exon usage in CA1 and DG 
regions of wild-type mice born to APPPS1-21 transgenic fathers.  
(A-C) Venn diagrams illustrating overlap of spliced genes in DG from males and females and CA1 from 
males in wttgwt vs. wtwtwt comparison. Red color represents significant alternative inclusion exons; blue 
represents significant alternative exclusion exons and greys are the sums of previous two. Genes, padj ≤ 
0.05; log2FC ± 0.25. For DG males: wttgwt n=7; wtwttg n=5 and wtwtwt n=5; for DG females: wttgwt n=5; wtwttg 
n=4 and wtwtwt n=5 and for CA1 males: wttgwt n=7; wtwttg n=8 and wtwtwt n=6. 
4.2.4.2.Functional pathways linked to alternative exons in wild-type mice born to an 
APPPS1-21 transgenic father or mother 
In order to define biological processes affected by genes that had an alternative exon usage in 
wt mice born to an APPPS1-21 tg father (wttgwt) compared to control wt mice, I screened the 
pathways linked to these genes using Cytoscape/ClueGO (Bindea et al., 2009; Shannon et al., 
2003). I also established the splicing similarities between wttgwt and APPPS1-21 tg mice. Almost 
all pathways identified in DG and CA1 regions of wttgwt mice were connected to inclusion events 
(Figure 4.2.33A-C). Analyzing only the top 20 most significant biological or molecular functions in 
CA1 and DG of wttgwt mice, I recognized that a vast number of them were connected with 
nervous system development (9 for DGm, 1 for DGf and 0 for CA1), signaling receptor activity (2 
for DGm, 5 for DGf and 1 for CA1), metabolic process (0 for DGm, 3 for DGf and 0 for CA1), 
cellular component organization (0 for DGm, 3 for DGf and 0 for CA1) and cell and neuronal 
projection (3 for DGm, 2 for DGf and 0 for CA1) (Figure 4.2.33A-C). Almost all global categories 
were also affected in APPPS1-21 tg mice, as previously reported in figure 4.1.14 and 16. 
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Figure 4.2.33. Several functions were affected by alternative exon usage in genes of wild-type mice 
born to APPPS1-21 transgenic fathers.  
(A-C) Network of functional categories (biological process, molecular function and cellular component 
ontologies) of significant differentially spliced genes in CA1 and DG regions of wt mice born to APPPS1-21 
tg fathers. The size of the nodes correlates inversely with statistical significance. Categories with a red 
color spectrum correspond to pathways associated with genes with inclusion of exons in wttgwt mice and 
with blue correspond to exclusion of exons. Categories that shared genes with inclusion and exclusion of 
exons are represented in grey. Genes, padj ≤ 0.05; log2FC ± 0.25 and pathways, pval < 0.05. (D-F) Top 20 
significant functional pathways ranked by -log pval after Benjamini-Hochberg correction of significant 
differentially expressed genes in brain regions of wttgwt vs. wtwtwt mice. For DG males:  wttgwt n=7 and wtwtwt 
n=5; for DG females wttgwt n=5 and wtwtwt n=5 and for CA1 males wttgwt n=7 and wtwtwt n=6. 
These results suggest that non-genetic factors transmitted from APPPS1-21 transgenic fathers 
promote a strong alteration of the transcriptome and alternative exon usage in both offspring, 
wild-type and transgenic mice. Besides, these results provide evidence for a substantial variation 
of alternative exon usage between the two wild-type groups, namely control wild-type (wtwtwt) 
mice and those originating from a transgenic father (wttgwt).  
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To verify the similarities in terms of genes and pathways affected by alternative exon usage 
between tg and wttgwt, I identified the number of common genes, and the pathways associated 
with them, both of them were compared to wt control mice. In DG from wttgwt males around 50% 
of genes with an alternative exon usage were also altered in tg mice (Figure 4.2.34A-C). From 
DG females, almost 75% of the genes were commonly affected (Figure 4.2.34D-F) and in CA1 
from males around 60% of the genes (Figure 4.2.34G-I). These results indicate a clear relation 
between wttgwt and tg mice regarding changes in exon usage, which is stronger than the 
connection concerning differentially expressed genes (Figure 4.2.23). 
 Figure 4.2.34. A large number of differentially spliced genes overlap between wt mice born to 
APPPS1-21 tg fathers and APPPS1-21 tg mice when both were compared to wt control mice 
(wtwtwt).  
(A-I) Venn diagrams illustrating overlap of differentially spliced genes in tg vs. wtwtwt and wttgwt vs. wtwtwt 
mice. Red color represents significant alternative inclusion exons; blue represents significant alternative 
exclusion exons and greys are the sums of previous two. Genes, padj ≤ 0.05; log2FC ± 0.25 and 
pathways, pval < 0.05.  For DG males: tg n=4; wt n=7 and wtwtwt n=5; for DG females tg n=7; wttgwt n=5 











































Also, I identified the overlap of differentially spliced and expressed genes in wttgwt mice (38 for 
DGm, 355 for DGf and 0 for CA1m) (Figure 4.2.35A-C). Only a 25% of differentially expressed 
genes in DG from males also showed an alternative exon usage (Figure 4.2.35A). This was 
around 41% in DG from females (Figure 4.2.35B).  And in CA1 differentially expressed genes did 
not show alteration of the spliced events (Figure 4.2.35C). These numbers differ from the 
number of common genes identified in transgenic mice, where there was an overlap of around 
30% in all three regions (Figure 4.1.48A-I). 
Figure 4.2.35. Subregion variability regarding common genes affected by differentially  
expressed and spliced genes in wt mice born to APPPS1-21 tg fathers (wttgwt) when were 
compared to wt control mice (wtwtwt).  
(A-C) Venn diagrams illustrating overlap of genes differentially expressed and differentially spliced genes 
in wttgwt vs. wtwtwt mice. Genes, padj ≤ 0.05; log2FC ± 0.25 and pathways, pval < 0.05.  For DG males: 
wttgwt n=7 and wtwtwt n=5; for DG females wttgwt n=5 and wtwtwt n=5 and for CA1 males wttgwt n=7 and wtwtwt 
n=6.  
Interestingly, differentially expressed genes that had an alternative exon usage in DG from male 
and female wttgwt mice were related to similar pathways as those from genes differentially 
expressed and spliced in APPPS1-21 tg mice (Figure 4.1.16). These included pathways linked to 
nervous system development, synapse, transmembrane regulation, chromatin modification and 
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Figure 4.2.36. Several networks were affected by differentially expressed and spliced genes in DG 
region of wild-type mice born to APPPS1-21 transgenic mice.  
(A-B) Network of functional categories (biological process, molecular function and cellular component 
ontologies) of significant differentially expressed and spliced genes in DG of wttgwt mice. The size of the 
nodes correlates inversely with statistical significance. Categories with a red color spectrum correspond to 
pathways associated with genes with inclusion of exons and up-regulated genes in wttgwt mice and blue 
correspond to exclusion of exons and down-regulated genes. Genes, padj ≤ 0.05; log2FC ± 0.25 and 
pathways, pval < 0.05. For DG males: wttgwt n=7 and wtwtwt n=5; for DG females wttgwt n=5 and wtwtwt n=5 
and for CA1 males wttgwt n=7 and wtwtwt n=6. 
4.2.5.Non-genetic inheritance of APPPS1-21 traits 
Previously, I described the cognitive performance, the transcriptome and the splicing events 
from wt and tg mice born to APPPS1-21 transgenic fathers or mothers. I observed that wt mice 
born to tg mothers (wtwttg) did not show many differences compared to wt control mice. In 
contrast, wt mice born to tg fathers (wttgwt) showed a strong variability compared to wt control 
mice (wtwtwt) and strongly resembled APPPS1-21 tg mice. Thus, I hypothesize that these 
phenotypes were likely mediated via sperm transmission of specific non-genetic factors. Several 
non-genetic factors of transmission, such as histone modifications, DNA methylation or non-
coding RNAs (ncRNAs), were described in the last years (Denham et al., 2015; Gapp et al., 
2014; Terashima et al., 2015). The injection of small RNAs from traumatized males into naïve 
oocytes induced a stress-like phenotype to the offspring (Gapp et al., 2014). Taking into account 
the important role that small RNAs have in intergenerational inheritance, here I focused 



















































































4.2.5.1.SmallRNAs as a mechanism of transmission of APPPS1-21 traits 
I screened sperm’s RNA from APPPS1-21 transgenic fathers of earlier described offspring and 
compared it to wild-type fathers. From the total of small RNAs only a few small nucleolar RNAs 
(snoRNAs), Piwi-interacting RNAs (piRNAs) and one novel microRNAs (miRNAs) showed a 
significant increase in transgenic mice (Figure 4.2.37A-B). I checked whether these specific 
small RNAs were previously found on mouse sperm samples and interestingly all of them were 
previously isolated from sperm samples of C57BL/6J mouse line (http://spermbase.org/) 
(Schuster et al., 2016). 
I identified miR-6240 and its immature form as being significantly differentially expressed in 
APPPS1-21 transgenic fathers. This miRNA was not previously linked to any mechanism or 
pathology, so it could be a potential target for further investigations. Besides, I found differential 
expression of different forms of snoRNAs and piRNAs in APPPS1-21 tg vs. wild-type fathers. To 
my knowledge, snoRNAs and piRNAs were not previously linked to intergenerational inheritance 
of phenotypic changes and might be new mechanisms of non-genetic transmission to the next 
generation. Snord15b-201, snord111-201, snord60-201, snord96a-201, snord47-201 (U47) were 
enriched in the RNA of APPPS1-21 transgenic fathers, however not much is known about their 
functions. It is known that snord47 was associated with tumorigenesis in glioblastoma (Xu et al., 
2017). The piRNA_000578, piRNA_018323 and piRNA_003040 were up-regulated in 
APPPS1-21 tg RNA sperm (Figure 4.2.37B); however little is known about their functions. All 
three piRNAs were previously identified in the cerebellum of a mouse model of Rett syndrome 
(Saxena, Tang, & Carninci, 2012). 
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Figure 4.2.37. Expression of small RNAs that could play an important role in the altered phenotype, 
transcriptome and splicing in wild-type and transgenic offspring of APPPS1-21 transgenic fathers.  
(A) Volcano plot illustrating the proportion of differentially expressed small RNAs between tg and wild-type 
fathers. Yellow dots represent small RNAs with log2FC ± 1; red dots with a padj < 0.05; green dots 
represent small RNAs that fulfilled both criteria and black dots represent the small RNAs that did not fulfill 
any of the criteria defined. (B) List of significant differentially expressed small RNAs with their specific padj 
and log2FC values. 
To the best of my knowledge, this is the first study that identified potential non-genetic factors for 
the transmission of a cognitive deficit phenotype caused by genetic mutations (in my case 
specifically, APP and PS1) in fathers. However, further research is necessary to confirm the 
direct correlation between these small RNAs and the inheritance observed in wild-type mice 
born to APPPS1-21 transgenic fathers. 
4.2.6.APP expression in wt mice born to APP fathers 
In addition, I speculated with the idea that APP per se might be transmitted by leakage through 
the sperm of tg fathers. While this should not be the case since the promoter of the double 
mutation, Thy1, is specific for neurons, I tested this experimentally. No differential expression of 
the human APP in sperm was observed between groups (Figure 4.1.57A), discarding the APP 
leakage as a factor. Besides, quantifying the expression of the human APP in CA1 region, I 
conclude that the expression of APP is specific for transgenic brain regions. 
Figure 4.2.38. No expression of APP in sperm of APPPS1-21 transgenic fathers.  









































4.3.Inter-individual differences in cognitive performance and 
linked molecular pathways in aging mice  
Previously I have established the cognitive performance, transcriptome and exon usage of wild-
type and transgenic mice born to APPPS1-21 transgenic parents. APPPS1-21 transgenic mice 
rapidly developed the pathology of Alzheimer’s disease (AD) and showed spatial impairments at 
3 months of age that were worsened at 9 months of age. The major risk to develop AD is aging. 
Here, I point the question of whether there could be specific gene expression changes 
exclusively related to aged individuals with cognitive impairments. For that, I chose to work on 
an aging mouse model because it is well established that inter-individual variability increases 
significantly with age, especially in terms of cognitive performance. This cognitive performance 
inter-individual variability would allow me to preselect aged mice with cognitive decline (Koivisto 
et al., 1995; Montesanto et al., 2012). It has repeatedly been demonstrated that environmental 
factors can profoundly impact the organism’s behavior, especially in behavioral tasks (Holm-
Hansen et al., 2016; D. Smith et al., 2015). In mice, it is very common to observe inter-individual 
variability in genetically identical mice. There is solid evidence pointing to epigenetic 
mechanisms as being involved in this individual variability, and the readout from these assays is 
often transcriptomic changes. 
4.3.1.Increased variability in cognitive performance in aging mice: 
choosing good vs. bad learners 
In order to assess the inter-individual variability in cognitive performance and identify specifically 
mice with cognitive impairments, I tested C57BL/6J wild-type mice at 17 months of age in two 
spatial memory tasks: Morris water maze and Barnes maze. I also recorded the exploratory and 
motor abilities in the open field task (Figure 4.3.1A). 
To  define bad vs. good learners, I carefully examined individual MWM performance for each 
mouse used in the test. Mice were trained for 9 days and tested at day 10 (probe test, PT). 
During the learning phase, all averaged mice learned the task and required less than 25 
seconds to find the platform in the last days of training (Figure 4.3.1B).  However, wt mice at 17 
months of age required significantly longer times to find the platform compared to a 3 months of 
age wt control mice (Figure 4.3.1B). When mice were plotted individually, a greater variability 
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between old mice was observed (Figure 4.3.1C). The distribution of the individual data points in 
the latency time was clearly a lot more widespread in the old mice than that of young mice. 
 
Figure 4.3.1. Increase inter-individual variability in cognitive performance in aging mice.  
(A) Experimental design. (B) Old (17m) and young (3m) group-average time and (C) individual time to find 
the target platform on each consecutive training day (Day 1-9). Two-way ANOVA after Sidak correction, *P 
< 0.05; **P < 0.01; ***P < 0.001. The dashed line represents the chance level of 25%. Error bars indicated 
SEM.   
In the PT, mice at 17 months of age showed greater inter-individual differences in their memory 
for the platform. Some did not learn the task (bad performers), whereas others (good 
performers) remembered the exact position of the platform (Figure 4.3.2A). Bad performers 
moved randomly into all four quadrants, while good performers spent the majority of the test time 
in the target quadrant (Figure 4.3.1B-D). There is a correlation (r2 = 0.5802) between the time a 
mouse spent in the target quadrant and the number of times that it crosses the platform, another 
indication of the strong memory of the platform position (Figure 4.3.1E-F). To study the 
molecular differences between bad (impaired cognition) and good (intact cognition) performers, I 
empirically set the threshold at the top/bottom 8 out of ~40 mice and assigned the best 8 and 























































Figure 4.3.2. Establishment of good and bad performers.  
(A) Percentage of time spent on the target quadrant vs. other three quadrants. (B) Percentage of time 
spent on the target quadrant vs. other three quadrants during probe trial and ranked by percentage of time 
during the probe trial. (C) Heatmap occupancy plots are showing a typical probe trial for a bad, middle and 
good performer (left to the right, respectively). (D) Representative tracings from the probe trial of one bad, 
middle and good performer mouse. (E) Number of platform crossings ranked by percentage of time during 
MWM probe trial. (F) Correlation between platform crossings and time spent in the target quadrant during 
the probe trial. Linear regression. ****P < 0.0001. Bad performers are defined with red color, middle 
performers with grey and good performers with green.   
To verify that motor abilities are not the cause of this variability, I checked the swim speed of 
individual mice and sorted them by time spent in the target quadrant (Figure 4.3.3A). There was 
no correlation (r2= 0.0896) between speed and performance (Figure 4.3.3B). Also, there were no 
significant differences in swimming speeds between good and bad performers (Figure 4.3.1C), 









































































Figure 4.3.3. No motor variability between good and bad performers.  
(A) Individual average speed during the first day of training ranked by percentage of time spent in the 
target quadrant. (B) Correlation between average speed during first day of training and percentage of time 
during the probe trial. Linear regression, ns = no significant differences. (C) Average speed during the first 
day training from good and bad performers. Student’s two-tailed T-test, ns = no significant differences. 
Error bars indicated SEM. Bad performers are defined with red color, middle performers with grey and 
good performers with green.  
To verify whether anxiety levels played a role in good and bad performance, I subjected mice to 
the open field test. While mice showed inter-individual differences in exploratory abilities, with 
some mice spending more time in the center and others near the walls, I did not observe any 
difference between our previously defined good vs. bad learners (Figure 4.3.4A, green and red 
bars, respectively). Anxiety levels did not correlate (r2= 0.0035) with performance in the MWM 
(Figure 4.3.1B). Thus, neither the motor ability nor anxiety levels affected (or influenced, decide 
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RESULTS
Figure 4.3.4. No changes in motor and abilities and anxiety levels between good and bad 
performers during the open field test.  
(A) Percentage of time spent in the central area of the field ranked by the percentage of time spent in the 
target quadrant during Morris water maze (MWM) probe trial (PT). (B) Correlation between percentages of 
time spent in the central area and percentages of time target quadrant during MWM PT. Linear regression. 
ns = no significant differences. (C) The average percentage of time spent in the central area from bad and 
good performers. Student’s two-tailed T-test, ns = no significant differences. Error bars indicated SEM. 
In order to corroborate that I can in fact separate good from bad performers in a spatial memory 
task, I tested a second cohort of mice in a different spatial memory test, namely the Barnes 
maze (BM). This learning task consists of placing a mouse in the center of a circular light surface 
with 20 possible escape holes symmetrically distributed around the circumference of the maze. 
Only one of the holes has an escape box below, and the mouse needs to explore the maze 
surface until it eventually finds the escape box and memorizes its spatial location. I conducted 
this test this test in a separate cohort of 17 month-old mice. Besides, this group was also tested 
in the open field. 
During the first day of the BM, mice were habituated to the new environment. Moreover, during 
the next 3 days, they were trained to find the dark escape box. The probe test was performed on 
the 10th day, after 8 days of training (Figure 4.3.5A). During the probe trial, mice at 17 months of 
age showed a robust inter-individual variability, with some mice spending most of the time 
around the escape hole (good performers), and others moving randomly around the surface or 
staying close to other random holes (bad performers) (Figure 4.3.5B-C). As in my previous 
Morris water maze experiment, I chose the extremes of the learning curve (in this case the top 



































Figure 4.3.5. Establishment of good and bad performers based on escape latency (or performance) 
in the Barnes maze (BM).  
(A) Experimental design. (B) Percentage of time spent in the target quadrant during the Barnes maze 
(BM) probe trial after 8 days of training. (C) Representative tracings from the probe trial of a bad, middle 
and good performer mouse. Bad performers are represented with red bars, middle performers with grey 
and good performers with green. 
Similar to my previous results, I did not observe any correlation (r2= 0.0015) between 
performance in the BM probe trial and speed of the mice. This cohort did not show any motor 
ability changes between performers either (Figure 4.3.6A-C). This means that this variability 
concerning learning does not correspond with motor impairments.  
Figure 4.3.6. No motor variability between good and bad performers.  
(A) Individual average speed in Barnes Maze (BM) probe trial ranked by percentage of time spent in the 
target quadrant. (B) Correlation between average speed during the first day of training and percentage of 
time during the probe trial. Linear regression. ns = no significant differences. (C) Average speed during PT 
between good and bad performers. Bad performers are defined with red color, middle performers with 
grey and good performers with green. Student’s two-tailed T-test, ns = no significant differences. Error 
bars indicated SEM. 
This observation was further validated in this cohort using the open field test. As expected, some 
mice spent more time in the center while others preferred the periphery, corresponding to 
different levels of anxiety (Figure 4.3.7A). However, this variability did not correlate (r2= 0.0011) 
with their performance in the BM (Figure 4.3.7B-C), again arguing against motor or anxiety-
















































































































Figure 4.3.7. No anxiety variability between defined good and bad performers during the open field 
test.  
(A) Percentage of time spent in the central area of the open field ranked by the percentage of time spent 
in the target quadrant during Barnes maze (BM) probe trial (PT) (B) Correlation between percentage of 
time spent in the central area and percentage of time target quadrant during BM PT. Linear regression. ns 
= no significant differences. (C) The average percentage of time spent in the central area from bad and 
good performers. Student’s two-tailed T-test, ns = no significant differences. Error bars indicated SEM. 
These data suggest that aged wild-type mice raised under identical conditions develop distinct 
abilities to learn and memorize a task, such as the MWM or the BM tasks.  
4.3.2.Transcriptional profiling and functional pathways analysis of 
good and bad performers 
To gain a better understanding of the molecular mechanisms associated with aged wild-type 
mice with cognitive decline, I analyzed the spatial-related brain regions from these bad 
performers and compared to good performers (intact cognition). I studied the transcriptome of all 
three hippocampal subregions, Cornu Ammonis 1 and 3 (CA1 and CA3) and Dentate Gyrus 
(DG) from good and bad performers of the first cohort of mice. Due to time limitations, only the 
transcriptomic profile of the first cohort was evaluated. 
Surprisingly, a little number of genes in CA1, CA3 and DG (maximum 16 in CA3) were 
significantly different (padj ≤ 0.05 and log2FC ± 0.25) between good and bad performers (Fig.
4.3.8A-C). Thus, I decided to evaluate the signaling pathways differentially affected between 
good and bad performers, using Gene Set Enrichment Analysis (GSEA) (Mootha et al., 2003; 
Subramanian et al., 2005). GSEA analysis allows studying the whole dataset functions without 
restricting the study to only genes with a specific threshold.   
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Figure 4.3.8. Changes in transcriptional profile in brain subregions of bad performers compared to 
good performers.  
(A-C) Number of significant differentially expressed genes between good and bad performers in (A) CA1, 
(B) CA3 and (C) DG. Statistical difference of FDR and log2FC values are indicated by red dots, and only 
one parameter is indicated by green dots and none of them by black dots. For CA1 subregion: good n = 7 
and bad n= 7; for DG good n = 7 and bad n= 8 and for CA3 good n = 3 and bad n= 4.  
In order to evaluate the cellular state of mice from the same line and at the same age but only 
differing in spatial cognitive abilities, I ran the full list of normalized counts from RNA sequencing 
of good (intact cognition) and bad (cognitive decline) performers through GSEA. To obtain a first 
idea of the mechanisms involved, I selected the top 50 most significant pathways (nominal pval 
≤ 0.05; FDR ≤ 0.1) from each category (biological process, molecular function and cellular 
component) ranked by Normalized Enrichment Score (NES). The NES indicates the level to 
which a group of genes is represented in the upper or lower part of the ranked list of genes in 
the expression dataset 13. Positive pathways are enriched in good performer mice, whereas 
negative pathways are enriched in bad performers (Figure 4.3.9-11). From these top 50 
pathways, I screened in detail which broader term could be used to summarize the pathways. 
This allowed me to identify the most important mechanisms that could promote these differences 
in spatial performance.  
The main significant functional changes were observed in CA1 and DG regions of aged mice 
(Figure 4.3.9A-H). Analyzing the broader biological processes associated with the top 50 
preselected pathways, I discovered that similar functions were over and underrepresented in 
CA1 and DG subregions of bad performers (aged mice with cognitive impairments) (Figure 
4.3.9A-F). Genes related to mitochondrial activity, respiratory chain, general and RNA metabolic 
processes, translation, protein localization and ribosome biogenesis and assembly were down-
regulated in CA1 and DG regions of aged mice with cognitive impairments (Figure 4.3.9B and 
E). On the contrary, up-regulated genes in CA1 and DG regions of bad performers (impaired 
cognition) were linked to kidney tissue, vessel and embryo development and cellular component 
organization (Figure 4.3.9C and F).  Specifically, in the DG region of bad performers, pathways 
linked to response to a stimulus, coagulation, immune system, apoptotic and metabolic 
processes were enriched (Figure 4.3.9K-L). In the CA3 region of mice with cognitive 
impairments, genes related to immune system, metabolic and apoptotic processes were 
underrepresented (Figure 4.3.9G-H). 
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Figure 4.3.9. Biological processes are differentially affected in good and bad performer mice.  
(A, D and G) Top 10 preselected biological processes over or underrepresented within the whole dataset 
of genes in “good” and “bad” performers in brain subregions: CA1 (A), DG (D) and CA3 (G). NES= 
Normalized Enrichment Score. Positive NES means overrepresentation in “good” performers, whereas 
negative NES means overrepresentation in “bad” performers. (B, C, E, F and H) Broader term summary 
of the top 25 overrepresented (B, E and H) and 25 underrepresented (C and F) pathways in “good” 
performers in the above   mentioned brain subregions. Nominal pval ≤ 0.05; FDR ≤ 0.25. For CA1 
subregion: good n = 7 and bad n= 7; for DG good n = 7 and bad n= 8 and for CA3 good n = 3 and bad n= 
4.  
Interestingly, genes with the top 50 significant molecular function ontologies altered in 
hippocampal regions of bad performers compared to good performers were in agreement with 
my observations in the biological process ontology (Figure 4.3.9 and 10). Categories such as 
catalytic activity, transport and channel activity linked to mitochondrial complex or genes 
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associated with protein biogenesis such as transcription regulatory activity and translation were 
down-regulated in CA1 and DG of bad performers (Figure 4.3.10A-F). In CA3 region of bad 
performers, only genes related to protein binding and structural molecular activity were enriched 
(Figure 4.3.10G-H).   
Figure 4.3.10. Molecular functions were differentially affected in good and bad performer mice.  
(A, D and G) Top 10 preselected biological processes over or underrepresented within the whole dataset 
of genes in good and bad performers in the brain subregions: CA1 (A), DG (D) and CA3 (G). NES= 
Normalized Enrichment Score. Positive NES means overrepresentation in good performers, whereas 
negative NES means overrepresentation in bad performers. (B, C, E, F and H) Broader term summary of 
the top 25 overrepresented (B, E and H) and 25 underrepresented (C and F) pathways in good 
performers in the above mentioned brain subregions. Nominal pval ≤ 0.05; FDR ≤ 0.25. For CA1 
subregion: good n = 7 and bad n= 7; for DG good n = 7 and bad n= 8 and for CA3 good n = 3 and bad n= 
4.  
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Lastly, the cellular structures altered in CA1 and DG regions of bad performers correspond to 
components implicated in previously described biological processes such as mitochondria 
activity, protein biogenesis, metabolic process and protein localization and transport. For 
example, genes linked to mitochondria, ribosome, secretory vesicle, cytoskeletal part and 
extracellular regions were altered in these regions (Figure 4.3.11A-O).   
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Figure 4.3.11. Cellular components are differentially affected in good and bad performer mice.  
(A, D and G) Top 10 preselected biological processes over or underrepresented within the whole dataset 
of genes in good and bad performers in the brain subregions: CA1 (A), DG (D) and CA3 (G). NES= 
Normalized Enrichment Score. Positive NES means overrepresentation in good performers, whereas 
negative NES means overrepresentation in “bad” performers. (B, C, E, F, H and I) Broader term summary 
of the top 25 overrepresented (B, E and H) and 25 underrepresented (C, F and I) pathways in “good” 
performers in the above mentioned brain subregions. Nominal pval ≤ 0.05; FDR ≤ 0.25. For CA1 
subregion: good n = 7 and bad n= 7; for DG good n = 7 and bad n= 8 and for CA3 good n = 3 and bad n= 
4.  
In summary, the majority of pathways deregulated in the hippocampal regions of aged mice with 
cognitive impairments were linked to development, mitochondria activity, respiratory chain 
complex, RNA metabolic process, ribosome biogenesis and assembly, translation, protein 
localization, immune system, apoptotic processes, coagulation and response to a stimulus. Of 
note, pathways linked to mitochondria, respiratory chain, ribosome biogenesis, RNA metabolism, 
translation and protein localization were as well underrepresented in APPPS1-21 transgenic 
mice (Figure 4.1.8 and 11), which showed as well spatial cognitive deficits. This suggests that an 
alteration of pathways linked to energy metabolism (mitochondria activity, respiratory chain 
complex) and protein biogenesis (ribosome biogenesis, RNA metabolism, translation and protein 
localization) has an impact on spatial cognitive abilities in aged wild-type mice. Alteration of 
energy metabolism pathways in aged-mice has been previously described. However, I identified 
for the first time that these dysfunctions were specific to aged-mice those present cognitive 
impairments. Besides, pathways linked to development were increased in old performers and 
APPPS1-21 transgenic mice. However, APPPS1-21 transgenic mice showed mainly altered 
pathways connected to nervous system development, and bad performers show and up-
regulation of genes linked to kidney, bone, vessels and artery development.  
4.3.3.Blood biomarkers of  “good" and “bad” performers 
Based on my previous results, I was able to identify the altered pathways related to aged mice 
with distinct cognitive abilities. Next, I wondered whether I could identify a biomarker that 
allowed me to predict the cognitive abilities of aged mice. To this end, I analyzed the expression 
of small RNAs in the blood from good (intact cognition) and bad (impaired cognition) performers. 
Analyzing the global distribution of blood samples using Principal Component Analysis (PCA), I 
identified certain separation between good and bad performers (Figure 4.3.12A).  Interestingly, a 
group of small RNAs reached statistical significance (Padj ≤ 0.05, log2FC ± 0.5) in bad 
compared to good performers (Figure 4.3.12A). The majority of down-regulated small RNAs in 
bad performers corresponded to microRNAs (miRNAs), 17 microRNAs from 19 small RNAs, the 
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rest were Piwi-interacting RNAs (piRNAs). I investigated the validated target mRNAs from these 
down-regulated small RNAs in the blood of bad performers and discovered that were related to 
nervous system development, catabolic processes and ossification (Figure 4.3.12C). Moreover, 
two microRNAs were up-regulated in the blood of the bad performers, miR-423-3p and 
miR-9769-3p. These up-regulated miRNAs target mRNAs involved in immune system 
development and response to cytokine (Figure 4.2.12C). Investigating the specific function of the 
deregulated miRNAs, I identified some potential candidates for detecting the cognitive abilities of 
aged mice. For example, human miR-501-3p was down-regulated in the serum of Alzheimer’s 
disease (AD) patients and up-regulated in the brain of the same donors (N. Hara et al., 2017). It 
also played an important role in working memory in a mouse model of vascular cognitive 
impairment (Toyama et al., 2018). Moreover, miRNA-100-5p was identified in a mouse model of 
AD, APP/PS1, targeting mTOR and inducing changes in neuronal survival (Ye et al., 2015) and 
miRNA-146a-5p was associated with inflammatory signaling in neurodegenerative diseases 
(Alexandrov, Dua, & Lukiw, 2014). MiRNA-664-3p expression in the spleen tissue of 6 wild-type 
mouse strains was related to pathways that play an important role in longevity, such as FOXO, 
mTOR and MAPK (B. P. Lee et al., 2017). These results suggest that some of these miRNAs 
could be further investigated as biomarkers of cognitive abilities. 
Figure 4.3.12. Blood small RNAs used as biomarkers of good and bad learners.  
(A) Principal Component Analysis (PCA) plots for comparison of good and bad performers (B) Heatmaps 
of differentially expressed small RNAs in the blood of good vs. bad. High expression is indicated by the 
red color spectrum and low expression by the blue color spectrum. Padj ≤ 0.05, log2FC ± 0.5. (C) Network 
of functional categories (biological process, molecular function and cellular component ontologies) of 
validated target genes. Categories with a red color correspond to target-genes associated to miRNAs that 
were up-regulated in good performers and red up-regulated in bad performers. MiRNAs, padj ≤ 0.05; 













































































catabolic processcentral nervoussystem neuron


















5.1.The early stage of Alzheimer’s disease in APPPS1-21 
mouse model 
Alzheimer’s disease (AD) is a neurodegenerative disease and the most common form of 
dementia.  Over the last few decades, it has become clear that AD is a multifactorial disease (K. 
Iqbal & Grundke-Iqbal, 2010; Iturria-Medina et al., 2016; Talwar et al., 2017). Aside from 
treatments that slow down specific symptoms from the pathology, no cure exists for AD. The 
inefficiency of treatments is probably due to the late diagnosis of the disease. Thus, in recent 
years, several studies have focused their investigations on the understanding of the molecular 
and phenotypic changes associated with the early stages of pathology (Filippi et al., 2018; Gatta 
et al., 2014; Parra-Damas et al., 2014). These studies have evaluated the early pathology from 
different fields; one of them was gene expression analysis (Blalock et al., 2004; Gatta et al., 
2014; Parra-Damas et al., 2014). Alzheimer’s disease has a genetic component. Genetic factors 
have been intensively investigated for years, and several genes have been associated with AD 
forms. Specific mutations in the amyloid precursor protein (APP), presenilin 1 (PSEN1) and 
PSEN2 induce the familial form of AD (Goate, 2006; Levy-Lahad et al., 1995; Sherrington et al., 
1995). The expression of the isoform of apolipoprotein, ApoeE4, increases the risk for familial 
and sporadic forms of AD (Strittmatter et al., 1993). Despite the exhaustive investigations, the 
genetic impact is complex, and the results are still controversial, and more research is still 
necessary to understand the genetic influence at early AD stages (Blalock et al., 2004; Gatta et 
al., 2014; Parra-Damas et al., 2014). In this study, I described the cognitive impairments and 
gene expression changes in a well-established mouse model of AD at an early AD stage (3 
months of age).  
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5.1.1.Spatial cognitive deficits in APPPS1-21 transgenic mice are 
detectable at 3 m 
Alzheimer’s disease is characterized by gradual loss of memory. The most widely used AD 
mouse models show memory impairments at different time points (Arendash et al., 2001; 
Chapman et al., 1999; Govindarajan et al., 2013; Kelly et al., 2003; Lalonde, Lewis, Strazielle, 
Kim, & Fukuchi, 2003; Radde et al., 2006; Serneels et al., 2009) and in some cases before the 
accumulation of plaques (Dineley, Xia, Bui, Sweatt, & Zheng, 2002; Dodart et al., 1999; Oddo et 
al., 2003; Saura et al., 2005). The APPPS1-21 mouse model is a well-characterized model. This 
line has been reported to have a significant increase of soluble Aβ42 levels and deposition of 
amyloid plaques in different brain regions (Radde et al., 2006). At 3 months of age, this line had 
deposits of amyloid plaques affecting only the neocortex and DG region of the hippocampus, 
whereas at 6 months of age plaques appeared in the CA1 hippocampal region, striatum, 
thalamus and brainstem (Radde et al., 2006).  Moreover, this line showed cognitive deficits for 
specific behavioral tasks from 7 months of age (Govindarajan et al., 2013; Radde et al., 2006; 
Serneels et al., 2009),19. For example, it was reported that these mice showed impairments in 
reversal learning of a food-rewarded four-arm spatial maze at 8-months of age (Radde et al., 
2006). Additionally, APPPS1-21 mice exhibited spatial learning and memory deficits in Morris 
water maze (MWM) at 7-8 months and alterations of associative memory in the fear conditioning 
(FC) paradigm at 12 months of age (Govindarajan et al., 2013; Serneels et al., 2009; Zovoilis et 
al., 2011). Although the APPPS1-21 mouse line has been characterized at AD late stages, it is 
still not reported whether these mice show behavioral alterations early on. To the best of my 
knowledge, this present work is the first characterization of the behavior of the APPPS1-21 
mouse line at 3 months of age and I found that APPPS1-21 transgenic mice presented cognitive 
deficits at such an early stage. However, these deficits were restricted to spatial learning and 
memory task, assessed using MWM, as shown in figure 4.1.3 and 4.1.4 (D’Hooge & De Deyn, 
2001). In contrast to the cognitive deficits I found in this line, another model of AD known as 
APP/PS1 (APP K670N/M671L and PS1 M146L) did not exhibit spatial memory deficits or 
hippocampal plaques at 3 months of age (Sadowski et al., 2004; Yu et al., 2009). These studies 
and my data suggest a direct connection between cognitive deficits and deposition of Aβ 
plaques in the hippocampus (Gengler et al., 2010; Radde et al., 2006). However, such 
connection is still not clear, since some studies have found other AD mouse models showing 
cognitive deficits before the deposition of plaques (Oddo et al., 2003; Saura et al., 2005; Van 
Dam et al., 2003). These studies suggested an association between cognitive deficits and the 
increase of soluble Aβ (Oddo et al., 2003; Saura et al., 2005; Van Dam et al., 2003). One 
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example was the APP23 mouse line, which showed spatial cognitive deficits in the MWM task 
without amyloid deposition at 3 months of age, but a direct correlation with soluble Aβ levels 
(Van Dam et al., 2003). In APPPS1-21 line, the spatial cognitive deficits at 3 months of age could 
potentially be induced firstly by an increased Aβ42 soluble form and then by the deposition of Aβ 
plaques. Motor impairments or increase anxiety could also lead to a detrimental performance in 
the MWM. However, APPPS1-21 mice did not differ in the travel speed in the MWM or show 
increased anxiety in the open field test (OF), compared to wild-type controls, strongly suggesting 
that the poor performance of these mice in the MWM was indeed due to a cognitive impairment 
(Figure 4.1.2 and 4.1.6). APPPS1-21 mice tended to show a more “reckless” behavior in the 
open field, spending more time in open spaces, even at 3 months of age (Figure 4.1.2). This 
reduction of anxiety was not previously observed in APPPS1-21 transgenic mice at 5 or 8 
months of age (Radde et al., 2006). One explanation could be that this transgenic line shows a 
reduction of anxiety levels at early ages but it is then normalized in the late adulthood. 
In associative tasks with a spatial component, such as the fear conditioning test, 3-month old 
APPPS1-21 transgenic mice were not affected (Figure 4.16). This might indicate that at this 
early stage of the pathology tasks that engage more brain areas and are part of the innate 
response to peril, like the fear conditioning test, are less sensitive to the initial cellular and 
molecular hallmarks of the disease. In contrast, refined tasks, such as spatial navigation, that 
may be more fragile in nature, start to show the first signs of the underlying degeneration. These 
findings indicate that the APPPS1-21 mouse model rapidly develops the pathology of 
Alzheimer’s disease, showing cognitive deficits already at 3 months of age.    
5.1.2.Age-progressive decline of spatial memory and motor abilities 
Aging is one of the major risk factors for Alzheimer’s disease, and the probability of suffering 
from dementia is higher at old stages (Guerreiro & Bras, 2015). Here, I confirmed the 
progressive nature of learning and memory decline in the APPPS1-21 mouse model of AD.  
Hippocampus-dependent memory was worse at 9 months compared to 3 months of age in 
APPPS1-21 transgenic mice. In the present study, none of the transgenic (tg) groups, those born 
to an APPPS1-21 tg father or mother (tgtgwt or tgwttg respectively), acquired the task or learned in 
the Morris water maze (MWM) (Figure 4.2.9 and 4.2.10). The observed severe impairment at 9 
months of age is in line with the reported exponential increase of Aβ42 levels in the mouse brain 
and the spread of amyloid plaques covering the entire neocortex and almost the whole 
hippocampus (Radde et al., 2006). These results are consistent with previous observations of 
progressive cognitive impairment also of different AD mouse models, although the impairments 
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were exhibited at different ages and for different performance tasks (Arendash et al., 2001; 
Chapman et al., 1999; Kelly et al., 2003; Sadowski et al., 2004; Van Dam et al., 2003). 
Specifically, the gradual spatial decline was observed in APPK670N/M671L/PS1M146L from 8 to 
22 months of age (Sadowski et al., 2004) and APP23 from 3 to 25 months (Kelly et al., 2003; 
Van Dam et al., 2003).  
Notably, APPPS1-21 tg offspring born to an APPPS1-21 tg father seemed to show more severe 
impairments than APPPS1-21 tg mice born to an APPPS1-21 tg mother (Figure4.2.10). This can 
be in part a consequence of the worsening of their motor abilities at 9 months of age during the 
open field (OF) and the MWM tasks (Figure 4.2.8 and 4.2.11). It is known that aging also 
promotes motor disabilities (Wirths & Bayer, 2008), although none were demonstrated before for 
this model 18. Additionally, none of the transgenic groups of mice showed alterations in basal 
anxiety levels at 9 months of age as shown in figure 4.2.8. Several AD mouse models, including 
ours, showed associative memory impairments at old stages (Cheng, Logge, Low, Garner, & 
Karl, 2013; Corcoran, Lu, Turner, & Maren, 2002; Jacobsen et al., 2006; Kilgore et al., 2010; 
Knafo et al., 2009). The time point of this decline varies between models. APPSwe/PS1ΔE9 line 
showed associative memory deficits already at 6 months (Kilgore et al., 2010), whereas APP/
PS1 exhibited impairments at 12-14 months of age (Knafo et al., 2009).  
Previous studies of the AD mouse model used for this study have shown that APPPS1-21 
transgenic mice exhibited associative memory decline, but no motor impairments at 8 and 12 
months of age (Govindarajan et al., 2013; Zovoilis et al., 2011). In the present study, APPPS1-21 
transgenic mice at 9 months of age showed a significant decrease of the average motion during 
the training day and an increase of freezing behavior after 24 hours of contextual fear 
conditioning (Figure 4.2.12). There are two possible meanings for these findings. The first is that 
APPPS1-21 transgenic groups showed a better associative memory compared to control and 
their 3 months age counterparts. Secondly is that the decrease of mobility is translated as 
freezing episodes, giving a large number of percentage of freezing at the end of the test. Since 
APPPS1-21 transgenic mice showed motor impairments in open field, Morris water maze and 
average motion during the training day and previous studies confirmed the associative memory 
impairments at this age; I assumed that the percentage of freezing is an artifact from their motor 
impairments. In the future, I will need to change the analyses and extract more sensitive 
parameters in order to use and evaluate APPPS1-21 mice in fear conditioning.  
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5.1.3.No gender differences in behavioral phenotypes of offspring 
APPPS1-21 mice  
Several controversial results have been observed about gender effects in behavior experiments 
of mice from different strains (Bridgewater et al., 2017; Chow, Epp, Lieblich, Barha, & Galea, 
2013; Frick, Burlingame, Arters, & Berger-Sweeney, 2000; Johnston & File, 1991; King et al., 
1999; Kreiner, Chmielarz, Roman, & Nalepa, 2013; Rummel, Epp, & Galea, 2010; Voikar, Koks, 
Vasar, & Rauvala, 2001). Moreover, not many studies showed a comparable behavior analysis 
between males and females from an AD mouse model (King et al., 1999; Pistell, Zhu, & Ingram, 
2008). In the present study, no significant gender-specific differences were observed in all 
parameters of Morris water maze, open field (OF) and fear conditioning test (FC) (Appendix 
figure 1-9). Differences were only restricted to particular groups and specific parameters in the 
open field and fear conditioning tasks. Specifically, wild-type and transgenic females born to an 
APPPS1-21 transgenic father exhibited significantly faster speeds than corresponding males in 
the OF and during the training day of FC (Appendix figure 1 and 5). Previous studies found that 
female mice from a wild-type strain showed more activity and faster speeds in the OF and MWM 
tests than males from the same strain (Frick et al., 2000; Tucker, Fu, & McCabe, 2016). At 9 
months of age, only wild-type mice born to an APPPS1-21 transgenic mother showed higher 
anxiety levels than females (Appendix 9). In contrast, in the MWM task, there was no difference 
between males and females within the group they belonged to (either experimental or control) at 
3 and 9 months of age (Appendix 2, 3, 7 and 8) . One possible reason is that males and females 
from this mouse model of AD showed similar levels of Aβ and amyloid deposition at least at early 
stages (Radde et al., 2006).  
Sex differences in an AD mouse model have only been reported to date by Smith et al. (1999) in 
the APPswe mouse line (King et al., 1999). They identified behavior differences between males 
and females at 3 and 9 months of age. Females showed impairments in the MWM retention and 
circular platform performance at 3 months of age. Males showed increased activity in the open 
field and the Y-maze at 3 months of age. And at 9 months of age, males and females exhibited 
difficulties to detect a visible platform in the water maze task (King et al., 1999). It is known that 
the sex-specific differences vary by strain (Voikar et al., 2001). Thus, it is not a surprise to 
observe different results between APPPS1-21 and APPswe mouse lines. It is crucial to study 
sex-specific behavior and molecular differences in order to understand in detail the pathology 
and possible treatment responses. However, in the past not many studies evaluated the 
behavior abilities of both genders. 
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5.1.4.Transcriptional profiling and pathway analysis in APPPS1-21 
transgenic mice at 3m 
Alzheimer’s Disease (AD) has a strong genetic component, several studies have reported 
genetic mutations causing AD (Roses et al., 2010; W. Shao, Peng, & Wang, 2017) and also the 
whole transcriptome changes at late stages of the pathology (Annese et al., 2018; Twine et al., 
2011). However, few studies evaluated the entire transcriptome at an early AD stage using the 
next-generation sequencing (Gatta et al., 2014; Parra-Damas et al., 2014).  In the present study, 
I analyzed the transcriptomic state of 2 hippocampal subregions (CA1 and DG) from 3 month-old 
APPPS1-21 transgenic mice as a readout of the cellular state at an early AD stage. Previous 
studies identified distinct dysregulation of the transcriptome at different stages of the pathology 
in different AD mouse lines (Bossers et al., 2010; Cribbs et al., 2012; Gatta et al., 2014; J. A. 
Miller et al., 2008; Podtelezhnikov et al., 2011). At early stages, the majority of changes in gene 
expression were considered to be part of a compensatory network pursuing the recovery of the 
physiological state (Bossers et al., 2010; Gatta et al., 2014). At late stages, the alteration of the 
transcriptome was mainly associated with the advanced progression of neurodegeneration 
pathology (Bossers et al., 2010; Cribbs et al., 2012; Gatta et al., 2014; J. A. Miller et al., 2008; 
Podtelezhnikov et al., 2011). During the progression of AD, different studies identified several 
changes in gene expression in different brain areas involved in synaptic function, neuronal death 
and autophagy, mitochondrial function, inflammatory response, intracellular calcium 
homeostasis, dendritic spine formation, lipid metabolism, cellular adhesion, transport, signaling 
pathways and cognitive decline (Blalock et al., 2004; Bossers et al., 2010; Gatta et al., 2014). 
The model used in this study, APPPS1-21 mice, showed some of these transcriptomic changes 
in the hippocampal subregions at 3 months of age (Figure 4.1.7). To gain a better understanding 
of whether amyloid deposition impacted transcription and to what extent, the transcriptome of 
CA1 was also evaluated, a region not affected by plaques at 3 months of age in this AD model 
(Radde et al., 2006). Notably, the transcriptome of the hippocampal subregion (DG) affected by 
amyloid plaques was strongly altered compared to the hippocampal subregion without plaques 
(CA1) as shown in figure 4.1.7. These data suggest that amyloid plaque deposition promotes 
changes in the transcription activity, but a more in-depth analysis would be needed to determine 
whether amyloid plaques are the consequence of pathology or the protective response to 
soluble Aβ oligomer forms (Erten-Lyons et al., 2009; Sloane et al., 1997; Treusch, Cyr, & 
Lindquist, 2009). From these changes, genes overrepresented in the transgenic CA1 region 
participated in pathways involved in: synaptic activity, cognition, cell-cell adhesion and lipid 
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metabolism (Figure 4.1.8). In contrast, genes linked to RNA metabolic processes, ribosome 
biogenesis and mitochondrial activity were underrepresented in the CA1 of transgenic mice 
(Figure 4.1.8). Furthermore, in the DG, functional gene analyses indicated that genes related to 
synaptic activity, nervous system development, metabolic process, cell adhesion and signal 
transduction were overrepresented in DG of males and females (Figure 4.1.8). In contrast, 
transgenic mice showed a reduction of expression of genes involved in energy metabolism and 
protein biogenesis. These categories were similarly deregulated in DG from males and females, 
despite the low percentage of commonly affected genes. The alteration of similar functional 
networks is in agreement with the fact that both genders showed similar performance abilities, 
and Aβ levels and amyloid deposition at early stages (Radde et al., 2006). 
Since the most relevant alterations in gene expression were related to synaptic activity, 
neurogenesis, lipid metabolism, energy metabolism and protein biogenesis, I discussed these 
mechanisms in further detail.  
5.1.4.1.Up-regulation of genes involved in synaptic pathways  
Aging and late stages of Alzheimer’s disease have been associated with synaptic dysfunction 
and reduction of genes linked to synaptic activities (Annese et al., 2018; Scheff & Price, 2006). 
In contrast, in the present study genes related to synaptic activities were up-regulated in CA1 
and DG hippocampal subregions of APPPS1-21 mice at early stages of the pathology. Genes 
such as Slc17a6, Pde11a, Igsf9b, Sv2c and Ston2, which were involved in synaptic vesicle, 
exocytosis of neurotransmitter and synaptic development were up-regulated in APPPS1-21 mice 
(Bai, Xu, Collins, & Ghishan, 2001; Fawcett et al., 2000; Janz & Sudhof, 1999; Maritzen, 
Podufall, & Haucke, 2010; Woo et al., 2013) (Appendix table 3). In line with the increase of 
synaptic gene transcripts, a previous study found that at early Braak stages (I and II), levels of 
genes linked to synaptic activity and plasticity were increased in the hippocampus of 3xTg-AD 
female mice and prefrontal cortex of humans (Bossers et al., 2010; Gatta et al., 2014). Up-
regulation of genes related to synapse was associated with protective activities against Aβ 
neurotoxicity (Haberman, Quigley, & Gallagher, 2012; Kaur & Levy, 2012; Mitchell et al., 2009). 
Furthermore, recent findings using different stimulation protocols confirmed the increased of 
hippocampal synaptic excitability in 3xTgAD mouse from 4 to 6 months (K. E. Davis, Fox, & 
Gigg, 2014). This enhancement of genes associated with synaptic activities seemed to be 
accompanied by an increase of hippocampal and cortex activities (Busche et al., 2008; K. E. 
Davis et al., 2014; Palop et al., 2007; Saura, Parra-Damas, & Enriquez-Barreto, 2015). Changes 
in synaptic activity at early AD stages might be part of a complex mechanism that tries to 
maintain normal synaptic activity by counteracting the neuronal dysfunction. 
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5.1.4.2.Up-regulation of genes involved in nervous system development pathways  
The Dentate Gyrus (DG) subregion plays a critical role in neurogenesis (Bonaguidi et al., 2011; 
Cameron & McKay, 2001; van Praag et al., 2002). Thus, it is not surprising that the majority of 
deregulated genes in the DG of APPPS1-21 transgenic mice were linked to neurogenesis, such 
as central nervous system differentiation, neuron projection morphogenesis, dendrite 
morphogenesis and regulation of neuron migration (Figure 4.1.11). Interestingly, I observed an 
increase of transcripts linked to nervous system development in transgenic mice that showed 
spatial cognitive deficits. Not many genetic studies of AD have described alterations of genes 
related to neurogenesis at early stages of the pathology (Bossers et al., 2010; Gatta et al., 
2014). However, several studies have found changes in neurogenesis response in AD mouse 
models or human postmortem AD brains (Clelland et al., 2009; Haughey et al., 2002; Sun et al., 
2009; Woitke et al., 2017).  Some findings corroborated an increase of neurogenesis response 
in AD mouse models or human AD brains (Q. Chen et al., 2008; K. Jin, Galvan, et al., 2004; K. 
Jin, Peel, et al., 2004; Lopez-Toledano & Shelanski, 2007; Yu et al., 2009), whereas others 
studies suggested no effect or a decrease of neurogenesis activity (Haughey et al., 2002; J. J. 
Rodriguez et al., 2008; Sun et al., 2009; R. Wang, Dineley, Sweatt, & Zheng, 2004). My data is 
in line with a previous study that showed an increase of proliferation and neuronal differentiation 
in the hippocampus of J20 mice (a mouse model of AD) at 3 months of age. Since the oligomeric 
Aβ form was also increased, they claimed that the enhanced neurogenesis is induced by Aβ 
(Lopez-Toledano & Shelanski, 2007). In contrast, previous findings showed a reduction of 
proliferation and survival of neural progenitor cells in the DG of different AD mouse models at 
late AD stages (12-14 months) (Haughey et al., 2002). Moreover, a previous genetic study 
identified an up-regulation of genes related to nervous system development at early stages of 
the pathology (Braak I-II) and a reduction of these pathways at late stages (Braak V-VI) (Bossers 
et al., 2010). Considering these studies and my data, I detected that there is a significant 
difference between neurogenesis response at early and late AD stages. The majority of the 
studies at early AD stages identified an enhancement or non-altered neurogenesis response 
(Bossers et al., 2010; Q. Chen et al., 2008; K. Jin, Galvan, et al., 2004; Lopez-Toledano & 
Shelanski, 2007), whereas several studies performed at old stages observed impaired 
neurogenesis (Bossers et al., 2010; Donovan et al., 2006; Haughey et al., 2002).  
In summary, my data and previous literature suggest that neurogenesis response plays an 
important role during AD progression, which differs between early and late AD stages. These 
results indicate that the up-regulation of neurogenesis-related genes and consequently response 
at early stages might be part of a compensatory network, which tries to delay the progression of 
the disease.  
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5.1.4.3.Up-regulation of genes involved in lipid metabolism pathways  
The role of lipids in neurodegenerative diseases has been intensively studied in the last decades 
(Bales, 2010; Hamilton et al., 2015; Koudinov & Berezov, 2005; Q. Liu & Zhang, 2014; Mills et 
al., 2013). However, not many studies described the role of dysregulated genes related to lipid 
metabolism at early AD stages (Barbash et al., 2017; Blalock et al., 2004; Podtelezhnikov et al., 
2011). In the present study, I observed that genes linked to lipid metabolic processes were 
exclusively increased in the CA1 of APPPS1-21 transgenic mice at early AD stages (Figure 
4.1.8). These genes were linked to positive regulation of triglyceride metabolic process, 
regulation of lipid catabolic process and steroid metabolic process. Recent findings also 
observed this enhancement of genes linked to lipid metabolism in the prefrontal cortex and 
hippocampus of human postmortem samples at early stages of AD (Blalock et al., 2003; Blalock 
et al., 2004; Podtelezhnikov et al., 2011). These studies suggest that the up-regulation of these 
genes play a role in protective mechanisms. This data suggests that there is an activation of 
different types of compensatory mechanisms that try to delay the pathology. 
5.1.4.4.Down-regulation of genes involved in energy metabolism 
Mitochondrial impairments have been involved in several brain disorders, such as Down 
syndrome, autism, Parkinson and Alzheimer’s disease (Bhat et al., 2015; Lin & Beal, 2006; 
Nunnari & Suomalainen, 2012; Valenti, de Bari, De Filippis, Henrion-Caude, & Vacca, 2014). 
Previous studies have shown that transcripts associated with energy metabolism were down-
regulated in mouse and human brain regions at advanced stages of AD and during normal aging 
(Annese et al., 2018; Berchtold et al., 2008; Fang et al., 2016; Gatta et al., 2014; Leshchyns'ka 
& Sytnyk, 2016; Liang et al., 2008; J. A. Miller et al., 2008; Sekar et al., 2015; Valla, Berndt, & 
Gonzalez-Lima, 2001). Damage to mitochondrial DNA leads to a reduction of mitochondrial gene 
expression and therefore to a decrease in mitochondrial proteins increasing the proportion of 
reactive oxygen. This increase of oxidative stress and mitochondrial dysfunction triggers 
neurodegeneration (Beal, 2005; Bhat et al., 2015; Di Carlo, Giacomazza, Picone, Nuzzo, & San 
Biagio, 2012; Lin & Beal, 2006; Swerdlow, Burns, & Khan, 2014; Trushina & McMurray, 2007). 
Furthermore, other studies suggested that mitochondria processes could lead to and promote 
several AD pathological processes, such as altering APP expression, APP processing, Aβ 
accumulation and inducing inflammation (Ichimura, Parthasarathi, Quadri, Issekutz, & 
Bhattacharya, 2003; Swerdlow et al., 2014). In contrast to previous findings that observed 
mitochondrial alterations at late AD stages, APPPS1-21 transgenic mice showed a decrease of 
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transcripts related to energy metabolism already at an early AD stage (3 months of age) (Figure 
4.1.8 and 4.1.11). Pathways linked to mitochondrial function, respiratory chain complex, ATPase 
activity and ion transport were strongly reduced in APPPS1-21 mice at 3 months of age. 
Examples of genes down-regulated in the DG of APPPS1-21 mice included Cox4i1 (cytochrome 
C oxidase subunit in mitochondrial electron transport (Lomax, Hewett-Emmett, Yang, & 
Grossman, 1992)), Ndufa1 and Ndufa3 (subunits of the mitochondrial membrane respiratory 
chain NADH dehydrogenase (Janz & Sudhof, 1999; Loeffen et al., 1998)) and Mrpl20 
(mitochondrial ribosomal protein (Kenmochi et al., 2001)) (Appendix table 3). The majority of 
studies at early stages have not identified down-regulation of genes related to mitochondria 
activity (Gatta et al., 2014; Parra-Damas et al., 2014). One prominent difference compared to the 
mouse AD lines (3xTg-AD and APPSw,Ind) used in these two studies is that APPPS1-21 mice 
showed cognitive deficits at 3 months of age (Gatta et al., 2014; Parra-Damas et al., 2014). 
Moreover, mitochondrial dysfunction has been associated with cognitive decline (Finsterer, 2012; 
Y. Hara et al., 2014; Khacho et al., 2017; McEwen, 2012; McManus, Murphy, & Franklin, 2011; 
Valenti et al., 2014). In summary, my data strongly suggest that there is a correlation between 
alteration of energy metabolism pathways and the onset of decline in cognitive abilities.  
5.1.4.5.Down-regulation of genes involved in protein biogenesis 
Similar to mitochondrial dysfunctions, ribosome and translation alterations have been reported 
for late AD stages or with aging (Berchtold et al., 2008; Ding, Markesbery, Chen, Li, & Keller, 
2005; Hernandez-Ortega, Garcia-Esparcia, Gil, Lucas, & Ferrer, 2016; Langstrom, Anderson, 
Lindroos, Winblad, & Wallace, 1989; X. Li et al., 2004). A study observed dysfunction of protein 
synthesis specifically in the posterior cingulate of AD postmortem human brain (Berchtold et al., 
2008). In the present study, I identified that genes associated with protein synthesis were down-
regulated in APPPS1-21 transgenic mice at early AD stage, such as genes related to ribosome-
related processes, translation and protein localization and transport (Figure 4.1.8 and 4.1.11). In 
line with my data, a previous finding described a substantial decrease in polyribosomes 
activities, altered tRNAs forms and levels of rRNA processing in cortical brain regions of AD 
subjects at early stages (Ding et al., 2005). This previous study suggested that the impairment of 
protein synthesis was one of the earliest alterations in AD pathology (Ding et al., 2005). 
Moreover, a previous research detected a reduction in gene expression and protein levels linked 
to the process of protein synthesis in human brain tissue at early stages of AD (Braak I-II) 
(Hernandez-Ortega et al., 2016). The precise mechanisms by which genes related to protein 
synthesis are altered remain to be identified. One possibility is that part of these changes is 
affected by oxidative stress causing mitochondrial genetic dysfunction.  
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In line with previous studies using human AD samples (Hernandez-Ortega et al., 2016), I 
identified a reduction of genes involved in protein synthesis at early AD stage. APPPS1-21 mice 
showed a decrease of catabolic and anabolic processes already at 3 months of age. 
Considering that APPPS1-21 mice showed certain features at early stages typical of late stages, 
such as cognitive deficits or reduction of genes related to energy metabolism and protein 
biosynthesis, I conclude that this transgenic model has an aggressive AD pathology. Moreover, I 
was also able to identify specific genetic changes that are more likely to be part of a 
compensatory network, such as up-regulation of genes involved in synaptic activities and 
neurogenesis.  
5.1.5.Alternative exon usage and pathway analysis in APPPS1-21 
transgenic mice at 3m 
Different exon usage of specific genes has been reported in various Alzheimer’s disease (AD) 
postmortem brain tissues and in AD mouse models at different stages and cognitive decline 
(Beffert et al., 2005; Hinrich et al., 2016; M. K. Lai et al., 2014; Mazin et al., 2013; Stilling et al., 
2014; Tollervey et al., 2011; Twine et al., 2011). APPPS1-21 transgenic mice showed changes in 
expression of genes involved in splicing processes, such as U12 type spliceosomal complex, 
spliceosomal tri snRNP complex, catalytic step 2 spliceosome and spliceosomal complex.  
Moreover, it is known that several genes directly associated with AD show different exon usages, 
such as amyloid precursor protein (App), apolipoprotein E (Apoe) (Beffert et al., 2005; Twine et 
al., 2011), microtubule-associated protein tau (Mapt) (Goedert & Jakes, 1990) or presenilin 1 
(Ps1) (De Jonghe et al., 1999). I was able to identify different exon usage in CA1 and DG of 
APPPS1-21 transgenic mice of App, Ps1 and Mapt (Appendix table 1).   
Furthermore, I identified massive changes in differentially exon usage in the DG and the CA1 
brain subregions of APPPS1-21 transgenic mice, specifically exon inclusions (Figure 4.1.13). 
The number of genes affected for alternative exon usage was larger than for expression levels 
and covered the majority of biological processes in CA1 and DG hippocampal subregions of 
APPPS1-21 mice. There is no agreement of whether these two processes of regulation, gene 
expression and mRNA processing, altered similar or distinct networks (Stilling et al., 2014; 
Tollervey et al., 2011). Some studies detected that these mechanisms changed different 
pathways 118, others suggested that these processes affected similar genes 117. In this study, 
despite the seemingly small overlap among the genes differentially expressed and differentially 
“spliced” (alternative exon usage) (30%), these two regulatory mechanisms affected similar 
global categories (Figure 4.1.15). These functions affected: tissue and nervous system 
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development, synaptic activity, RNA metabolic process, energy metabolism, microtubule and 
cytoskeleton organization, cell metabolic process, chromatin modification, cell death, 
transmembrane transport and response to a stimulus (Figure 4.1.16). The role of some of these 
functions in early AD stages was already described in the previous section. The categories 
affected by both regulatory mechanisms suggest that APPPS1-21 transgenic mice at early 
stages try to return to a homeostatic state by modifying the expression of specific genes and 
also altering the mRNA processing of specific genes. 
Furthermore, alternative exon usage has been detected in interesting candidate genes that were 
previously associated with memory process and neurodegenerative pathologies (Appendix table 
4). The alteration of exon usage of these genes maybe plays an essential role in the progression 
of AD pathology. Further investigations are necessary in order to confirm the association of this 
alternative exon usage forms and AD pathology.  For example, I identified in the DG from males: 
Slc6a17, Dlgap4, Slc6a9 and Dock3. Solute carrier family 6 member 17 (Slc6a17) was involved 
in the vesicular transport for neurotransmitters and amino acids in synaptic transmission 
(Hoglund, Adzic, Scicluna, Lindblom, & Fredriksson, 2005). A specific mutation in this gene 
promoted the loss of dendritic spines, mental disabilities and behavior problems (Z. Iqbal et al., 
2015). DLG associated protein 4 (Dlgap4) encodes a protein member of PSD95-interacting 
proteins and participates in the molecular synapse organization and neuronal cell signaling 
(Fernandez et al., 2009; Minocherhomji et al., 2014). The family of PSD95 regulates neuronal 
plasticity and is essential to keep physiological learning and memory abilities (Carlisle, Fink, 
Grant, & O'Dell, 2008; Migaud et al., 1998). Solute carrier family 6 member 9 (Slc6a9) encodes 
the glycine transporter 1 GlyT1 and the inhibition of this transporter enhances the function of 
NMDA receptors and improves memory retention (Tsai et al., 2004). Dedicator of cytokinesis 3 
(Dock3) coding protein is part of a family of guanine nucleotide exchange factors (GEFs) and 
participates in cell-adhesion and a presenilin-binding protein (Nagase et al., 1997). It has been 
associated with AD by the interaction with presenilin and the ability to stimulate Tau/MAPT 
phosphorylation (Namekata, Kimura, Kawamura, Harada, & Harada, 2014). And, it is also 
implicated in various neurological disorders (de Silva et al., 2003; Namekata, Kimura, Harada, et 
al., 2014).  
Moreover, in the DG from female APPPS1-21 mice showed differentially exon usage in genes 
including, Nrxn3, Dnm3 and Kdm5a genes. Neurexin 3 protein (Nrxn3) has been involved in 
synaptic cell adhesion and presynaptic voltage-gated calcium signaling (Missler et al., 2003). 
The interaction of neurexin with neuroligin has been related to AD progression (Sindi, 
Tannenberg, & Dodd, 2014). Dynamin 3 (Dnm3) encodes for a member of GTP-binding proteins 
that is involved in cytoskeleton remodeling and clathrin-mediated synaptic vesicle endocytosis 
(Ferguson & De Camilli, 2012; Raimondi et al., 2011). The family of dynamin has been 
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associated with different neurodegenerative pathologies, such as Parkinson’s disease or AD 
(Aidaralieva et al., 2008; Gonzalez-Jamett et al., 2014; Trinh et al., 2016). Lysine (K)-specific 
demethylase 5A (Kdm5a) gene encodes for a histone demethylase that demethylates the Lys-4 
of histone H3 (H3K4) (G. B. Shao et al., 2014). Dysregulation of H3K4 methylation has been 
involved in several pathologies including autism, intellectual disability or schizophrenia (Shen, 
Shulha, Weng, & Akbarian, 2014).  
For example, in the CA1 from male APPPS1-21 mice, some interesting candidate genes were 
differentially spliced, such as the Nrxn3, Frmd4a or Reln genes. FERM domain containing 4A 
(Frmd4a) encodes for a protein that participates in the cell structure, transport and signaling. The 
expression of this gene was reduced in brains of Alzheimer’s disease patients, promoting high 
levels of Tau secretion (Lambert et al., 2013). The reelin (Reln) gene encodes for reelin, which is 
a glycoprotein that participates in synaptogenesis and neural migration (Dazzo et al., 2015). It 
has been related to several pathologies, such as Alzheimer’s disease, epilepsy or schizophrenia 
(Lane-Donovan et al., 2015; Negron-Oyarzo, Lara-Vasquez, Palacios-Garcia, Fuentealba, & 
Aboitiz, 2016; Zaki et al., 2007).  
These previous findings suggest that these genes can play an essential role in the pathology of 
Alzheimer’s disease and it is, therefore, important to evaluate the impact that alternative exon 
forms of these genes could have in the pathology. 
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5.2.Paternal line-specific inheritance of cognitive deficits in 
APPPS1-21 mice via non-genetic mechanisms 
5.2.1.Spatial cognitive behavior in wild-type mice born to one 
APPPS1-21 parent 
Internal conditions are modified during the course of life of an individual by interaction with 
external environmental factors. Changes in epigenetic factors mainly drive the interaction 
between these two conditions. External factors can promote reversible or permanent changes of 
the epigenome of an individual, inducing phenotypic changes (Ho, Tang, Belmonte de Frausto, & 
Prins, 2006; Martinez et al., 2009; Vucetic, Kimmel, & Reyes, 2011; Waterland & Jirtle, 2003). 
Multiple of these modifications can be transmitted to the next generations, stimulating changes 
in their internal conditions, which can be temporal or permanent (Anway et al., 2005; Byrnes, 
2005; Carone et al., 2010; Chamorro-Garcia et al., 2013; de Castro Barbosa et al., 2016b; Dias 
& Ressler, 2014b; Dunn & Bale, 2009; Gapp et al., 2014; Ng et al., 2010; Ost et al., 2014; 
Ribeiro et al., 2017; Schmauss et al., 2014; Vassoler et al., 2013; Wei et al., 2014; S. Zhang et 
al., 2017). Some studies reported intergenerational or transgenerational inheritance as a 
protective mechanism, such as improving cognitive performance and synaptic plasticity by 
paternal spatial training or prevention of obesity in rat offspring when mothers exercise at low 
intensity during pregnancy (Ribeiro et al., 2017; Vassoler et al., 2013; S. Zhang et al., 2017). 
However, in some other cases, this transmission of information became a disadvantage for the 
next generation.  For example, exposure of at least one parent to early traumas, diabetes, high-
fatty diets, morphine or opioids led to negative consequences to their offspring (Anway et al., 
2005; Byrnes, 2005; Chamorro-Garcia et al., 2013; de Castro Barbosa et al., 2016b; Dunn & 
Bale, 2009; Gapp et al., 2014; Ng et al., 2010; Ost et al., 2014; Schmauss et al., 2014; Wei et 
al., 2014). These studies were based on the internalization of external factors and posterior 
transmission of this information to their offspring. Additionally to external factors, there is a 
strong association between the genotype and the epigenome (Ladd-Acosta & Fallin, 2016; M. P. 
Lee, 2012). Here, I described for the first time the behavioral repercussion of the parental origin 
of the APP and PS1 transgenes. In this study, I used the APPPS1-21 transgenic mouse to 
describe the potential impact of the parental origin of the APP (human APP with K670N and 
M671L mutations) and PS1 (human PS1 with L166P mutation) transgenes. These transgenes 
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promote phenotypic alterations in the transgenic mice, including cognitive impairments and 
cerebral amyloidosis (Radde et al., 2006). 
APPPS1-21 transgenic offspring (tg) born to tg fathers (tgtgwt) or tg mothers (tgwttg) showed 
spatial learning and memory impairments at 3 and 9 months of age. However, tgtgwt exhibited 
more severe deficits during acquisition and learning in the Morris water maze (MWM), a spatial 
memory task, than tgwttg at 3 and 9 months (Figure 4.1.4, 4.1.5, 4.2.9 and 4.2.10). The learning 
deficits were not due to distinct motor abilities since both groups showed similar traveling speeds 
during the open field and Morris water maze tasks at 3 months of age (Figure 4.2.2 and 4.2.5). 
This data suggests that the origin of the transgene has an impact on the behavioral phenotype of 
the next generation. Previous studies have shown a direct connection between behavioral 
changes in the offspring and paternal epigenetic transmission of information related to a 
particular form of stress (Gapp et al., 2014; Rodgers et al., 2015).  
In order to confirm the possible implication of non-genetic factors associated with the APP and 
PS1 transgenes from the mother or father, I investigated the behavioral phenotype of wild-type 
mice born to one APPPS1-21 transgenic parent.  
The behavioral study of these wild-type mice confirmed a certain form of non-genetic 
transmission associated with the parental origin of the transgene. Wild-type mice born to 
APPPS1-21 transgenic fathers showed difficulties in learning a spatial task (the MWM) already 
at 3 months of age (Figure 4.2.3 and 4.2.4). On the contrary, wild-type mice born to APPPS1-21 
transgenic mothers learned the spatial task similar to the control group (wild-type mice born to 
two wild-type parents) (Figure 4.2.3 and 4.2.4). Interestingly, this transmission was specific for a 
spatial learning and memory task, such as the MWM. Other abilities, such as associative skills 
were not affected. As shown in the fear conditioning test (Figure 4.2.6). In contrast to other 
studies, I found that this kind of transmission altered in the same manner the behavior of both 
genders in the offspring (Appendix figure 1-9) (Alter et al., 2009; de Castro Barbosa et al., 
2016b; Vassoler et al., 2013). 
Analyzing wild-type mice born to an APPPS1-21 transgenic father or mother at 9 months of age, 
I observed consistent results with the data obtained at 3 months of age. Wild-type mice born to 
APPPS1-21 transgenic fathers also showed impairments in spatial learning and memory abilities 
at 9 months of age. In contrast, wild-type mice born to transgenic mothers (wtwttg) still learned the 
task and performed as well as the wild-type control mice born to wild-type parents. As shown in 
the Morris water maze test (Figure 4.2.3 and 4.2.4). These results suggest that intergenerational 
transmission of a specific behavior is quite stable and persists over time. Notably and similar to 
what I observed with transgenic and wild-type mice at 3 months of age, no remarkable cognitive 
differences were visible between wild-type female and male mice born to a transgenic father or 
mother at 9 months of age (Appendix figure 6-9). Regarding motor abilities, only wttgwt mice 
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showed a significant reduction in swimming speed during the MWM and open field tasks at 9 
months of age, a decline that was similar to their co-offspring transgenic group (tgtgwt) (Figure 
4.2.10). 
Most importantly, these results suggest gender-specific mechanisms that have a negative impact 
on their offspring in the case of paternal transmission. While it is difficult to pinpoint what those 
factors may be, based on the published literature, there might be gender-specific epigenetic 
changes that interplay with the APP and PS1 transgenes, which can be transmitted differently to 
the next-generation 85,118,(Brykczynska et al., 2010; de Castro Barbosa et al., 2016b; X. Feng 
& Guang, 2013; Gapp et al., 2014; Hammoud et al., 2009; Rodgers et al., 2013; Siklenka et al., 
2015). 
The fact that identical wild-type mice born to the same strain presented different behavioral 
abilities pose a big issue for future mating designs. And breeding schemes need to be carefully 
controlled for at least this line in the future. Parameters such as the origin of the transgene, the 
selection of the control group, the establishment of specific environmental conditions and 
refreshing of mouse colonies have to be properly defined. It is essential to select an appropriate 
control group, which should not interfere with the experimental data. For that, it is necessary to 
evaluate first whether the wild-type littermate from a transgenic line is suitable or not to be used 
for the study. Moreover, the observation behavior differences between wild-type mice emphasize 
the importance to investigate in further detail the form of non-genetic inheritance associated with 
a transgene in this and other mouse lines.  It is crucial to evaluate the impact of epigenetic 
marks in order to predict behavioral phenotypes, maintain colony stability and to obtain 
reproducible results. The main challenge to assess epigenetic marks is their continuous change 
during the lifetime of an individual in response to the external conditions. Thus, it is essential to 
design statistical tools to predict and evaluate the level of epigenetic contribution to the 
phenotype changes, using regularized regression, non-parametric methods or machine learning 
(de los Campos et al., 2009; Gonzalez-Recio, 2011; Gonzalez-Recio et al., 2008; Slatkin, 2009; 
Tal, Kisdi, & Jablonka, 2010; Varona et al., 2015). For that, it is also necessary to improve the 
accuracy and efficiency of epigenome-wide mapping and to develop new next-generation 
sequencing equipment, which allows for sequencing in large scale at an affordable cost. 
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5.2.2.Transcriptional profiling and pathway analysis in APPPS1-21 
wild-type mice at 3m 
In my study, I observed that wild-type mice born to an APPPS1-21 transgenic father showed 
different spatial cognitive abilities at 3 and 9 months of age. These phenotypic changes suggest 
the existence of some transmission of gender-specific epigenetic factors through the germ-line. 
These transmitted epigenetic factors and environmental factors can modify the epigenetic 
program, which together with the genomic program, play an essential role during development 
(Skinner, 2011b; I. C. Weaver, Meaney, & Szyf, 2006). In some specific adult cells and tissues, 
these epigenetic persists into adulthood, promoting an altered expression pattern of genes and 
the phenotype, or even increasing the probability to develop a pathology (Skinner, 2011a, 2011b; 
Skinner, Manikkam, & Guerrero-Bosagna, 2010). Here, I analyzed the transcriptome of 2 
hippocampal regions implicated in spatial memory of wild-type mice born to an APPPS1-21 
transgenic father or mother at 3 months of age. I identified changes in the expression pattern of 
genes in the CA1 and DG of wild-type mice born to one APPPS1-21 transgenic parent. Notable, 
the transcriptomic profile from wild-type mice born to an APPPS1-21 transgenic mother (wtwttg) 
was almost not affected.  Only a few genes showed significant differential expression in CA1 and 
DG of wtwttg mice. Whereas, wild-type mice born to an APPPS1-21 tg father (wttgwt) showed 
differential expression of several genes. Both groups of mice were compared to wild-type mice 
born to wild-type parents (wtwtwt), as shown in figure 4.2.21. Thus, I did not further investigate in 
detail the pathways related to the transcriptome of wt mice born to APPPS1-21 tg mothers 
(wtwttg). These transcriptomic differences between two identical wild-type mice reaffirm the idea 
that APPPS1-21 transgenic mothers and fathers transmit different epigenetic factors to the 
offspring, promoting distinct alterations to the adult cellular state. In this study, I did not address 
how these epigenetic factors from the germline escape the reprogramming process or how these 
epigenetic marks persist into adulthood. The mechanisms remain unknown, and further 
investigations are necessary.  
In the present study, I evaluated in detail the transcriptome of CA1 and DG hippocampal 
subregions of wild-type mice born to APPPS1-21 transgenic fathers at 3 months of age. To note, 
there was a tendency to up-regulated genes in CA1 and DG of wild-type mice born to 
APPPS1-21 transgenic fathers (wttgwt) (Figure 4.2.21). The DG from male and female wttgwt mice 
showed more transcriptomic differences than the CA1 of wttgwt (Figure 4.2.21). Despite the little 
number of shared genes between regions and genders, in global these regions and genders 
showed distinct transcriptome profile suggesting that the transmitted epigenetic factors induce 
changes in different tissue in a gender-specific way. In line with my data, previous 
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transgenerational transcriptome findings identified tissue-specific and sex-specific changes in 
gene expression in various tissues of F3 generation rats from grandparents treated with 
vinclozolin or fed with high-fat diets (Alm, de Castro Barbosa, Barres, Krook, & Zierath, 2017; 
Skinner, Manikkam, Haque, Zhang, & Savenkova, 2012). In contrast to this tissue-specific 
alterations, paternal high-fat diets altered similar gene expression and pathways changes from 
retroperitoneal adipose and islet tissues (Ng et al., 2014). Thus, in future studies will be 
interesting to evaluate how different is the transcriptome from other brain regions and other 
tissues of wild-type mice born to one APPPS1-21 transgenic parent. It is important to investigate 
the level of gene expression changes promoted by intergenerational epigenetic factors, in order 
to predict other phenotypic changes and discover potential reversal mechanisms.  
Although CA1 and DG hippocampal subregions of wild-type mice born to an APPPS1-21 
transgenic father (wttgwt) showed differential expression of genes, alteration of common 
functional categories was identified in these brain regions. Notable, several of the up-regulated 
genes in wttgwt hippocampal subregions were involved in pathways previously categorized for 
APPPS1-21 transgenic mice such as synapse, nervous system development, cell-cell adhesion, 
signal transduction and lipid metabolism (exclusively in CA1 from males) (Figure 4.2.24). 
Moreover, genes connected with transcription process, mitochondrial functions, protein 
localization, cellular metabolic and RNA metabolic process (DG from males) were 
underrepresented in wild-type and transgenic mice born to APPPS1-21 transgenic fathers 
(Figure 4.2.24). Since the majority of these pathways were previously described in detail, I did 
not explain them here.  
Taken together, this data indicates that non-genetic transmission from transgenic APPPS1-21 
fathers has a strong repercussion in their offspring, altering the behavioral phenotype and the 
cellular state of wild-type and transgenic offspring. Wild-type mice born to APPPS1-21 tg fathers 
(wttgwt) exhibited similar altered pathways than APPPS1-21 transgenic mice at 3 months of age. 
It will be necessary for future research to evaluate whether the transcriptomic state detected in 
wild-type mice born to APPPS1-21 transgenic fathers at 3 months of age is stable or change 
along the course of aging. Overall, I identified for the first time transcriptomic changes 
associated with the origin of the APP and PS1 transgene.  
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5.2.3.Alternative exon usage and pathway analysis in APPPS1-21 
wild-type mice at 3m 
In addition to the transcriptomic changes, wild-type mice born to APPPS1-21 tg fathers (wttgwt) 
exhibited a massive alteration of the alternative exon usage in CA1 and DG regions, with an 
increased tendency of exon inclusion events, as shown in the figure 4.2.30. To my knowledge, 
the present study is the first to identify alterations of expressed exons associated with an 
intergenerational inheritance process. In line with transcriptomic data, CA1 or DG brain regions 
of wild-type mice born to APPPS1-21 transgenic mothers (wtwttg) showed few changes in 
alternative exon usage compared to control wild-type mice, as displayed in the figure 4.2.30. The 
precise mechanisms by which paternal or maternal intergenerational epigenetic factors promote 
exon usage changes in specific genes remain to be elucidated. One explanation could be that 
the germ-line epigenome alters the physiological mRNA processing mechanism during 
development promoting a different exon usage of particular genes, which could persist in 
specific tissues into adulthood. An experiment that could proportionate some evidence of the 
alteration of the mRNA processing process would be to investigate the alternative exon usage of 
wild-type mice born to APPPS1-21 transgenic mice in early life.  
Furthermore, similar to APPPS1-21 tG mice, DG of male and female mice born to APPPS1-21 
transgenic fathers (wttgwt) showed an aberrant modification of the alternative exon usage events 
(Figure 4.2.30). In contrast, few changes in alternative exon usage of genes were detected in 
CA1 region of wttgwt mice, which were associated with presynaptic pathways (Figure 4.2.30).  
Some interesting genes that were previously related to memory process or Alzheimer’s disease 
were identified in the most significant “spliced” genes (top 10,  ranked by log2FC) in each region 
of wttgwt mice (Appendix table 5). For example in DG males, Ptpru, Wdr13 and Sbf1 genes had 
an alternative exon usage. WD repeat domain 13 (Wdr13) encodes a protein of a family involved 
in cell cycle regulation, transcription process, chromatin organization and protein trafficking 
(Singh et al., 2012). Deletion of Wdr13 gene promotes better performance of a spatial cognitive 
task and up-regulation of synaptic proteins (Mitra et al., 2016). Protein tyrosine phosphatase 
receptor type U (PtpruI) and set binding factor 1 (Sbf1) encode for members of a family of 
protein tyrosine phosphatase (PTP) that played a role in cell growth, mitosis, differentiation and 
synaptogenesis. This family has been associated with several pathologies including Alzheimer 
disease (AD), Parkinson’s disease (PD) and multiple sclerosis (MS) (W. J. Hendriks et al., 2013).  
In DG from female wttgwt mice, several interesting genes showed alternative exon usages, such 
as Nrxn3, Hook3 and Pms2. Neurexin 3 (Nrxn3) encodes for a protein involved in presynaptic 
voltage-gated calcium signaling and synaptic cell adhesion (Missler et al., 2003). The interaction 
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of neurexin with neuroligin has been related to AD progression (Sindi et al., 2014). Hook 
microtubule tethering protein 3 (Hook3) encodes for a member of the microtubule-binding protein 
family, which was linked to AD (Herrmann et al., 2015; Walenta, Didier, Liu, & Kramer, 2001) as 
well. PMS1 homolog 2 (Pms2) encodes for a member of a mismatch repair system. Dysfunction 
of DNA repair process has been associated with neurodegeneration (Baker et al., 1995; 
Jeppesen, Bohr, & Stevnsner, 2011).  
For example, in the CA1 brain region of wttgwt mice, Gabra2 and Agpat1 genes had an 
alternative exon usage. Gamma-aminobutyric acid (GABA) A receptor (Gabra2) encode for a 
GABA-A receptor. Expression of this receptor was altered in AD and aged brains (Rissman, De 
Blas, & Armstrong, 2007). 1-acylglycerol-3-phosphate O-acyltransferase 1 (Agpat1) encodes for 
an acyltransferase that has been found as a new candidate for AD (Sherva et al., 2011).  
Moreover, about 33% of significant alternative exon usage overlapped with differentially 
expressed genes in DG males and 70% in DG females of wild-type mice born to APPPS1-21 
transgenic fathers (wttgwt) (Figure 4.2.35). Differentially expressed genes in CA1 region of wttgwt 
mice did not present changes in the exon usage. In contrast, differentially expressed and spliced 
genes in DG region of male and female wttgwt mice were involved in nervous system 
development, synapse, transmembrane transport, microtubule modification, chromatin 
modification and RNA metabolic process (Figure 4.2.36).  
These results support the idea that some non-genetic factors in paternal germ-line induce 
behavior, transcriptome and alternative exon usage changes in the wild-type mice born to 
APPPS1-21 transgenic fathers. Furthermore, this increases the evidence of the critical role of 
non-genetic inheritance in offspring mice born to transgenic fathers and the necessity to 
evaluate this transmission in other transgenic lines. 
5.2.4.Transmission of non-genetic factors by germ-line  
Severe changes in behavioral level, transcriptomic profile and alternative exon usage from wild-
type offspring born to APPPS1-21 transgenic fathers strongly suggest a non-genetic 
transmission of the “information” through the germ cells. The specific mechanism for the 
maternal or paternal transfer to the offspring and changes assorted to it is currently unknown. It 
seems that specific epigenetic marks could escape from the reprogramming process and 
transmit certain information to the next generations (Pasque, Jullien, Miyamoto, Halley-Stott, & 
Gurdon, 2011; Skinner, 2011b). Distinct epigenetic marks were described as possible 
transmitters of intergenerational information through the germline 85,118,(Brykczynska et al., 
2010; de Castro Barbosa et al., 2016b; X. Feng & Guang, 2013; Gapp et al., 2014; Hammoud et 
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al., 2009; Rodgers et al., 2013; Siklenka et al., 2015). Since the transmission of cognitive deficits 
was only detected between APPPS1-21 transgenic fathers and their offspring, I assumed that 
some non-genetic factors would be transmitted through the sperm. Previous studies have 
demonstrated the role of non-coding RNAs (ncRNAs) for certain forms of intergenerational 
transmission of stress (Gapp et al., 2014; Rodgers et al., 2015) or environmental enrichment 
(Benito et al., 2018). In this study, I observed that intergenerational inheritance of a cognitive 
phenotype induced by APP and PS1 transgene involved changes in sperm small RNAs. The 
sperm RNA of APPPS1-21 transgenic fathers showed an overexpression of specific small RNAs, 
which corresponded to different small nuclear RNAs (snoRNAs) (snord15b-201, snord111-201, 
snord60-201, snord96a-201, snord47-201 (U47)), piwi-interacting RNAs (piRNA_000578, 
piRNA_018323 and piRNA_003040) and one novel microRNA (miRNA-6240) (Figure 4.2.37). 
These small RNAs have been previously identified in RNA isolated from sperm (http://
spermbase.org/). Although these small RNAs have been identified previously in the sperm, not 
much is known about their functions. Snord47 was involved in tumorigenesis suppression (Xu et 
al., 2017); all three piRNAs were previously identified in the cerebellum of the Mecp2 knockout 
mouse (model of Rett Syndrome) (Saxena et al., 2012) and piRNA_003040 was highly 
expressed in the renal cell carcinoma (Y. Li et al., 2015). 
It is not the first time that small RNAs were suggested for intergenerational or transgenerational 
transmission. Previously, some miRNAs (Benito et al., 2018; Rodgers et al., 2015) and transfer 
RNAs (tRNAs) (Q. Chen et al., 2016; Sharma et al., 2016) were associated with this kind of 
transmission. Thus, miRNA-6240 could be a potential candidate for intergenerational 
transmission of a cognitive phenotype induced by an APP and PS1 transgene.  
Furthermore, it is the first time to my knowledge that snoRNAs were associated with 
intergenerational inheritance. SnoRNAs are small structures of RNAs that in the past were only 
linked to the process of ribosome biogenesis (rRNA), by guiding site-specific modifications of 
pre-rRNA (Rogelj, 2006). In the last decade, snoRNAs have been involved in other functions, 
such as regulation of chromatin structure (Schubert et al., 2012), regulation of splicing (Kishore 
et al., 2010; Scott et al., 2012; Q. F. Yin et al., 2012), mediators of oxidative stress (Michel et al., 
2011; Scott et al., 2012) and precursors of small RNAs with miRNA-like functions (Brameier et 
al., 2011; Ender et al., 2008; Ono et al., 2011; Scott et al., 2009). Previous findings indicated that 
fragments of snoRNAs are processed and involved in similar functions than miRNAs (Brameier 
et al., 2011; Ender et al., 2008; Falaleeva & Stamm, 2013; Garcia-Lopez et al., 2015; Ono et al., 
2011; Scott et al., 2009; Taft et al., 2009). Moreover, snoRNAs were found in the sperm, where 
these structures showed similar levels of expression than miRNAs in different stages of male 
germ cell development (Garcia-Lopez et al., 2015). In addition to the involvement of snoRNAs in 
the process of development, my data suggest a potential role of the snoRNAs in 
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intergenerational transmission, directly or as a precursor form of specific miRNAs. Further 
experiments are necessary to confirm this new role of snoRNAs.  
Moreover, piRNAs are small structures (20-30 nucleotides) highly expressed in the germline of 
several species (Fu & Wang, 2014; Klattenhoff & Theurkauf, 2008). The primary function of 
these small RNAs is to silence the transposable elements during germ cell development in order 
to maintain the integrity of the genome (A. A. Aravin, Hannon, & Brennecke, 2007; Fu & Wang, 
2014; Ghildiyal & Zamore, 2009; Grivna, Beyret, Wang, & Lin, 2006; Siomi, Sato, Pezic, & 
Aravin, 2011). These structures also have been related to the silence of imprinted genes and 
regulation of translation (Gou et al., 2015; Lim, Tao, & Kai, 2009; Morazzani, Wiley, Murreddu, 
Adelman, & Myles, 2012; Rouget et al., 2010; Watanabe et al., 2011). Few studies have 
described the potential role of piRNAs in intergenerational inheritance (Ashe et al., 2012; 
Brennecke et al., 2008; Le Thomas et al., 2014). Some studies in Drosophila suggest that the 
process of piRNA biogenesis was regulated by specific transgenerational inherited maternal 
piRNAs (Grentzinger et al., 2012; Le Thomas et al., 2014). Besides, the alteration of piRNA 
pathways led to DNA damage and meiotic arrest (Carmell et al., 2007; Kuramochi-Miyagawa et 
al., 2004; Shoji et al., 2009). In the present study, specific piRNAs were overexpressed in the 
sperm of APPPS1-21 transgenic fathers, which means that the population of piRNAs transmitted 
varies. Since most of the piRNAs map unique sites in the genome and are necessary for 
silencing homolog transposable elements (TE) (Brennecke et al., 2007; Gainetdinov, 
Skvortsova, Kondratieva, Funikov, & Azhikina, 2017; Klattenhoff et al., 2009), it appears logical 
to think that alterations of the sperm piRNA population might promote a distinct silencing of TE, 
altering the development process. Moreover, some piRNAs have been involved in 
posttranscriptional regulation of mRNAs (Gou et al., 2015; Lim et al., 2009; Morazzani et al., 
2012; Rouget et al., 2010; Watanabe et al., 2011). Specific piRNAs interact with the embryonic 
posterior morphogen Nanos promoting deadenylation and mRNA decay in Drosophila embryos 
(Rouget et al., 2010). I speculate that different piRNAs populations regulate differently the 
expression of specific genes inducing changes in cognitive skills of APPPS1-21 offspring 
cognitive skills. An experiment that could provide new information about the role of these specific 
piRNAs in intergenerational transmission would be the following: the injection of antisense 
inhibitors of the single piRNAs detected in the sperm of APPPS1-21 tg mice in fertilized oocytes 
and the study of the development process and the behavior phenotype at adult age.  
It’s early to indicate a direct association between these small RNA structures and previously 
described changes in the cognition abilities and the cellular state of wild-type mice born to 
APPPS1-21 transgenic fathers.  Further investigations need to be performed. One interesting 
future experiment would be to microinject the combination of the overexpressed small RNAs in 
the sperm of APPPS1-21 transgenic fathers into wild-type fertilized oocytes and study the 
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cognitive abilities of the offspring (Benito et al., 2018; Rodgers et al., 2015). A previous study 
showed that the injection of a combination of miRNAs obtained from stressed father sperm 
promoted a similar stress phenotype than the paternal stressed offspring (Rodgers et al., 2015). 
It will thus be interesting to observe whether the microinjection of a specific combination of small 
RNAs from APPPS1-21 transgenic fathers would promote similar cognitive response and 
transcriptomic changes in the injected offspring than the APPPS1-21 offspring. Additionally, it 
would be important to study the effect of single piRNA and snoRNA microinjection.  
The specific molecular mechanism by which the sperm small RNAs may communicate the 
cognitive phenotype to an adult offspring is not clear. One could think that these small RNAs 
initiate a cascade of changes that stimulate different epigenetic or gene expression patterns 
during development promoting alterations of learning skills into adult offspring (Rodgers et al., 
2015; Skinner, 2011b). Previous data suggested that specific patterns of DNA methylation in the 
male germline were maintained in the brain of the offspring (Franklin et al., 2010).  
Moreover, the intergenerational inheritance of cognitive deficits induced by a genetic transgene 
probable also involves another kind of epigenetic factors, such as DNA methylation of histone 
modifications. These epigenetic factors have been implicated in distinct forms of 
intergenerational inheritance (Brykczynska et al., 2010; Guerrero-Bosagna et al., 2012; 
Hammoud et al., 2009; Siklenka et al., 2015; Wei et al., 2014). Thus, it is important to investigate 
in the future the role of these epigenetic factors in the transmission of the cognitive phenotype 
associated with the APP and PS1 transgene.  
Other interesting questions that need to be answered are: how APP and PS1 double mutation 
explicitly affects the non-genetic factors that are transmitted in the germline and when it 
happens? How alteration in the germline remains stable over the time? How epigenetic 
information affects specific cells and tissues from the organism and not others? And finally, how 
phenotypic alteration stays over the time? 
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5.3.Inter-individual differences in cognitive performance and 
associated molecular pathways in aging mice 
5.3.1.Inter-individual differences in cognitive performance 
Life expectancy is globally increasing and hence, age-related diseases, such as 
neurodegenerative diseases. Aging is the major risk factor for developing Alzheimer’s disease. 
Thus, it is crucial to properly understand age-related diseases and process of aging per se. 
Aging is a complex process that represents a progressive accumulation of molecular damage 
over the time, and therefore it is difficult to study. One of the reasons is that promotes multiple 
changes at different times and affects distinct manner on each individual, organ or cell type 
(Chahal & Drake, 2007; Denic, Glassock, & Rule, 2016; Gallagher et al., 2006; Lessard-
Beaudoin et al., 2016; Stark, Yassa, & Stark, 2010). This might because numerous factors have 
a repercussion to the process of aging, such as genetic and epigenetic factors or external 
environmental conditions (Bellizzi et al., 2005; Gami & Wolkow, 2006; Harrison et al., 2009; C. S. 
Kim, Park, & Kim, 2017; Oh et al., 2018; v et al., 2006). 
It was demonstrated that environmental factors could profoundly impact the process of aging, 
promoting a distinct severity level of aging and inducing more or less severe consequences 
(Harrison et al., 2009; Solon-Biet et al., 2014; Strasser, Volaklis, Fuchs, & Burtscher, 2018). One 
of the acute effects of aging is cognitive impairment. Cognitive abilities vary between individuals 
during all life, but the inter-individual variability increases significantly with age (Gallagher et al., 
2006; Koivisto et al., 1995; Stark et al., 2010). Young mice show less variability in a specific 
cognitive task than old mice. Thus, I used mice at late middle age, 17 months of age, in order to 
evaluate their variability in cognitive abilities. Observing the averaged mice, the old mice showed 
more difficulties in learning the task than young mice (3 months of age). Evaluating individual 
behaviors, I discovered that there was a substantial variation in cognitive abilities during the 
acquisition and learning of a spatial memory task, even these mice grew in same environmental 
conditions. Some mice learned the spatial task (“good” performers), whereas others they did not 
learn spatial task (“bad” performers). This high variability was observed in two different spatial 
tasks, Morris water maze and Barnes maze, and none of the cases were correlated to motor 
abilities or anxiety levels (Figures4.3.2 and 4.3.5). This data confirms that old mice show higher 
cognitive variability for a specific spatial task than young mice. This variance existed even they 
were mice from the same line, age and grew in same conditions. 
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5.3.2. Differences in the transcriptional profiling and functional 
pathways of aged “good” and “bad” performers 
Aging is triggered by several molecular changes, and the analysis of the transcriptome allows to 
obtain a first overview of these changes. Previous studies identified specific pathways that 
commonly change with aging in different aged species (from yeast to humans). These pathways 
were involved in protein metabolism, immune system, energy metabolism, growth factor 
signaling, gene expression and mRNA processing (Frenk & Houseley, 2018). The strong 
alteration of the transcriptome was in agreement with several theories arguing that during aging 
there is an increase of senescence and inflammation increase of senescence and inflammation, 
reduction of respiratory chain activity, dysfunction of mitochondria and decrease of ribosome 
biogenesis (Bratic & Larsson, 2013). Several of these studies have investigated the molecular 
state of old mice comparing them to young individuals or assessing them at different ages (Bors 
et al., 2018; de Magalhaes et al., 2009; Glass et al., 2013; Verbitsky et al., 2004; Yang et al., 
2015). Here, I analyzed transcriptome changes by comparing aged-individuals of the same age 
with different cognitive abilities, good (intact cognition) and bad performers (impaired cognition). 
Since the spatial memory explicitly involved the hippocampus (Logue, Paylor, & Wehner, 1997), I 
investigated the transcriptomic profile and functional pathways of the hippocampus subregions 
(CA1, CA3 and DG). A little number of statistical transcriptomic differences was identified 
between “good” and “bad” performers in all hippocampal regions (Figure 4.3.8). Analyzing the 
gene set enrichment of these performers, I detected several functional changes in all the 
hippocampus subregions, as shown in figures 4.3.9-11).   
In CA1 and DG subregions of bad performers, I was able to identify the down-regulation of 
genes defined as the hallmarks of aging (Frenk & Houseley, 2018), such as genes related to 
mitochondria activity, protein synthesis machinery and RNA metabolic process. The down-
regulation of genes related to mitochondria function and ribosome biogenesis has been highly 
characterized in several tissues from different aged-species 277,280-285. In contrast, I did not 
report a clear increase expression in CA1 and DG regions of bad performers of others hallmarks 
of aging, which were the immune system, inflammatory response and heat shock factors (C. K. 
Lee et al., 2000; T. Lu et al., 2004; Peters et al., 2015). The absence of altered immune and 
inflammatory pathways in CA1 and DG regions of bad performers might be to the fact that genes 
associated with these processes were altered in both age-groups, good and bad performers, 
and were not dependent on cognitive abilities.  Thus, I was not able to identify these categories 
of genes in CA1 and DG regions when I compared bad to good performers. Only the CA3 region 
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of bad performers showed an alteration of genes related to inflammatory response, immune 
system and apoptotic process.  
In summary, aged-mice showed a high cognitive inter-individual variability, which allowed me to 
identify good (intact cognition) and bad (impaired cognition) performers. In this approach, I was 
able to detect differentially expressed genes that were previously linked to age process. 
However, to the best of my knowledge, this work is the first to show that aging genes are 
specifically connected to aged-mice with severe cognitive impairments. 
5.3.3.Detection of biomarkers to screen cognitive abilities 
Several environmental factors influence the process of aging (Bellizzi et al., 2005; Gami & 
Wolkow, 2006; Harrison et al., 2009; C. S. Kim et al., 2017; Oh et al., 2018; v et al., 2006). Here, 
I observed that those identical mice at the same age and grown in the same environmental 
conditions showed different cognitive abilities. Even these external conditions were well 
controlled; probably uncontrolled factors still stimulated the cognitive variability between 
individuals.  
Moreover, several studies aimed to identify markers that allow the early detection of distinct 
pathologies (Hampel et al., 2010; Shaw, Korecka, Clark, Lee, & Trojanowski, 2007). Here, I 
wondered whether there would be a specific biomarker in the blood to detect in non-invasive 
manner the cognitive abilities of aged-individuals, specifically aged-mice. Several studies on the 
identification of biomarkers of aged-cognitive decline or cognitive deficits associated with 
Alzheimer’s disease have been focused on imaging (PET amyloid imaging or structural MRI) 
and CSF measurements (Sonnen et al., 2008; Wicklund & Petersen, 2013). Some studies proof 
that epigenetic factors or non-coding RNAs were useful markers for the diagnosis of specific 
diseases (Lopez et al., 2015; Rao et al., 2013; Zhao, Bhattacharjee, Dua, Alexandrov, & Lukiw, 
2015). Thus, I evaluated the expression of small RNAs in the blood of mice with intact (good 
performers) and impaired cognition (bad performers). I was able to identify some small RNAs 
that were statistically different in the blood of good and bad performers, as shown in figure 
4.3.12.  To note, down-regulated small RNAs in bad performers target genes related to nervous 
system development, catabolic processes and ossification, whereas enriched small RNAs in bad 
performers target genes linked to immune system development and response to cytokines 
(Figure 4.3.12). From these small RNAs I could identify potential candidates for the detection of 
cognition abilities.  I detected different expression levels between good and bad performers of 
miRNA-501-3p, miRNA-100-5p, miRNA-664-3p and miRNA-146-5p (Figure 4.3.12). These 
miRNAs were down-regulated specifically in aged-mice with cognitive deficits (bad performers). 
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All of them have previously been involved in interesting pathways or pathologies. The 
expression of miRNA501-3p was down-regulated in the serum of AD patients and up-regulated 
in the brain of the same patients (N. Hara et al., 2017). MiRNA-100-5p bound to mTOR 
transcript promoting changes in neuronal survival in the cortex of AD mouse model (Ye et al., 
2015). MicroRNA-664-3p has also been related to mTOR pathways and involved in longevity 
processes (B. P. Lee et al., 2017). The expression of miRNA146a-5p was implicated in 
inflammatory signaling in neurodegenerative pathologies.  
Although these are preliminary results and further research is necessary, I was able to identify 






Alzheimer’s disease (AD) is a neurodegenerative disease and the most common form of 
dementia. The number of AD cases increases exponentially every year (Prince et al., 2015). 
Although AD has been investigated for a long time, the precise molecular mechanisms involved 
remain to be elucidated, especially at early stages of the pathology. Furthermore, a cure does 
not exist to date. The treatments currently available are administered too late and are only 
temporarily effective for certain dementia-associated symptoms. These difficulties to discover an 
effective treatment are probably due to the complexity of the pathological process. There is 
emerging evidence that AD pathology is affected by the combination of several factors, such as 
genetic and environmental factors (W. Shao et al., 2017; A. R. Smith, Mill, Smith, & Lunnon, 
2016). Changes in gene expression have an impact on the progression of the pathology 
(Bossers et al., 2010; J. Lee et al., 2018; Parra-Damas et al., 2014). Thus, it is necessary to 
investigate the role of gene expression at early stages in the pathology in order to diagnose and 
begin treatment earlier. Several of the new drugs are firstly tested in AD mouse models. It is 
therefore of great importance to define in detail transcriptional profile changes in these models. 
Here, I provided new insights into changes in gene expression at different contexts of cognitive 
deficits.  
First, I assessed the behavioral phenotype, transcriptional state and alternative exon usage 
related to early AD stages in APPPS1-21 mice, a well-established model of AD-like pathology. 
The present results indicate that APPPS1-21 transgenic males and females develop an 
undistinguishable rapid progression of AD, showing cognitive impairments restricted to spatial 
memory at 3 months of age. Cognitive deficits declined with age, and mice performed worse in 
spatial learning and memory test at 9 months of age, compared to their 3-month old 
counterparts. Moreover, APPPS1-21 hippocampal subregions (CA1 and DG) showed gender- 
and subregion-specific changes in gene expression and alternative exon usage already at 3 
months of age. Despite the fact that APPPS1-21 hippocampal subregions and genders showed 
transcriptomic differences at the individual level, similar global biological processes were 
affected in these hippocampal subregions. The findings of this study reveal that two global 
processes occur in the APPPS1-21 hippocampal subregions at 3 months of age. First, there is 
an activation of genes involved in compensatory mechanisms, presumably as an attempt to 
return to a non-pathological status (increased of synaptic activity and neurogenesis). Second, 
and due to the fast progression of the disease in this model, there is a deregulation of pathways 
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SUMMARY
typically altered in late AD stages, such as energy metabolism and protein synthesis. Restoring 
the mitochondrial and ribosomal functions might be a promising therapeutic strategy to treat the 
AD-related memory decline. 
In this study I also identified for the first time a gender-specific transmission to F1 offspring of 
epigenetic factors induced by the paternal origin in the APPPS1-21 mouse model, promoting 
cognitive and genetic changes to F1. There is increasing evidence that epigenetic information 
complements the genetic inheritance from parents to the offspring (Blake & Watson, 2016; 
Zeybel et al., 2012). The described findings uniquely revealed that wild-type offspring of 
APPPS1-21 transgenic fathers, but not mothers, showed spatial cognitive impairments, 
transcriptomic changes and alternative exon usage at 3 and 9 months of age (only behavior). 
These changes were associated with specific expression of small RNAs in the sperm. It is 
interesting to note that the majority of small RNAs expressed in APPPS1-21 transgenic fathers 
were small nuclear RNAs (snoRNAs) and Piwi-interacting RNAs (piRNAs). Hence, it is the first 
time to my knowledge that snoRNAs and piRNAs are described as potential transmitters of 
intergenerational inheritance. These data provide evidence for the existence of new factors that 
contribute to the phenotype of wild-type and transgenic mice born to APPPS1-21 transgenic 
parents. This novel information is crucial to take into account when analyzing the behavioral 
phenotype and for future colony breeding strategies of this mouse model and potentially also 
other transgenic lines. It will be essential in the future to complement the genetic information with 
epigenetic information in animal breeding. 
Finally, I identified genes and pathways altered exclusively in aged mice that showed cognitive 
deficits but not in aged mice with intact cognitive abilities. Aging is the major risk for developing 
Alzheimer’s disease (AD). Thus, it is logical to think that aged mice with cognitive deficits will 
share more molecular alterations with AD mice than aged-mice with intact cognitive abilities. I 
demonstrated that old mice (17 months of age) showed higher inter-individual variability in 
performance than young animals.  From these individuals, I preselect aged mice with and 
without cognitive deficits. Interestingly, hippocampal brain subregions of cognitive impaired 
aged-mice showed deregulation of biological processes previously defined as hallmarks of 
aging, such as energy metabolism, protein synthesis and RNA metabolism. The present data 
indicate that deregulation of these pathways affects specifically aged mice with cognitive deficits. 
Moreover, I identified specific small RNAs expressed in the blood that correlate with age-
cognitive variability. These findings suggest that they can be used as biomarkers for the 
evaluation of cognitive abilities. 
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SUMMARY
In this thesis, I described several molecular pathways related to cognitive decline and potential 
candidates for future treatments of cognitive deficits associated with aging or Alzheimer’s 
disease. Moreover, I detected potential biomarkers in the blood to evaluate the cognitive abilities 
in mice in a non-invasive manner.  
Furthermore, I identified for the first time novel forms of small RNAs that are associated with the 
transmission of behavioral and molecular changes in wild-type offspring induced by the 
transgenic parental genotype in a gender-specific manner. This present study raises new issues 
to consider when mating transgenic mice, defining an appropriate control group and interpreting 
behavioral results. 
  
Figure 6.1. Summary of the data described in the three approaches from this thesis.  
(A) Changes in cognition, transcription and exon usage in an early AD stage in an APPPS1-21 mouse 
model. (B) Gender-specific transmission of epigenetic factors by the paternal origin in the APPPS1-21 
mouse model, promoting cognitive and genetic changes to F1. (C) Inter-individual variability in aged mice 
and gene expression changes associated with aged mice that presented cognitive deficits. Identification of 












































































































































































































































































































































Appendix figure 1. Male and female wt and tg mice born to APPPS1-21 transgenic fathers or 
mothers did not show motor abilities and anxiety level differences, except for APPPS1-21 tg 
females that showed an slight increase in their motor abilities.  
Open field test in male and female wild-type and transgenic mice born to a transgenic father (wttgwt M 
(n=17) and F (n=15) and tgtgwt M (n=13) and F (n=14)) or mother (wtwttg M (n=17) and F (n=15) and tgwttg M 
(n=7) and F (n=9)) and control wild-type mice (wtwtwt M (n=18) and F (n=16)) at 3 months of age. (A and 
B) Total traveled distance (A) and average speed (B) during the open field test. (C, D and E) Percentage 
of time (C) and distance (D) spent in the central area of the field and number of visits to the center (E). M 
= male. F = female. Student’s two-tailed T test, ns = no significant differences; **P < 0.01; ***P < 0.001; 
****P < 0.0001. Error bars indicated SEM.  
 
Appendix figure 2. Male and female wt and tg mice born to APPPS1-21 transgenic fathers or 
mothers did not show differences in learning a spatial task at 3 months of age.  
Morris water maze (MWM) in male and female wild-type and transgenic mice born to a transgenic father 
(wttgwt M (n=18) and F (n=12) and tgtgwt M (n=13) and F (n=12)) or mother (wtwttg M (n=11) and F (n=7) and 
tgwttg M (n=10) and F (n=7)) and control wild-type mice (wtwtwt M (n=16) and F (n=14)) at 3 months of age. 
(A, C, E, G and I) male vs. female group-average time to find the target platform on each consecutive 
training day (Day 1-8). Two-way ANOVA after Sidak correction, *P < 0.05; **P < 0.01. The dashed line 
represents chance level of 25%. First probe trial (PT1, day 6) and second probe trial (PT2, day 10). (B, D, 
F, H and J) Comparison of male and females of each group equivalents analyzing the areas under the 
learning curves (AUC) of escape latency for each group. M = male. F = female. Student’s two-tailed T test, 
ns = no significant differences; **P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. Error bars indicated 
SEM. 
 184













0.051 ns ns ns ns
















ns ns ns ns ns


















ns ns ns ns *















ns ns ns * 0.073













ns ns ns ** 0.065
M F M FM F M F M F
A B C D E
APPENDIX
Appendix figure 3. Male and female wt and tg mice born to APPPS1-21 transgenic fathers 
or mothers did not show differences in spatial memory at 3 months of age.  
Morris water maze (MWM) in male and female wild-type and transgenic mice born to a transgenic father 
(wttgwt M (n=18) and F (n=12) and tgtgwt M (n=13) and F (n=12)) or mother (wtwttg M (n=11) and F (n=7) and 
tgwttg M (n=10) and F (n=7)) and control wild-type mice (wtwtwt M (n=16) and F (n=14)) at 3 months of age. 
(A-L) Percentage of time (A and C) and distance (B and D) spent on the target quadrant between male 
(M) and female (F) mice during first probe trial (PT1, day 6) (A and B) and second probe trial (PT2, day 
10) (C and D). M = male and F = female. Student’s two-tailed T test, ns = no significant differences; *P < 
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APPENDIX
Appendix Figure 4. Male and female wt and tg mice born to APPPS1-21 transgenic fathers or 
mothers did not show differences in fear conditioning at 3 months of age. 
Fear conditioning (FC) in male and female wild-type and transgenic mice born to a transgenic father (wttgwt 
M (n=20) and F (n=15) and tgtgwt M (n=14) and F (n=14)) or mother (wtwttg M (n=17) and F (n=7) and tgwttg 
M (n=10) and F (n=9)) and control wild-type mice (wtwtwt M (n=18) and F (n=16)) at 3 months of age. (A) 
Average of motion during training day. (B and C) Percentage of time (B) and time (C) freezing during 
training (first column) and testing day (second column). M= male. F= female. Student’s two-tailed T test, 
ns = no significant differences; *P < 0.05; **P < 0.01. Error bars indicated SEM. 
Appendix Figure 5. Male and female wt and tg mice born to APPPS1-21 transgenic fathers or 
mothers did not show differences in motor abilities and anxiety level at 9 months of age. 
Open field test in male and female wild-type and transgenic mice born to a transgenic father (wttgwt M 
(n=18) and F (n=13) and tgtgwt M (n=14) and F (n=8)) or mother (wtwttg M (n=5) and F (n=2) and tgwttg M 
(n=1) and F (n=3)) and control wild-type mice (wtwtwt M (n=16) and F (n=15)) at 9 months of age. (A and 
B) Total traveled distance (A) and average speed (B) during the open field test. (C, D and E) Percentage 
of time (C) and distance (D) spent in the central area of the field and number of visits to the center (E). M 
= male. F = female. Student’s two-tailed T test, ns = no significant differences; **P < 0.01; ***P < 0.001; 













































80ns ns ns ns ns ns ns ns ns ns ns ns ns ns ns
M F M FM F M F M F M F M FM F M F M F M F M FM F M F M F
wt wtwt wt tgwt wt wttg tg tgwt tg wttg
A B C













ns ns ns ns
















** ns ns ns


















** ns ns ns















ns 0.061 ns 0.061
M F M FM F M F M F












8 ns ns0.061 0.061
M F M FM F M F M F
E
APPENDIX
Appendix Figure 6. Male and female wt and tg mice born to APPPS1-21 transgenic fathers or 
mothers did not show differences in learning a spatial task at 9 months of age.  
Morris water maze (MWM) in male and female wild-type and transgenic mice born to a transgenic father 
(wttgwt M (n=16) and F (n=10) and tgtgwt M (n=13) and F (n=7)) or mother (wtwttg M (n=5) and F (n=1) and 
tgwttg M (n=1) and F (n=3)) and control wild-type mice (wtwtwt M (n=14) and F (n=12)) at 9 months of age. 
(A, C, E, G and I) male vs. female group-average time to find the target platform on each consecutive 
training day (Day 1-8). Two-way ANOVA after Sidak correction, *P < 0.05; **P < 0.01. The dashed line 
represents chance level of 25%. First probe trial (PT1, day 6) and second probe trial (PT2, day 10). (B, D, 
F, H and J) Comparison of male and females of each group equivalents analyzing the areas under the 
learning curves (AUC) of escape latency for each group. M = male. F = female. Student’s two-tailed T test, 
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Appendix figure 7. Male and female wt and tg mice born to APPPS1-21 transgenic fathers or 
mothers did not show differences in spatial memory at 9 months of age.  
Morris water maze (MWM) in male and female wild-type and transgenic mice born to a transgenic father 
(wttgwt M (n=16) and F (n=10) and tgtgwt M (n=13) and F (n=7)) or mother (wtwttg M (n=5) and F (n=1) and 
tgwttg M (n=1) and F (n=3)) and control wild-type mice (wtwtwt M (n=14) and F (n=12)) at 9 months of age. 
(A-L) Percentage of time (A and C) and distance (B and D) spent on the target quadrant between male 
(M) and female (F) mice during first probe trial (PT1, day 6) (A and B) and second probe trial (PT2, day 
10) (C and D). M = male and F = female. Student’s two-tailed T test, ns = no significant differences; *P < 
0.05; **P < 0.01. The dashed line represents chance level of 25%. 
Appendix figure 8. Male and female wt and tg mice born to APPPS1-21 transgenic fathers or 
mothers did not show differences in fear conditioning at 9 months of age.  
Fear conditioning (FC) in male and female wild-type and transgenic mice born to a transgenic father (wttgwt 
M (n=19) and F (n=12) and tgtgwt M (n=12) and F (n=6)) or mother (wtwttg M (n=5) and F (n=2) and tgwttg M 
(n=1) and F (n=3)) and control wild-type mice (wtwtwt M (n=14) and F (n=15)) at 3 months of age. (A) 
Average of motion during training day. (B and C) Percentage of time (B) and time (C) freezing during 
training (first column) and testing day (second column). M= male. F= female. Student’s two-tailed T test, 
ns = no significant differences; *P < 0.05; **P < 0.01. Error bars indicated SEM. 
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APPENDIX
Appendix table 1. Significant alternative exon usage of App, Ps1 and Mapt genes from male and 
female DG and male CA1 of APPPS1-21 transgenic mice compared to control wild-types (wtwtwt).  
Exon usage, padj ≤ 0.05, log2FC±0.25. For DG males:  tg n=4 and wtwtwt n=5; for DG females tg n=7 and 
wtwtwt n=5 and for CA1 males tg n=6 and wtwtwt n=6. 
Appendix table 2. Variability between tg mice born to an APPPS1-21 tg father or mother and 
between APPPS1-21 tg mice together and control wild-type (wtwtwt) mice.  
Percentage of gene expression compared to the total transcriptome analyzed (48710 mRNAs) in male and 
female DG and male CA1 in tg vs. wtwtwt and in tgtgwt vs. tgwttg comparison. Padj ≤ 0.05, log2FC ± 0.25. For 
DG males: transgenic (tgtgwt and tgwttg) n = 1,3 and wtwtwt n= 5; for DG females transgenic (tgtgwt and tgwttg) 




E009 (-0.741), E008 (-0.475), E010 (-0.448), E007 (-0.410), E006 
(-0.143), E004 (-0.110), E005 (0.428), E002 (0.536)
Ps1 E004 (-0.816), E008 (-0.681), E009 (-1.372), E010 (-0.331), E011 
(1.222), E012 (-0.718), E013 (1.483), E014 (1.581)
Mapt E012 (-0.595)
DG males
APP E016 (-1.215), E009 (-0.813), E010 (-0.755), E008 (-0.470), E007 
(-0.334), E002 (0.491), E016 (-1.215)
Ps1 E004 (-0.780), E008 (-0.844), E009 (-1.229), E010 (-0.392), E012 
(-0.622), E013 (0.950), E014 (1.0361)




App E009 (-0.968), E010 (-0.761), E008 (-0.513), E007 (-0.502), E006 
(-0.222), E004 (-0.145), E005 (0.438), E002 (0.592), E009 
(-0.968)
Ps1 E004 (-0.655), E008 (-0.948), E009 (-1.398), E010 (-0.292), E012 
(-0.541), E013 (1.062), E014 (1.188)








% DE mRNAs 
in 
tgtgwt vs. tgwttg
DG males 0.4 2.8
DG females 0.006 3.3
CA1 males 0.05 0.11
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Appendix table 3. Top differentially expressed genes in male and female DG and male CA1 of 
APPPS1-21 transgenic mice. 
Genes, padj ≤ 0.05; log2FC ± 0.25 and pathways, pval < 0.05. (D-F) Top 20 significant functional pathways 
ranked by -log pval after Benjamini-Hochberg correction of significant differentially expressed genes in 
brain subregions of wttgwt vs. wtwtwt mice. Genes, padj ≤ 0.05; log2FC ± 0.25 and pathways, pval < 0.05. 
For DG males: transgenic tg n = 4 and wtwtwt n= 5; for DG females tg n=7 and wtwtwt n=5 and for CA1 




Up Kcnk9 (1.321), Slc17a6 (1.227), Dcc (1.205), Gpr165 (1.187), 
Plcxd3 (1.185), Gh (1.173), Pde11a (1.165), Lancl3 (1.155), 
Cntnap3 (1.137), Igsf9b (1.135), Xkr4 (1.118), Pcsk1 (1.116), 
Lmbrd2 (1.098), Ppargc1b ( 1.056), Tenm3 (1.052), Ston2 (0.899),
Do
wn
Cox4 (-0.470), Mrpl20 (-0.450), Ndufa3 (-0.542), Clec2d (-0.757), 
Adam8 (-0.769), Slc38a5 (-0.771), Ovgp1 (-0.798), Mir703 (-0.815), 




Up Cst7 (1.302), Erich5(1.158), Gm44724 (1.145), Ncam2 (1.021), 
Thy1 (1.017), Ston2 (0.952), Ptchd1 (0.941), Hist2h (40.935), 




Mrpl2 (-0.389), Ndufa1 (-0.397), Ndufa3 (-0.445),  Daw1 
(-1.051),Dnah10 (-1.058), Folr1 (-1.060), 2410004P03Rik (-1.060), 





Up Thy1 (1.230), Psen1 (0.746), App (0.601), Tenm3 (0.482), Pcdhgb1 
(0.477), Kcnh5 (0.457), Pcdhga6 (0.436), Kcnk9 (0.425), Igsf9b 
(0.420), Klf12 (0.412),Cdh6 (0.410),  Hs6st3 (0.403),
Do
wn
Gm44891 (-0.444), A230103L15Rik (-0.447), Gm37999 (-0.449), 
Gm42970 (-0.451), Gm42769 (-0.453), Gm44677 




Appendix table 4. Top 10 genes that had a significant alternative exon usage in male and female 
DG and male CA1 of APPPS1-21 transgenic mice.  
Top 10 significant differentially spliced genes in in male and female DG and male CA1 of wtgtgwt mice 
compared to wtwtwt mice ranked by log2FC. Genes, padj ≤ 0.05; log2FC ± 0.25. For DG males: wttgwt n=7 
and wtwtwt n=5; for DG females wttgwt n=5 and wtwtwt n=5 and for CA1 males wttgwt n=7 and wtwtwt n=6. 
Appendix table 5. Top 10 genes that had a significant alternative exon usage in male and female 
DG and male CA1 of wild-type mice born to APPPS1-21 transgenic fathers.  
Top 10 significant differentially spliced genes in in male and female DG and male CA1 of wtgtgwt mice 
compared to wtwtwt mice ranked by log2FC. Genes, padj ≤ 0.05; log2FC ± 0.25. For DG males: wttgwt n=7 





Inclusion Rapgef4 (2.978),Csmd1 (2.194),Slc6a9 (2.165),  Dock3 
(2.057),Babam2 (2.056), Cdk16 (1.948),Npff (1.843),
()Atp6ap1 (1.815),Limk1 (1.769), 
Exclusion Gabbr1 (-1.840), Ptbp2 (-1.845),Mcm3ap (-1.900),  
Nrxn1 (-1.924), Arhgap4 (-1.925), Ptprg (-1.972),Dlgap4 




Inclusion Mir8108 (2.233),Dnm3 (2.192),Mtif2 (2.114),  Lama4 
(2.107),Nrxn3 (2.044),Mapk1ip1l (2.018),Dennd4c 
(2.008),Synj1 (1.973),Myof (1.954),Synj1 (1.954), 
Exclusion Arcn1 (-2.993),  Xpr1 (-3.003),  Cbl (-3.035),  Tbc1d8b  
(-3.133), Stra6(-3.195), Iars2 (-3.338),  Cacna1b 





Inclusion Nrxn3 (3.097),  Frmd4a (2.255),  Psen1 (1.581),  Epha7 
(1.552),  Tom1l2 (1.516), Psen1 ()1.483,  Vwf (1.390),  
Cbl (1.287), Nsf (1.237),  Psen1 (1.222)
Exclusion Atp1a2 (-1.280),  Map1a (-1.282),  Ptprz1 (-1.285),   
Farp1 (-1.348),  Cfh (-1.361),  Psen1 (-1.372), Nr4a1 





Inclusion Cd200 (1.927),Gabrb3 (1.894),4930447C04Rik (1.598),  
Hace1 (1.575),Tut4 (1.401),Rnf213 (1.335),A830018L16Rik 
(1.320),Spock3 (1.278),Tmem237 (1.273),C530008M17Rik 
(1.262),  
Exclusion Wdr13 (-1.674),Stambp (-1.686),Tns1 (-1.690),Sbf1 
(-1.690),Irak2 (-1.705),Ptpru (-1.714),Rab10os 




Inclusion Hook3 (2.870),Mir8108 (2.509),Ppfia1 (2.456),  Nrxn3 
(2.290),Pms2 (2.249),Unc80 (2.183),Scn2a 
(2.115),Dennd1b (2.105),Stxbp1 (2.103),Fank1 (2.066), 
Exclusion Srrm4 (-2.741),Maz (-2.758),Crim1 (-2.781),Gabrg1 
(-2.787),Paf1 (-2.787),Tnks1bp1 (-2.868),Tbc1d8b 





Inclusion Dlgap1 (0.654),Brat1 (0.648),Fbrsl1 (0.624),Rabl6 
(0.584),Htt (0.559),Gabra2 (0.556),Angptl4 (0.550),Smc6 
(0.515),Hyou1 (0.513),Rps4x (0.512), 
Exclusion Arhgap23 (-0.571),Agpat1 (-0.594),Crym (-0.596),Ppdpf 
(-0.667),Lmo4 (-0.687),Arhgef4 (-0.694),Dynll1 
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